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Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to 
infection. The inflammatory response is an integral part of sepsis and leads to the systemic 
inflammatory response syndrome (SIRS) and multiple organ failure. The overall objective of 
this thesis was to investigate whether hydrogen sulfide (H2S), substance P (SP) and Kupffer 
cells modulate the inflammatory response, organ damage and liver sinusoidal endothelial 
cells (LSECs) fenestrations in sepsis.  
H2S is a key mediator of inflammation and recent studies have implicated H2S in the 
pathogenesis of sepsis. However, these studies have limitations due to the disadvantages of 
the H2S-synthesising enzyme inhibitor and H2S donors used to conduct the experiments. 
Gene deletion technology offers a definitive approach to investigate the role of H2S in sepsis. 
The aim of this thesis was to investigate the potential role of endogenous H2S synthesised 
through cystathionine-γ-lyase (CSE) using CSE knockout (CSE KO) mice in caecal-ligation and 
puncture (CLP)-induced sepsis. This thesis also aimed to examine the underlying mechanisms 
by which CSE-derived H2S regulates inflammation and to determine the interaction between 
H2S and SP in regulating the inflammatory response in sepsis.  
Kupffer cells are tissue-resident macrophages in the liver that play an important role in 
inflammation associated with infection. The studies described in this thesis investigated the 
potential roles of Kupffer cells on liver and lung injury, inflammation and the systemic 
inflammatory response in sepsis using gadolinium chloride (GdCl3) to inactivate these cells. 
LSECs are specialised fenestrated endothelial cells in the liver that undergo structural 
alteration during inflammation and infection. The structural alterations in LSEC fenestrae 
iii 
 
following CLP-induced sepsis were examined and the effect of GdCl3, CSE gene deletion and 
PPTA gene deletion (PPTA, a SP encoding gene) were determined.  
The final aim was to investigate the alteration of circulatory H2S and SP levels and their 
association with the inflammatory response in patients with sepsis compared to non-septic 
patients with similar disease severity and organ dysfunction admitted to the hospital 
Intensive Care Unit (ICU).  
Following CLP-induced sepsis in mice, increased expression of liver and lung CSE (liver: ~1.98 
fold; lung: ~2.49 fold), increased liver H2S-synthesising activity (~1.27 fold) and plasma H2S 
levels (~1.45 fold) were observed. Mice deficient in the CSE gene showed significantly 
reduced sepsis-associated tissue (liver and lung) myeloperoxidase (MPO) activity, tissue 
(liver and lung) and circulatory levels of cytokines (TNF-α, IL-6 and IL-1β) and chemokines 
(MCP-1 and MIP-2α), and histological changes in the liver and lung. In addition, mechanistic 
studies revealed that the proinflammatory role of CSE-derived H2S was mediated by the 
activation of the ERK1/2-NF-B p65 signalling pathway. SP and NK-1R expression have been 
shown to play an essential role in sepsis-associated liver and lung injury. Mice with CSE gene 
deletion had significantly reduced tissue (liver and lung) and circulatory SP levels (liver: ~0.50 
fold; lung: ~0.42 fold; plasma: ~0.61 fold) and tissue (liver and lung) NK-1R expression (liver: 
~1.11 fold; lung: ~0.93 fold). This study showed that CSE-derived H2S in sepsis could 
upregulate SP and NK-1R expression, thereby contributing to liver and lung injury and 
inflammation. 
Examination of the effect of GdCl3 on the inflammatory response and organ injury following 
induction of sepsis showed there was protection against injury in the liver, as there was 
reduced MPO activity, cytokine (TNF-α, IL-6 and IL-1β) and chemokine (MCP-1 and MIP-2α) 
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levels and histological changes in the liver. In contrast, administration of GdCl3 failed to 
reduce lung injury and inflammation (as there was no change in MPO activity, cytokine and 
chemokine levels and histological changes) and the systemic inflammatory response (as 
evidenced by no change in circulatory cytokines and chemokines) in sepsis.  
Study of LSEC fenestrae following induction of sepsis revealed that CLP-induced sepsis was 
associated with defenestration (decreased diameter, frequency and porosity) and gaps 
formation in LSEC fenestrae (~9 fold). Mice with CSE gene deletion, PPTA gene deletion and 
mice treated with GdCl3 showed less defenestration (increased diameter, frequency and 
porosity) and fewer gaps (~0.16 fold) in LSEC fenestrae following sepsis.  
Studies of septic patients admitted to the ICU showed higher circulatory levels of H2S and SP 
compared to non-septic patients, which correlated with the inflammatory response in septic 
patients.  
In conclusion, the results presented in this thesis have shown that the CSE-derived H2S, SP 
and Kupffer cells all play a key role in modulating inflammation, associated organ damage 
and LSEC fenestrae in experimental sepsis. This thesis has also shown that higher circulatory 
levels of H2S and SP are associated with inflammatory response in septic patients and are 
consistent with results from experimental sepsis, suggesting that CSE-derived H2S and SP 
play an important role in the inflammatory process of sepsis in both experimental and human 
sepsis. This study contributes to a better understanding of the pathogenesis of sepsis and 
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1.1 General introduction  
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host 
response to infection (1). The inflammatory response is an integral part of sepsis that leads 
to systemic inflammatory response syndrome (SIRS) and multiple organ failure. This literature 
review summarises the pathophysiology of sepsis, describing the mediators and cells involved 
as well as the underlying mechanisms and multiple organ failure during sepsis.  
Hydrogen sulfide (H2S) and substance P (SP) are known mediators of inflammation in sepsis. 
This review is focused on the physiological roles of H2S and SP and their pathological 
significance in sepsis. Kupffer cells are tissue resident macrophages in the liver. They are the 
primary responders to infection and act by engulfing pathogenic microorganisms and 
subsequently releasing a series of inflammatory mediators. This review discusses the 
pathophysiological role of Kupffer cells in inflammation and sepsis. Liver sinusoidal 
endothelial cells (LSECs) are specialised fenestrated endothelial cells in the liver and play a 
key role in the transfer of substrates from sinusoidal blood to the hepatic parenchyma 
through space of Disse. They are known to undergo structural alteration in different 
physiological and pathological conditions. This review also encompasses the physiological role 
of LSEC fenestrae and its alteration in different pathophysiological conditions including sepsis. 
Finally, based on the existing knowledge of H2S, SP, Kupffer cells and LSECs in sepsis, this 




1.2 Sepsis  
1.2.1 Definition and epidemiology  
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host 
response to infection. In lay terms, sepsis is a life-threatening condition that arises when the 
body’s response to an infection injures its own tissues and organs (1, 2). Septic shock is a 
subset of sepsis in which underlying circulatory, cellular and metabolic abnormalities are 
associated with a greater risk of mortality than with sepsis alone (2). The definitions of sepsis 
and septic shock have been unified considerably by the recommendations of the European 
Society of Intensive Care Medicine and the Society of Critical Care Medicine in 2016 (1, 2). 
Based on their recommendations, organ dysfunction during sepsis can be identified by the 
Sequential [Sepsis-related] Organ Failure Assessment (SOFA) Score (summarised in Table 1.1) 
(1-3). Despite advances in care, sepsis remains a major health problem worldwide and reports 
on incidence are increasing. This is likely to reflect ageing of the population, high rates of 
comorbidities that increase susceptibility to infection, and increasing numbers of 
immunocompromised patients such as those with malignancies, organ transplants or HIV 
infection (4-7). For instance, in the United States, sepsis incidence rates increased from 359 
cases per 100,000 population in 2003 to 535 cases per 100,000 population in 2009 (49% 
increase), accounting for more than $20 billion in costs and 5.2% of the total United States 
hospital costs in 2011 (4, 6, 8). Although the true incidence is unknown, conservative 
estimates indicate that sepsis is a leading cause of mortality and critical illness worldwide and 
in-hospital mortality rates remain high at 25-30% (4, 6). The scale and seriousness of this 




Table 1.1 Sequential [Sepsis-related] Organ Failure Assessment Score (adopted from Singer et al. 
2016) (1).  
 
1.2.2 Animal models of sepsis 
A number of animal models have been developed and modified to study the pathophysiology 
of sepsis (9, 10). They include exogenous administration of endotoxin lipopolysaccharide 
(LPS), alteration of the animal’s endogenous barrier to normal bacterial flora (caecal-ligation 
and puncture, CLP) and exogenous administration of various pathogens (intravenous (i.v.) 
infusion of live bacteria, administration of faecal matter into the peritoneal cavity and the 
placement of infectious foreign material into the soft tissue of extremity). All of these models 
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have contributed significantly to our understanding of mechanisms of sepsis pathophysiology. 
Although these models replicate many features of human sepsis, injection of LPS and caecal-
ligation and puncture surgery are the most commonly used animal models to study sepsis.  
Even though many researchers use administration of endotoxin LPS to study sepsis, the 
clinical features of human sepsis are quite different from LPS-induced endotoxaemia in mice 
and rats (10, 11). The kinetics and magnitude of hemodynamic changes and peritoneal and 
systemic cytokinemia in LPS-induced endotoxaemia do not accurately mimic the 
hemodynamic changes and cytokine levels of human sepsis (12, 13). For example, the 
hemodynamic response observed during LPS-induced endotoxaemia in mice is a 
hypodynamic response, as opposed to the hyperdynamic response observed in septic 
patients (9, 10). Changes in the serum cytokine profile are transient and much greater in 
magnitude than those observed in septic patients (12). Many anti-cytokine clinical trials based 
on promising results from this model have turned out to be unsuccessful (13, 14). 
Furthermore, LPS injection in rodents causes suppressed gluconeogenesis and subsequent 
hypoglycaemia, whereas the opposite results occur in patients with sepsis (10). Injection of 
LPS in this model also causes activation of the innate immune system, which can have 
deleterious effects; therefore, any intervention that blunts the inflammatory response is likely 
to be beneficial. In contrast, sepsis in patients is triggered by an infectious process and the 
immunological responses to microbial challenge that can have both beneficial and deleterious 
effects. For these reasons, LPS injection is currently considered to be a suitable model for 
endotoxic shock but not for sepsis.  
On the other hand, sepsis in the CLP model causes a persistent endogenous release of bacteria 
from the perforated caecum into the abdominal cavity, resulting in bacterial peritonitis that 
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successfully mimics human sepsis (9-11). A major advantage of this model is that the initial 
hyperdynamic cardiovascular changes such as cardiac output and systemic vascular 
resistance, accurately reflect the response seen in human sepsis (15, 16). Another major 
advantage of this model is that it reproduces the relative magnitude of the release of serum 
cytokines and chemokines observed in human sepsis (12, 17, 18). In addition, the CLP model 
has the advantage of inducing sepsis of varied severity, which is used for investigating both 
acute and chronic sepsis. However, it is important to use a consistent protocol in this model 
to obtain reliable and reproducible results, as the length of the caecum ligated, size of the 
needle used and number of punctures determine the outcome of resulting sepsis. 
Furthermore, in experiments using small animals (mice and rats), an increased sample size 
can resolve the problem of variability that can sometimes be seen in this model.  
In summary, different animal models can be used to study different aspects of sepsis and the 
choice of animal model depends on the type of pathological change to be studied in sepsis. 
For instance, the CLP model is good for studying hemodynamic and metabolic changes and 
biochemical, immune and inflammatory responses in sepsis, whereas i.v. infusion of live 
bacteria may be suitable for observing the blood clearance kinetics of bacteria. Although LPS-
induced endotoxaemia is to some extent similar to human sepsis, the dissimilarities in 
hemodynamic and inflammatory changes between these two conditions make the LPS 
injection model less relevant to the study of human sepsis.   
1.2.3 Pathophysiology of sepsis  
The pathogenesis of sepsis is a complex and multifactorial disease and so far no single 
mediator, system, pathway or pathogen has been reported to drive this disease. Despite 
extensive basic and clinical studies, the pathophysiology of sepsis is still poorly understood. 
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Sepsis is most commonly associated with bacterial infections but may also be caused by 
viruses and fungal infections. Although gram-positive pathogens have been documented to 
be most common cause of sepsis, there is now evidence that sepsis caused by gram-negative 
bacteria occurs with equal frequency in some settings (19, 20). Staphylococcus aureus, 
Streptococcus pneumonia and Escherichia coli are the most common causes of sepsis, while 
Pseudomonas aeruginosa is reported to be the most lethal (21, 22). However, many cases of 
sepsis are attributed to mixed infection and polymicrobial origin (23). 
Innate and adaptive immune systems preserve host integrity against invading pathogens 
during sepsis. The interaction between the host immune system and molecular components 
of invading pathogens is crucial for initiating immune events during sepsis (24). Immune cells 
such as monocytes/macrophages, neutrophils and natural killer cells recognise biochemical 
patterns displayed by pathogens and trigger active responses, either directly or indirectly by 
activating intracellular signalling pathways (25, 26). Immune cells utilise pattern recognition 
receptors (PRRs) to recognise highly conserved pathogen associated molecular patterns 
(PAMPs) such as bacterial cell wall components (lipopolysaccharide, LPS and peptidoglycans). 
Toll-like receptors (TLRs) are a family of pattern-recognition receptors present on mammalian 
macrophages, dendritic cells and other cells that initiate innate immune responses (27). To 
date, at least 11 human TLRs have been identified; each is known to detect specific PAMP and 
have a specific intracellular signalling pathway. Of these, TLR-4s and TLR-2s have been widely 
studied in sepsis. The peptidoglycan from gram-positive bacteria and the LPS from gram-
negative bacteria bind to TLR-2 and TLR-4, respectively (27). Once activated, TLRs trigger a 
cascade of signals such as mitogen-activated protein kinase (MAPK) and phosphatidylinositol-
4, 5-bisphostate 3-kinase (PI3K) activation and engage a sequence of cytoplasmic interactions 
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that result in activation of transcription factor nuclear factor-B (NF-B) and transcription of 
targeted proinflammatory genes. The resulting release of mediators such as proinflammatory 
cytokines and chemokines, adhesion molecules and lipid mediators as well as generation of 
reactive oxygen and nitrogen species (ROS and RNS) and complement-activation products can 
lead to a systemic inflammatory response, multiple organ failure and death.  
 
Figure 1.1 Schematic representation of the pathogenesis of sepsis. During sepsis, bacteria and their 
components, including LPS and peptidoglycan, activate pattern recognition receptors (PRRs such as 
TLR2 and TLR4, respectively) present on the surface of immune cells (27). Activation of these receptors 
can lead to the recruitment of adapter proteins at the receptor site and subsequently stimulate 
intracellular signalling pathways such as MAP kinases (MAPK) (25, 26). Activation of MAPK such as 
ERK1/2 can lead to the activation of IB kinases (IKK), which in turn degrades IB and allows 
translocation of NF-B subunits into the nucleus. Binding of NF-B subunits to the promoter region of 
the DNA can lead to the transcription and release of proinflammatory mediators such as cytokines, 
chemokines and adhesion molecules (28, 29). Activation of TLRs can also lead to the generation of 
reactive oxygen species (ROS) through NADPH oxidase (30, 31). Together, these inflammatory 





The inflammatory response is an integral part of sepsis. A finely-tuned balance between the 
immune and inflammatory systems, and between the pro- and anti-inflammatory networks 
is crucial for maintaining the balance between protective and tissue-damaging responses 
during sepsis (24, 32). The initial hyperinflammatory response, a result of an overwhelming 
immune response to infection, leads to imbalance between pro- and anti-inflammatory 
pathways during sepsis (33). The subsequent anti-inflammatory response serves as a negative 
feedback to downregulate proinflammatory mediators and to modulate their effects, thereby 
restoring homeostasis. Although anti-inflammatory mediators counterbalance pro-
inflammatory substances, prolonged and excessive production of these mediators leads to 
immune dysregulation and may cause increased host susceptibility to concurrent infections, 
subsequently, and a range of clinical sequelae (24). 
The present chapter focuses mainly on the proinflammatory pathways such as NF-B and 
MAPK signalling, the role of immune cells, and proinflammatory mediators such as cytokines 
and chemokines in pathophysiology of sepsis.  
1.2.3.1 The nuclear factor-κB (NF-B) transcription factor  
 NF-B is a transcription factor belonging to the Rel protein family (34). NF-B is formed by 
various homo- and hetero-dimeric combinations of Rel family proteins such as c-Rel, RelA 
(p65), RelB, NF-B1 (p50 and its precursor, p105) and NF-B2 (p52 and its precursor, p100) 
(34, 35). The combination of the p50/p65 heterodimer is the most predominant form of NF-
B (36). In normal resting cells, NF-B is bound to inhibitory B (IB) proteins such as IBα, 
IBβ and IBε in the cytoplasm. IB proteins interact with NF-B through multiple ankyrin 
repeats that inhibit its DNA binding activity. Of these, IBα blocks the nuclear translocation 
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of p65 whereas IBβ masks both p65 and p50. In addition, IBα provides a negative feedback 
mechanism for the termination of the NF-B response (35, 37-39).  
1.2.3.1.1 The role of NF-B in sepsis  
NF-B is an important transcription factor involved in regulating immune and inflammatory 
responses to infection. Activation of NF-B plays a central role in the pathophysiology of 
sepsis. A greater level of NF-B activity is associated with a higher rate of mortality and poorer 
clinical outcomes in septic patients. For example, it has been shown that NF-B activity is 
significantly higher in non-surviving septic patients than in surviving septic patients during 
their illness (40, 41). A significant increase in NF-B activity is also observed in the alveolar 
macrophages of patients with septic lung injury (42). Inhibition of NF-B activation prevents 
multiple organ injury and improves survival rates in rodent models of sepsis (43-47). For 
example, mice deficient in NF-B-dependent genes are resistant to the development of septic 
shock and death from sepsis (48-50). More importantly, blockade of the NF-B pathway 
corrects septic abnormalities. For example, inhibition of NF-B activation restores systemic 
hypotension, ameliorates myocardial dysfunction and vascular derangement, diminishes 
intravascular coagulation, inhibits multiple inflammatory gene expression, reduces tissue 
neutrophil influx and prevents microvascular endothelial leakage in the rat model of sepsis 
(47, 51, 52).  
Extracellular signal-regulated kinases (ERKs), a family of serine/threonine protein kinases 
belonging to the MAPKs, play a key role in NF-B activation (53). Two isoforms of ERKs, p44 
MAPK (ERK1) and p42 MAPK (ERK2) are known and both are important in the NF-B activation 
process. Following stimulation of TLRs by bacteria and their components, a series of adaptor 
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proteins are recruited to the receptor site and activate ERK1/2. Subsequently, the 
coordination and interaction of the ERK1/2 and NF-B cascade is important in regulating the 
transcription of inflammatory mediators (28, 29). For example, ERK1/2 activation has been 
shown to be an important temporal regulator of NF-B and, subsequently, NF-B-dependent 
gene expression (54). Specific inhibitors of ERK1/2 have been shown to inhibit NF-B  
activation or to suppress the expressions of proinflammatory genes following sepsis (44). 
NF-B activation is a central event in regulating cytokine response and subsequent 
chemokines and adhesion molecules in sepsis. The upstream signalling pathways that activate 
NF-B proteins result in its translocation to the nucleus, where it binds to the consensus 
sequence in the promoter or enhancer regions of NF-B target genes and induces 
transcription of genes for cytokines, chemokines and adhesion molecules. Excessive 
generation and release of these mediators by activation of NF-B in sepsis leads to an 
extensive activation of the inflammatory cascade and widespread organ injury (34, 35). For 
example, elevation of inflammatory mediators during sepsis has been shown to depend on 
NF-B activation, while inhibition of NF-B activation decreases production of inflammatory 
cytokines, chemokines and adhesion molecules, ameliorating disease severity during 
endotoxaemia and sepsis (43, 44, 52, 55, 56). These results suggest that NF-B is an important 
signalling cascade that plays a central role in the pathophysiology of sepsis.  
1.2.3.2 Role of immune cells in sepsis  
Immune cells are the first cellular responders to invading organisms and are therefore vital to 
host response. Among the immune cells, macrophages and neutrophils are key cells in the 
pathogenesis of sepsis. Macrophages, after being stimulated by pathogenic substances, can 
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augment the release of classic proinflammatory cytokines such as tumour necrosis factor-α 
(TNF-α), interleukin-1 (IL-1) and interleukin-6 (IL-6), and in addition release an array of other 
cytokines, including interleukin-12 (IL-12), interleukin-15 (IL-15) and interleukin-18 (IL-18) and 
other small molecules (57, 58). The high mobility group B1 (HMGB1) has been identified as a 
cytokine-like product of macrophages that appears much later after LPS stimulation and may 
represent a more tractable target for intervention (59). This hyperinflammatory state in sepsis 
is called systemic inflammatory response syndrome (SIRS) and is associated with an enhanced 
release of chemokines and expression of adhesion molecules that lead to a major infiltration 
of neutrophils and monocytes into the body organs. Activated neutrophils and macrophages 
also generate large amount of ROS, including hydrogen peroxide (H2O2), hypochlorous acid 
(HOCl) and other hydroxyl radical via nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidases and myeloperoxidase, and RNS such as nitric oxide and peroxynitrite anions (30, 31). 
Although the activated immune cells initially promote clearance of bacteria, their products 
can bring both reversible and irreversible changes in proteins and DNA, resulting in 
diminished biochemical functions that subsequently contribute to organ injury and death in 
sepsis (60).  
1.2.3.3 Role of cytokines in sepsis 
Cytokines are a group of soluble, low molecular weight glycoproteins that are synthesised and 
released by many types of cells (mainly monocytes, macrophages and neutrophils and also 
from lymphocytes, mast cells and fibroblasts) in response to tissue damage. They are 
important regulators for host defence, tissue repair and other homeostasis functions and are 
often secreted when bacteria or bacteria-derived components are exposed to the host 
immune response.  
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Cytokines are the key elements in the pathogenesis of sepsis and the “cytokine storm” 
(overwhelming release of the cytokines) is thought to be responsible for triggering 
inflammation in sepsis. The major proinflammatory cytokines that stimulate systemic 
inflammation are TNF-α, IL-1 and IL-6 (58). Activation of TLRs by pathogens trigger the 
production and release of “early” cytokines such as TNF-α and IL-1. These are released during 
the first 30-90 mins after exposure to LPS and work synergistically to release secondary 
cytokines such as IL-6 and other lipid mediators and ROS. These mediators signal endothelial 
cells to upregulate chemokines and adhesion molecules and begin the recruitment of 
neutrophils and other inflammatory cells to the site of infection (61, 62). In addition, these 
mediators signal the release of anti-inflammatory cytokines such as interleukin-4 (IL-4), 
interleukin-10 (IL-10) and interleukin-13 (IL-13), which may counter-regulate the 
inflammatory response and play a role in tissue repair (49). Although cytokines are crucial for 
host defence, overwhelming levels of cytokines can result in the systemic inflammatory 
response syndrome (SIRS) and multiple organ dysfunction in sepsis. Therefore, cytokines are 
considered to play a key role in the pathogenesis of sepsis.  
Among all cytokines, TNF-α is one of the most important and a primary mediator of 
inflammation in the pathogenesis of sepsis (63, 64). Through type I and II TNF receptors 
(TNFRs), TNF-α increases NF-B-mediated transcription of proinflammatory mediators and 
coordinates with other cytokines such as IL-1 and IL-6 to initiate acute phase response in 
sepsis. For example, TNF-α, together with IL-1, exert profound effects upon the endothelium, 
vasculature and coagulation cascade during sepsis (65, 66). The importance of 
proinflammatory cytokines has been reported in both experimental and human sepsis. 
Animal studies have demonstrated that concentrations of TNF-α in plasma were significantly 
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increased in severe sepsis and in animals that subsequently died (67). Administration of a 
combination of TNF-α and IL-1 acted synergistically to cause increased toxicity in rabbits (65, 
66). Patients with fulminant meningococcal septicaemia are also reported to have high 
plasma levels of TNF-α (68). Experiments conducted with anti-TNF-α antibodies have shown 
decreased levels of other cytokines and improved survival in animal models of septic shock 
(69, 70). In baboons infused with live Escherichia coli, anti-TNF-α almost reduced circulating 
IL-1β, IL-6 and IL-8 (71, 72) levels to the normal. In contrast, the role of IL-6 in the 
pathophysiology of sepsis remains unclear. In animal models of sepsis, blockage of IL-6 has 
produced inconsistent protection (61). In addition, infusion of IL-6 into human volunteers and 
experimental animals has not induced a sepsis-like state (73). However, compared to other 
cytokines, IL-6 has been found to be a better predictor of severity and outcome in human 
sepsis and the development of multiple organ failure in patients with sepsis (74).  
1.2.3.4 Role of chemokines in sepsis  
Chemokines are a large family of 8-14 kDa-inducible cytokines that play a crucial role in 
trafficking and recruiting anti-bacterial leukocytes to the primary sites of the immune 
response (75). To date, more than 40 chemokines have been identified and are classified into 
four subfamilies (C, CC, CXC and CX3C chemokines) depending on the relative position of 
cysteine residues (76, 77). Of these, CC and CXC chemokines are the most widely studied 
peptides in inflammation and sepsis (78).  
It has been demonstrated that exposure to various pathogens results in a substantial increase 
in chemokines in both humans and animals. For example, circulatory levels of CXCL8 (IL-8) 
were significantly elevated in patients with bacterial sepsis (79). Similarly,  high plasma levels 
of CXCL9 (a monokine induced by interferon-γ, MIG), CCL2 (monocyte chemoattractant 
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protein-1, MCP-1), CCL3 (macrophage inflammatory protein-1α, MIP-1α), CCL4 (MIP-1β) and 
CCL8 (MCP-2) were also observed during sepsis (57). Although chemokines are crucial for host 
defence against invading pathogens, overexpression of these chemokines may play an 
important role in the inflammatory response and organ damage in sepsis. For example, MIP-
2, a CXC chemokine released by macrophages in sepsis, binds to CXCR1 and CXCR2 on 
neutrophils and has been associated with neutrophil-induced organ injury and death rates in 
CLP-induced sepsis (80). Neutralising the effects of CXCR2 stimulation in murine peritonitis 
resulted in an attenuated neutrophil response with less organ injury and improved survival 
(81).  
Although cytokines are considered to play a key role in the pathogenesis of sepsis and 
neutralising these mediators has shown protection in experimental sepsis models, clinical 
studies based on inhibiting the activity of cytokines have failed to improve the outcome in 
sepsis patients. Despite the encouraging results in experimental sepsis models, monoclonal 
antibodies targeted against TNF-α (82-84), soluble TNF-α receptors (85), IL-1 receptor 
antagonists (86-88) and soluble IL-1 receptors have failed to decrease mortality in phase II 
and III clinical studies (89, 90). The improved outcome of anti-cytokine therapies in septic 
animals compared with humans is thought to be a result of a short therapeutic window period 
for reversing the events of lethal sepsis in animals (91). Moreover, the ineffectiveness of anti-
cytokine therapies in patients arises as a result of a prolonged immunosuppressive state at 
later time points of sepsis development. Furthermore, although several experimental and 
clinical studies have shown the importance of chemokines and their receptors in the 
pathophysiology of sepsis, clinical approach based on chemokines failed to prove as a 
therapeutic targets.  
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To understand the complex role of inflammatory mediators in sepsis, there is a need to study 
newly characterised mediators. In addition, studying novel mediators will improve our 
understanding of their role in signal transduction, cross-talk, and synergistic and 
immunomodulating during sepsis. Recent research has shown that hydrogen sulfide (H2S), a 
gasotransmitter, plays an important role in the inflammatory process in experimental disease 
models of sepsis. Further understanding the inflammatory role of H2S and its interaction with 
other inflammatory mediators will help to design novel therapeutic targets for sepsis 
treatment.   
1.3 Hydrogen sulfide (H2S) 
 H2S has been known for decades as a toxic gas with a strong characteristic odor of rotten 
eggs. Recent research has shown that H2S is generated endogenously in many tissues and 
exerts various physiological functions. It has been proposed as a third physiological 
gasotransmitter, following nitric oxide (NO) and carbon monoxide (CO).  
1.3.1 Physical and chemical properties of H2S  
H2S is a colorless, flammable gas with a strong odor of rotten eggs or the obnoxious odor of a 
blocked sewer. It is a weak acid (pKa 6.96). At physiological conditions (pH 7.4), approximately 
one third of H2S remains in a non-dissociated form and two thirds dissociate into H+ and HS- 
(hydrosulfide anion), which may subsequently dissociate into H+ and S2-. Since the latter 
reaction only takes place at high pH, the level of S2- in vivo is very low. At present it is unknown, 
whether the biological effects of H2S are mediated directly by H2S, HS-, or whether a 




1.3.2 Enzymatic and non-enzymatic pathways for H2S production 
H2S is generated endogenously by both enzymatic and non-enzymatic pathways. Through an 
enzymatic pathway, many mammalian tissues produce H2S from sulfur amino acids such as 
homocysteine and L-cysteine, during their metabolism. This reaction is catalysed by three 
enzymes, cystathionine-γ-lyase (CSE, EC 4.4.1.1), cystathionine-β-synthase (CBS, EC 4.2.1.22) 
and 3-mercaptopyruvate sulfurtransferase (3-MST, EC 2.8.1.2), along with cysteine 
aminotransferase (CAT, EC 2.6.1.3) (92-94). Of these, CSE and CBS are the major H2S-
synthesising enzymes and their activity is dependent on the availability of pyridoxal-5’-
phosphate (PLP), an active form of vitamin B6, which acts as a co-factor for CSE and CBS. 
Although CBS and CSE are widely expressed in cells and tissues, CSE is the predominant H2S-
synthesising enzyme in the peripheral organs and vascular system, whereas CBS is mainly 
distributed in the central nervous system. As the end product of the CSE- and CBS-catalysed 
cysteine metabolism, H2S exerts a negative feedback effect on the activity of these two 
enzymes. It has been found recently that H2S is also produced from D-cysteine by the enzymes 
D-amino acid oxidase (DAO) and 3-MST. This pathway is mainly localised within the 
cerebellum and kidney (95).  
H2S is also produced from non-enzymatic pathways from stored sulfur compounds; however, 
this is physiologically much less significant. Two forms of sulfur stores in cells have been 
identified: acid-labile sulfur and bound sulfane-sulfur (96, 97). Under acidic conditions (low 
pH), H2S is released from acid-labile sulfur compounds such as iron-sulfur clusters (97). In the 
presence of reducing agents or under reducing conditions, H2S is also produced from bound 




Figure 1.2 Schematic representation of endogenous H2S generation through enzymatic and non-
enzymatic pathways. The enzymatic source of H2S involves the action of transsulfuration pathway 
enzymes cystathionine--lyase (CSE) (EC 4.4.1.1), cystathionine--synthase (CBS) (EC 4.2.1.22) and 3-
mercaptopyruvate sulfurtransferase (3-MST) (EC 2.8.1.2). Both CSE and CBS catalyse the synthesis of 
H2S by utilising homocysteine and L-cysteine as substrates (99, 100), whereas 3-MST utilises 3-
mercaptopyruvate (generated by cysteine aminotransferase (CAT) from L-cysteine and D-amino acid 
oxidase (DAO) from D-cysteine) to generate H2S (95, 101). H2S is also generated from stored sulfur 
pools such as acid-labile sulfur and sulfane-sulfur through the non-enzymatic pathway. H2S is released 
from iron-sulfur clusters of non-heme sulfur proteins under acidic conditions (97) and from sulfane-
sulfur of persulfide and polysulfide with the help of reducing agents (98). 
 
1.3.3 H2S catabolism and mode of action  
The major catabolic pathway of H2S is via a series of redox conversions in the mitochondria 
that ultimately leads to the formation of thiosulfate. This pathway is mediated by three 
enzymes, sulfidequinoneoxido-reductase (SQR), and sulfur dioxygenase and sulfur 
transferase. Apart from this catabolic pathway, H2S has recently been shown to 
physiologically react with other molecules owing to the nucleophilic capacity of the 
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hydrosulfide ion (HS-) (99). Currently, there are three general forms of hydrogen sulfide 
interaction within the biological milieu reported under physiological conditions; as a 
reductant (100), through protein s-sulfhydration (327) and interaction with metal ion 
containing molecules (101). The discovery of these interactions have also led to the 
elucidation of the direct targets and mechanisms by which H2S exerts its observed 
physiological effects.  
1.3.4 Physiological role of H2S  
H2S is thought to perform a wide range of physiological functions, including neuromodulation 
and neuroprotection (102), vasorelaxation (103), cytoprotection and anti-oxidation (104, 
105), angiogenesis (106), cellular energy production and metabolism (107, 108). H2S also 
regulates cellular processes such as proliferation, migration and apoptosis (106).  
Functionally, by acting on ATP-dependent potassium (KATP) channels, endogenous H2S can 
hyperpolarise cell membranes, vascular smooth muscle cells, gastrointestinal smooth muscle 
cells, cardiomyocytes, neurons and pancreatic-β cells, thereby regulating vascular tone, 
intestinal contractility, myocardial contractility, neurotransmission and insulin secretion, 
respectively (103, 109). Despite a direct vasodilator effect on vascular smooth muscles, H2S 
can modulate nitric oxide (NO)-mediated vasodilation (110). H2S is a strong reducing agent 
(anti-oxidant) and reacts with ROS and RNS, limiting their toxic effects and resulting in the 
protection of proteins and lipids from ROS/RNS-mediated damage (111). H2S produced by 3-
MST can scavenge ROS in mitochondria and protect cells from oxidative stress (104). Further, 
H2S plays a role in the angiogenesis process. The angiogenic effects of H2S are mediated 
through the activation of the vascular endothelial growth factor (VEGF) (112). In addition to 
serving as a signalling molecule, H2S participates in mitochondrial function and cellular 
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bioenergetics. It also acts as a mitochondrial electron donor, which results in the stimulation 
of ATP synthesis (113).  
In the central nervous system, H2S acts as a neuromodulator. It enhances the sensitivity of N-
methyl-D-aspartate (NMDA) receptors to glutamate, thereby promoting hippocampal long-
term potentiation (learning and memory) as well as phosphorylation of these receptors by 
protein kinase A (PKA) (105). H2S also evokes calcium (Ca+2) waves in astrocytes and microglia 
cells, which play an important role in the regulation of brain pH levels, neurotransmitter levels 
and neuronal excitability (114). Additionally, H2S donor NaHS is linked to the inhibition of 
apoptosis, a decrease of oedema formation in the brain and amelioration of cognitive 
dysfunction (115) (Figure 1.3).  
 
 
Figure 1.3 Possible physiological functions of H2S. Illustration of the current known physiological 
effects of H2S. H2S performs wide range of physiological functions in both central nervous system and 
peripheral organs, including neuromodulation (102), vasorelaxation (103), cytoprotection, antioxidant 
(104, 105), energy production and metabolism (107, 108) and other cellular processes (106).  
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1.3.5 Pathological effects of H2S  
Despite physiological functions, the pathological roles of H2S have been demonstrated in a 
number of diseases in both the central nervous system and the peripheral organs. In the 
central nervous system, H2S has a proven neuromodulatory role in the protection of neurons 
from oxidative stress (116) and cytotoxicity (111). H2S promotes glutamate-mediated 
transmission via NMDA receptors, which might also have implications for neurodegenerative 
diseases in which excessive activation of NMDA receptors is involved (117). On the other 
hand, in peripheral organs H2S has been reported to be deficient in various animal models of 
arterial and pulmonary hypertension (118), myocardial injury (119), gastric mucosal injury 
(120), colitis (121) and cirrhosis (122). Exogenous H2S-releasing drugs attenuate 
cardiovascular dysfunction (123) and repair the damage of gastrointestinal mucosa (124). In 
addition, H2S scavenges RNS, peroxynitrite (ONO2-), oxygen free radicals and lipid 
peroxidation, resulting in cardiovascular protection and neuroprotection (111, 125). In 
contrast, increased levels of H2S have also been reported in various animal models of 
inflammatory diseases such as sepsis (43, 44, 126), endotoxaemia (127) and acute pancreatitis 
(128, 129). Therefore, it is clear that endogenous H2S plays an important role in the 
pathophysiology of different diseases in both the central nervous system and peripheral 
organs.   
1.3.6 Role of H2S in inflammation  
Numerous studies have proposed that H2S plays a key role in the pathogenesis of 
inflammatory diseases such as acute pancreatitis (128-132), inflammatory bowel disease 
(IBD) (133-136), hindpaw oedema (137), burn injuries (138), endotoxaemia (139) and sepsis 
(44, 126, 140, 141). The role exerted by H2S in inflammation remains controversial because it 
21 
 
has been reported to have both pro- and anti-inflammatory effects. Previous research has 
indicated that H2S is likely to be an endogenous regulator of inflammatory response in various 
inflammatory diseases. Table 1.2 lists the pro- and anti-inflammatory role of H2S in animal 
models of inflammatory disease. The mixed results of both pro- and anti-inflammatory effects 
of H2S appear to be due to differences between studies such as variation in the choice of H2S 
donor or inhibitor, route of administration and dosage regime, as well as chosen method of 
inducing disease or injury. 
Although H2S has wide implications in different inflammatory disease conditions, this chapter 
is primarily focused on the inflammatory role of H2S in the pathophysiology of sepsis.  
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H2S  inhibitor H2S  donor 
      
CLP-induced sepsis Mouse SiRNA (7 mg/kg) i.v.  Pro-inflammatory (126) 
CLP-induced sepsis Mouse PAG (50 mg/kg) i.p. NaHS                 
(180 µmol/kg) i.p.          
Pro-inflammatory (142-144) 
LPS-induced endotoxaemia 
10 mg/kg i.p. 
Mouse PAG (50 mg/kg) i.p.  Pro-inflammatory (145) 
LPS-induced endotoxaemia 
~4 µg/kg i.p. 





LPS-induced endotoxaemia  
1 mg/kg i.p. 
Rat PAG (50 mg/kg) i.p.  Pro-inflammatory (147) 
Burns injury (30% exposure 
for 8s) 




pancreatitis; 50 µg/kg/hr, 
10 hours, i.p.  
Mouse SiRNA (7 mg/kg) i.v.  Pro-inflammatory (149) 
Caerulein-induced 
pancreatitis; 50 µg/kg/hr, 
10 hours, i.p. 
Mouse CSE gene deletion  Pro-inflammatory (129) 
Caerulein-induced 
pancreatitis; 50 µg/kg/hr, 
10 hours, i.p.  
Mouse PAG (100 mg/kg) 
i.p. 
 Pro-inflammatory (150, 151) 
Sodium taurocholate-
induced pancreatitis 
Rat PAG (80 mg/kg) i.p. NaHS (28 
µmol/kg) i.p.  
Pro-inflammatory (152) 
Haemorrhagic Shock Rat PAG (50 mg/kg)   Pro-inflammatory (153) 
Carrageenan-induced hind 
paw oedema                        
150 μL, 2% (w/v) 
intraplantar injection 
Rat PAG (50 mg/kg) i.p.   Pro-inflammatory (154) 
Carrageenan-induced hind 
paw oedema                        
150 μL, 1% (w/v) 
intraplantar injection 
Rat PHE-4i (2, 5, and 10 
mg/kg) i.p. 
 Pro-inflammatory  (155) 




CLP-induced sepsis Mouse PAG (50 mg/kg) i.p.  NaHS/Laws (10-
100 µmol/kg) s.c. 
Anti-inflammatory (156) 




10 mg/kg i.p. 
Rat  S-Diclofenac      
i.p. 
Anti-inflammatory (158) 
LPS-induced endotoxaemia  
4 mg/kg i.v. 
Rat  GYY4137 (50 
mg/kg) i.v. 
Anti-inflammatory (159) 
Burns injury (40% exposure 
for 10s) 




pancreatitis ; 50 µg/kg/hr, 
10 hours, i.p.  




pancreatitis                       
250 mg/100g i.p. 
Rat PAG (50 mg/kg) i.p. NaHS (5, 10, 20 or 




Rat PAG (50 mg/kg) i.p.  Anti-inflammatory (163) 
Renal ischaemia 
reperfusion, 60min 





Pig  Na2S (1.28 
µmol/10min) i.v. 
Anti-inflammatory (165) 




joint arthritis                        
10 µL, 2% i.a.                               











paw oedema 150 µL, 2% 
w/v, intraplantar injection 
Rat  S-Diclofenac 
(11.8-47.2 
µmol/kg) i.p.  
Anti-inflammatory (169) 
Colitis Rat PAG (50 mg/kg/) 
i.p.  
NaHS (1.7 mg/kg) 





Rat  NaHS (54 




Table 1.2 Summary of studies investigating the role of hydrogen sulfide (H2S) in animal models of 
disease/injury. This table shows reported role of H2S in different inflammatory experimental disease 
animal models and injury. Studies used different approaches to modulate endogenous H2S levels 
results are mixed, showing both pro- and anti-inflammatory effects of H2S even in similar models of 
disease. However, there appear to be differences between studies such as variations in the choice of 
H2S donor or inhibitor, route of administration and dosage regime, as well as chosen method of 
inducing disease or injury. (i.p., intraperitoneal; s.c., subcutaneous; i.v., intravenous; i.a., 
intraarticular; i.c., intracolonic; PAG, DL-propargylglycine; NaHS, sodium hydrogen sulfide; and Na2S, 
disodium sulfide).   
 
1.3.6.1 Role of H2S in sepsis 
Understanding the role of H2S in sepsis and septic shock is particularly important due to the 
high mortality rates associated with these conditions. Several early studies have confirmed 
the inflammatory role of H2S in sepsis. Two animal models of sepsis have been used to study 
the role of H2S: administration of the LPS endotoxin and CLP-induced sepsis.  
Early studies used the LPS-induced endotoxaemia model to study the role of H2S in sepsis. 
Injection of LPS resulted in an overproduction of endogenous H2S, as shown by a marked 
increase in plasma H2S concentrations, CSE activity and CSE mRNA levels in liver and kidney 
tissues associated with an increased inflammatory response, and by multiple organ damage 
(127, 172, 173). Administration of NaHS aggravated endotoxaemia-induced leukocyte 
infiltration of tissues and multiple organ damage, whereas these symptoms were alleviated 
by pretreatment with CSE inhibitor DL-propargylglycine (PAG) (174). In addition, formation of 
H2S in endotoxaemia was greatly inhibited by NO-releasing flurbiprofen, highlighting the 
potential interaction between NO and H2S in endotoxaemia (175). Together, these results 
suggested that H2S had a proinflammatory role in LPS-induced endotoxaemia. In contrast, 
other studies have reported H2S has an anti-inflammatory role. For example, studies with H2S 
donors S-diclofenac and GYY4137 have reported decreased leukocyte infiltration, cytokine 
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and eicosanoid generation, and NF-B activation in LPS-induced endotoxaemia (158, 176). The 
discrepancy between different studies might be due to differences in the use of H2S donors 
and inhibitors, the route of administration and dosage regime. Furthermore, irrespective of 
the pro- or anti-inflammatory role of H2S, LPS-induced endotoxaemia does not mimic the 
cytokine profiles or hemodynamic changes of human sepsis (9).  
To avoid the limitations of LPS-induced endotoxaemia as a model for sepsis in humans (9), 
the inflammatory role of H2S was studied using another animal disease model: CLP-induced 
sepsis. In recent years, Bhatia and colleagues have shown that significantly increased 
expression of CSE and H2S levels are associated with leukocyte infiltration and organ injury in 
CLP-induced sepsis (126, 140, 177). H2S is also overproduced in the vascular tissues of rats 
with experimental shock induced by CLP-induced sepsis (178). Similarly, a preliminary study 
in patients with septic shock showed there was a significant increase in plasma H2S levels 
compared with healthy controls (172). Conversely, administration of the CSE inhibitor PAG 
decreased plasma H2S levels and inhibited leukocyte infiltration, liver and lung injury, and 
improved survival following CLP-induced sepsis (44, 140). A recent study used siRNA to silence 
CSE gene-protected mice against sepsis-induced leukocyte infiltration and liver and lung 
damage (126). Elevated levels of proinflammatory cytokines and chemokines correlated with 
increased CSE expression, activity and H2S synthesis in CLP-induced sepsis (43, 126, 173), and 
the proinflammatory cytokine and chemokine response was further augmented when H2S 
donor NaHS was administered to mice with sepsis (43, 44). Treatment with PAG attenuated 
activation of ERK1/2 and NF-B p65 and subsequent cytokine and chemokine production 
following CLP-induced sepsis (43, 44). Together, these results suggested that the temporal 
increase in CSE expression and H2S synthesis during sepsis correlated with the occurrence of 
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phosphorylation of ERK1/2 and activation of NF-B p65 and subsequently regulated 
generation of proinflammatory cytokines and chemokines.  
In contrast to the proinflammatory role, other studies have reported the protective effect of 
H2S in CLP-induced sepsis. For example, it has been reported that administration of H2S 
donors such as NaHS and Lawesson’s reagent improved neutrophil migration and survival rate 
through a mechanism involving the activation of KATP channels in CLP-induced sepsis (156). 
Similarly, another study using NaHS reported increased survival rates in mice by inhibition of 
the C/EBP homologous protein 10 (CHOP) following CLP-induced sepsis (157).  
Together, these studies have shown the inflammatory role of H2S in sepsis. Irrespective of the 
type of sepsis disease model, H2S has been reported to have both pro- and anti-inflammatory 
effects in LPS-induced endotoxaemia and CLP-induced sepsis. These mixed results showing 
both the pro- and anti-inflammatory effects of H2S are appear to be due to the use of different 
pharmacological donors and inhibitors of H2S. Dosage regime, route and time of 
administration of H2S donors and inhibitors may activate or inhibit different signalling 
pathways, which in turn produce either a pro- or anti-inflammatory effect in sepsis. Newer 
and more promising alternative tools are required to further investigate the complex 
inflammatory role of H2S in sepsis.  
1.4 Substance P (SP) 
1.4.1 Biosynthesis and physiological functions of SP  
SP is an 11 amino acid neuropeptide belonging to the tachykinin family and encoded by the 
preprotachykinin-A (PPTA) gene (179-181). SP shares tachykinins’ common carboxyl-terminal 
sequence Phe-X-Gly-Leu-Met-NH2, which is essential to interacting with its specific receptors 
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and producing biological actions (182). SP is widely distributed in the central nervous system 
and is released from nerve endings in several peripheral tissues, including the entire length 
of the gastrointestinal tract and the pancreas (183-186). Although SP has been described as a 
peptide of neuronal origin, studies on rodents have demonstrated that it is produced by 
inflammatory cells such as macrophages (187), eosinophils (188) and dendritic cells (189). The 
biological actions of SP are mainly mediated through a family of rhodopsin-like G-protein-
coupled receptors, of which neurokinin-1 receptor (NK-1R) has the highest affinity for SP 
(190). The most widely known roles of SP are in nociception and neurogenic inflammation 
(191, 192). However, the diverse expression of NK-1R suggests that SP also elicits local 
vasodilation and increases microvascular permeability and plasma extravasation, thereby 
enhancing the delivery and accumulation of leukocytes in inflamed tissue (193, 194).  
1.4.2 The role of SP in sepsis  
SP acts as a proinflammatory mediator in sepsis and studies in both experimental and clinical 
sepsis have provided evidence of its proinflammatory role. For example, in both LPS-induced 
endotoxaemia and CLP-induced sepsis SP levels were significantly increased in plasma and 
lungs and were associated with lung injury (195-200). Similarly, in patients with postoperative 
sepsis, circulatory levels of SP (related to the lethal outcome of sepsis) were significantly 
elevated (201-203). Intervention studies using NK-1R antagonists and mice deficient in the 
PPTA gene were protected against endotoxaemia and sepsis-induced lung injury (196, 198, 
200). These data suggest that SP has a proinflammatory role in sepsis and associated organ 
damage.  
An increased inflammatory response and organ injury through H2S-mediated activation of SP 
and NK-1R has also been reported in sepsis. H2S upregulates the generation of SP and 
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activation of NK-1R in CLP-induced sepsis (141), both of which are further augmented by 
administration of NaHS  (204). Conversely, administration of PAG reduced SP levels and NK-
1R following sepsis (141, 205, 206).  However, the mechanisms of H2S-mediated regulation of 
SP production and NK-1R receptor activation remain to be elucidated.  
1.5 Liver and liver sinusoidal endothelial cells  
1.5.1 Anatomy and function of the liver  
The liver is the largest organ in the body and is responsible for multiple dynamic functions. As 
the principal organ for maintaining systemic homeostasis, the liver has a major role in the 
metabolism, synthesis, storage, detoxification and secretion of numerous substrates (207). 
The liver is also vital in maintaining and establishing immune functions (208). The liver 
synthesises plasma proteins such as albumin and is involved in the metabolism of lipoproteins 
and bilirubin, together with bile formation and secretion. It also plays a key role in nutrient 
storage and the processing and regulation of blood glucose (209).  
Anatomically, the liver is located in the upper right quadrant of the abdominal cavity. An adult 
human liver weighs approximately two kilograms and comprises 2 to 5% of total body weight. 
The liver is functionally divided into mainly four lobes: left, right, median or quadrate and 
caudate, which are further subdivided into eight segments by divisions of the right, middle 
and left hepatic veins, with each segment receiving blood from its own portal pedicle. 
Uniquely, the liver receives its blood supply from two main sources: the portal vein and 
hepatic artery. Seventy percent of its blood is from the portal vein, which carries 
deoxygenated blood from the splanchnic circulation system while the remaining 30% comes 




Figure 1.4 Segmental anatomy of the liver (adapted from Siriwardena et al., 2014). Anatomically, 
the liver divided into eight segments by divisions of the right, middle and left hepatic veins, with each 
segment receiving blood from its own portal pedicle (210).   
 
The functional units of the liver are described as interconnecting lobules. Lobules are 
hexagonal in shape and contain a central vein surrounded by repeating branches of the portal 
triad (portal vein, bile ducts and hepatic artery). Depending on the area’s proximity to the 
central vein and portal triads, each lobule is classified into three anatomical zones: periportal 
or portal zone, midzonal or midlobular zone and centrilobular or central zone. In addition to 
the classical lobular delineation, the functional units of the liver are classified as acini, each of 
which are divided into three zones according to the level of oxygenation and nutrient 
exposure of the cells. Zone 1 contains cells receiving the most oxygenated and nutrient-rich 
blood (located closest to the portal triad), while zones 2 and 3 respectively contain cells that 
are exposed to less oxygenated and less nutrient-rich blood (remote from arteriolar blood 
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and located in the microcirculatory periphery of the acinus) (211) . The zones are depicted in 
Figure 1.5.  
 
Figure 1.5 Diagrammatic representation of the classic lobule and liver acinus (adopted from Cattley 
et al., 2002). Depending on the area’s proximity to the central vein and portal triads, each 
lobule is classified into three anatomical zones: periportal zone (close to the portal triad), 
midzonal zone and centrilobular zone (close to the central vein). The functional units of the 
liver are classified as acini, each of which are divided into three zones according to the level of 
oxygenation and nutrient exposure of the cells. Zone 1 exposed to most oxygenated and 
nutrient-rich blood (close to the portal triad), zone 2 and zone 3 exposed to less oxygenated 
and less nutrient-rich blood (close to the central vein) (211).  
 
1.5.2 The liver sinusoid  
The liver sinusoid is a unique and highly specialised capillary blood vessel. These channels 
have an average diameter of approximately 7 to 10 µm and connect the portal venous system 
with the terminal hepatic veins in the centre of the hepatic lobules (212). Blood flow is 
relatively slow in the liver sinusoids and allows for prolonged contact with the hepatocytes. 
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The smaller diameter and slow blood flow facilitate metabolic exchange between afferent 
blood and the hepatic parenchyma, which may play an important role in immune surveillance 
and cellular interactions. Flow of arterial and venous blood is regulated by contractions of 
sphincters in the walls of the sinusoids (213). The hepatocytes, arranged in single cell plates, 
are separated by sinusoids. The space between the sinusoidal wall and the hepatocytes is 
called space of Disse. Therefore, through its basolateral surface and the space of Disse, each 
hepatocyte has access to the blood and its content (214).  
Four types of cells constitute the liver sinusoid: liver sinusoidal endothelial cells (LSECs), 
Kupffer cells, stellate cells (also known as Ito cells or fat storage cells) and pit cells, each with 
specific morphology and function. LSECs constitute approximately 20% of liver cells, Kupffer 
cells 15% and stellate cells 5%. Depending on the disease process, each cell type can undergo 
morphologic or quantitative changes (215, 216). This chapter mainly focuses on Kupffer cells 
and LSECs and their role in the inflammation associated with infection.  
1.5.3 Kupffer cells  
Kupffer cells are the resident macrophages in the liver sinusoid. They differentiate from yolk 
sac cells and represent 80-90% of the body’s resident macrophages (217-219). Kupffer cells 
are mainly located in the lumen of the liver sinusoids, usually in close proximity to endothelial 
cells, and play a key role in host defence, homeostasis and regulation of metabolic functions 
in the liver (218). The major function of Kupffer cells is to clear particulate and foreign 
materials from portal circulation. Substrates including microorganisms, endotoxins, old and 
foreign cells, complement components, immune complexes and collagen fragments, are 
phagocytosed and degraded by the Kupffer cells (220).  
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1.5.3.1 Kupffer cells role in infection and inflammation 
Kupffer cells play an important role in the clearance of pathogenic substances carried to the 
liver through portal circulation and regulate immune and inflammatory responses. Pathogens 
or endotoxins enter the liver through portal circulation are phagocytosed by Kupffer cells, 
which activate specific membrane receptors (such as TLR4) present on their surface (221). 
TLR4 associates with CD14 on the surface of Kupffer cells, which then mediate endotoxin-
induced signal transduction and release proinflammatory mediators. Kupffer cells primarily 
produce TNF-α, but also other cytokines such as IL-6 and IL-1β, as well as NO and ROS 
(including superoxide) to modulate inflammatory and immune responses. Although these 
cells and cellular responses are necessary to combating infection and endotoxin, persistently 
high or overwhelming activation may result in an uncontrolled proinflammatory cascade, 
leading to a systemic inflammatory response and potentially to multiple organ failure (222-
224) (Figure 1.6).  
The role of Kupffer cells during infection and inflammation has been studied using 
experimental disease models of LPS-induced endotoxaemia (221, 222, 225, 226) and CLP-
induced sepsis (220, 227-230). Inactivation of Kupffer cells using gadolinium chloride (GdCl3) 
was shown to protect against LPS-induced liver injury and inflammation (222, 223, 231). 
Increased superoxide production and hepatic expression of TNF-α, IL-1β and IL-6 in response 
to LPS-induced Kupffer cell activation was decreased by GdCl3 (231-234). Similarly, inhibition 
of Kupffer cell phagocytosis by GdCl3 attenuated sepsis-associated hepatic dysfunction by 
reducing the expression of cyclooxygenase-2 (COX-2) and modulation of inflammatory 
response. At the same time, Kupffer cells released the anti-inflammatory cytokine IL-10 to 
overcome the inflammatory response. For example, the inflammatory response to 
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endotoxaemia is downregulated by the local release of IL-10 from Kupffer cells (235). These 
results suggest that Kupffer cells play a crucial in regulating inflammatory response associated 
with infection and endotoxaemia.  
 
Figure 1.6 Role of Kupffer cells in sepsis. Steps involved in the Kupffer cell-mediated inflammatory 
response during infection: 1) Entering of bacteria and their components into the gastrointestinal tract 
(GIT). 2) Translocation of bacteria and their components from the GIT into the liver via portal 
circulation. 3) Activation of Kupffer cells. 4) Release of cytokines and chemokines from activated 
Kupffer cells. 5) Migration of chemokines into systemic circulation. 6) Migration of neutrophils from 
circulation into the liver. 7) Activation of neutrophils and transformation of monocytes to 
macrophages. 8) Engulfment of bacteria and their components by macrophages and neutrophils. 9) 
Release of cytokines and chemokines from activated neutrophils and macrophages. 10) Migration of 
cytokines and chemokines into systemic circulation. 11) Increased inflammatory mediators in 




The role of Kupffer cells in multiple organ injury (particularly lung injury) and systemic 
inflammatory response was also investigated using different experimental inflammatory 
disease models. For example, it has been shown that treatment with GdCl3 attenuates LPS-
induced pulmonary injury by decreased activation of caspase-3 (236). Similarly, ozone-
induced pulmonary injury was abrogated by pretreatment with GdCl3 (237). In contrast, 
pretreatment with GdCl3 increased leukocyte infiltration into the lungs as well as chemokine 
levels in LPS-induced lung alveolitis and endotoxaemia (223, 234). Furthermore, pretreatment 
with GdCl3 decreased expression of anti-inflammatory cytokine IL-10 in CLP-induced 
peritonitis (230). Despite the local effects on liver and lung injury, mice pretreated with GdCl3 
showed significant increases in mortality in CLP-induced sepsis (227). Conversely, rats 
pretreated with GdCl3 showed decreases in mortality by suppression of superoxide 
production associated with endotoxaemia (226, 238). Additionally, both GdCl3 and clodronate 
liposomes have been shown to lower serum levels of TNF-α, IL-6 and IL-1β, which were 
increased following LPS-induced endotoxaemia and sepsis (220, 225, 228, 239). However, 
treatment with GdCl3 had no effect on elevated serum TNF-α levels in other disease models 
(222, 226, 240).  
The results of previous studies on the effect of GdCl3 on liver and lung injury and the systemic 
inflammatory response indicate that there is currently a poor understanding of the role of 
Kupffer cells in different disease models of endotoxaemia and sepsis. This discrepancy might 
be due to the use of different experimental disease models and observations of injury or 
inflammation in only one organ rather than multiple organ systems. Studying the effect of 
GdCl3 on multiple organ injury or inflammation using a single disease model would help to 
contribute a better understanding of the role of Kupffer cells in sepsis.  
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1.5.4 Liver sinusoidal endothelial cells (LSECs) 
1.5.4.1 Structure and functions of LSECs 
LSECs are specialised endothelial cells lining the hepatocytes that form a barrier between the 
sinusoidal blood and hepatic parenchyma, from which they are separated by space of Disse. 
LSECs represents approximately 15-20% of liver cells but only 3% of the total liver volume. 
Unlike vascular endothelial cells, LSECs do not have an organised basement membrane (both 
diaphragm and underlying basal lamina) and are fenestrated. LSECs fenestrations are pores 
that range in size from 50 to 250 nm in diameter. Most LSECs fenestrations are aggregated 
into groups of 10-100 called sieve plates, which together with the subendothelial space of 
Disse (containing an extracellular matrix) constitute the liver sieve (241). These fenestrations 
are surrounded by a dense filamentous ring of actin (fenestration-associated cytoskeleton), 
while the sieve plates are surrounded by a network of microtubules. The fenestrated 
sinusoidal endothelium acts as a dynamic filter to exchange fluids, solutes and substrates 
between the sinusoidal blood and the space of Disse, sieving substrates on the basis of size 
(242, 243). The sinusoidal endothelium also acts as a scavenger system: endothelial scavenger 
receptors are responsible for clearing blood of physiological waste products such as oxidised 
low density proteins, matrix components and advanced glycation end products from normal 
cell turnover (244).  
LSEC porosity is determined by fenestration frequency (F/µm2) and fenestration diameter 
(FD). The natural porosity of the liver sinusoid increases from the portal triad (zone 1) towards 
the central vein (zone 3) owing to slight increases in fenestration frequency and perhaps also 
an increase in fenestration diameter. It has been demonstrated that there are approximately 
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double the number of sieve plates and fenestrations per sieve plate in the pericentral 
sinusoids than in the periportal sinusoids (216).   
1.5.4.2 Alteration of LSEC fenestration 
LSEC fenestrations are dynamic structures and alteration in their size and number can affect 
hepatic trafficking of lipoproteins and other endogenous substrates across the sinusoidal 
lumen and space of Disse, influencing liver function. Loss of fenestrae is called defenestration 
and can be due to reductions in fenestration size and/or fenestration number. LSEC 
fenestration diameter and frequency can vary between and within species (reviewed by 
Wisse et al.) (245). For example, New Zealand white rabbits have smaller fenestrations than 
rats and more fenestrations than chickens (246-248). Changes in fenestration diameter and 
number are also observed in response to various biological mediators such as hormones 
(serotonin) (249), neurotransmitters (adrenaline and acetylcholine) and growth factors 
(vascular endothelial growth factors) (250). LSEC fenestrations are inducible structures and 
cytoskeleton plays an important role in the formation and maintenance of fenestrae and liver 
sieve; agents that alter sieve plate structure and porosity induce changes in cytoskeleton and 
vice versa. For example, actin disrupting agents such as cytochalasin B (251), jasplakinolides, 
swinolide A and latrunculin A misakinolide A (252), each with their own distinct actin-
disrupting properties alter LSEC fenestration diameter and frequency.   
Fenestration diameter and frequency can also be altered by a variety of processes affecting 
liver function. Several studies have investigated the effects of acute and chronic exposure of 
different substances and conditions on LSEC fenestrae and how these changes affect liver 
function. For example, acute and medium exposure to alcohol in rats in vivo or in isolated 
LSECs in vitro is associated with increased LSEC fenestration diameter, frequency and 
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porosity. In contrast, with chronic long-term alcohol intake, humans and mice display LSEC 
defenestration (253-255). Drugs such as pantethine increase LSEC porosity, whereas nicotine 
decreases fenestrae diameter (256). In addition, the carcinogen dimethylnitrosamine (257) 
and surfactant poloxamer-407 reduce LSEC porosity by decreasing fenestration frequency, 
which leads to defenestration. Pathological conditions such as liver cirrhosis and fibrosis 
(258), oxidative stress (259, 260), endotoxaemia, infection, inflammation (261, 262) and more 
recently, normal ageing, have also been associated with loss of LSEC fenestrae.  
1.5.4.3 Infection, inflammation and LSEC fenestrae  
LSEC fenestrae are often altered in liver diseases associated with infection and inflammation 
and their lesions may contribute to the downstream functional impairment of parenchymal 
cells. Inflammatory mediators released from Kupffer cells and LSECs play a role in the loss of 
LSEC fenestrations. Excessive stimulation of Kupffer cells and LSECs during infection or 
endotoxaemia leads to secretion of an array of mediators including proinflammatory 
cytokines and biologically-active free radicals (oxygen and nitrogen radicals), which lead to 
LSEC damage and hepatocyte injury (235, 261-263). For example, it has been shown that LPS 
induces defenestration in LSECs by the release of proinflammatory mediators from activated 
LSECs and Kupffer cells (235, 261). Recent evidence has shown that interaction between 
programmed death (PD-1)  molecule of Kupffer cells and programmed death ligand-1 (PD-L1) 
of LSECs potentiate LSEC injury in sepsis (263). These results suggest that inflammatory 





1.6 Research rationale, hypothesis and objectives  
Sepsis and septic shock are common and serious medical problems in severely ill patients and 
leading causes of morbidity and mortality in medical and surgical intensive care units. The 
inflammatory response is an integral part of sepsis and the systemic inflammatory response 
to bacterial infection during sepsis is characterised by coagulatory, hemodynamic and 
metabolic changes that contribute to the progression to septic shock, MODS and even death. 
Although antibiotic treatment may efficiently eradicate the infection, it does not specifically 
reverse systemic inflammation and its sequelae. In addition, clinical approaches based on the 
cytokines (inhibition of cytokines) have failed to improve the outcome in septic patients. A 
better understanding of the mechanisms of sepsis and its sequelae may identify novel targets 
for the development of new and effective therapies.  
Recent research has shown that H2S acts as a mediator of the inflammatory process in 
experimental disease models of sepsis. Although previous studies have indicated the 
importance of H2S in sepsis using PAG, pharmacological inhibitor of the CSE enzyme, and H2S 
donors such as NaHS, Na2S and GYY4137, these drugs have limitations to use for investigating 
the role of H2S in sepsis (43, 44, 140, 141, 174, 177, 205, 206). For example, PAG has non-
specific actions, including alteration of homocysteine metabolism (264) and inhibition of AST 
(265) and ALT (266) enzyme activities, which are unrelated to CSE enzyme inhibition. Similarly, 
the therapeutic potential of H2S donors are limited due to difficulties in obtaining precisely-
controlled concentrations and the possible toxic impact of excess H2S (133, 172, 176, 267). In 
addition, the use of these drugs in different investigations have reported both pro- and anti-
inflammatory roles of H2S in sepsis. These contradictory results showing both pro- and anti-
inflammatory effects of H2S appear to be due to the use of different pharmacological donors 
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and inhibitors of H2S. Newer and more promising alternative tools are required to further 
investigate the complex inflammatory role of H2S in sepsis.  
The gene deletion approach overcomes the disadvantages of H2S inhibitors and donors and 
offers a definitive method for investigating the role of H2S in sepsis. Hence, the first part of 
this thesis (Chapters 3 to 5) uses mice deficient in the CSE gene to study the potential role of 
H2S in CLP-induced sepsis, examines the underlying mechanisms by which H2S regulates 
inflammation and explores interaction between H2S and SP in regulating inflammatory 
response in sepsis.  
Kupffer cells are tissue-resident macrophages in the liver. They play a crucial role in the 
clearance of invading pathogenic substances from portal circulation and subsequent 
inflammatory response during sepsis. Numerous efforts have been made to elucidate the role 
of Kupffer cells in liver and lung injury, inflammation and systemic inflammatory response in 
different experimental disease models using GdCl3 and clodronate liposomes (220-222, 225-
230). However, there are many divergent findings among the published studies. These 
discrepancies might be due to the use of different experimental disease models and the 
observation of injury or inflammation in only single organs rather than multiple organ 
systems. Studying the effect of GdCl3 on multiple organ injury or inflammation using a single 
experimental disease model of sepsis that closely mimics human sepsis would help contribute 
a better understanding of the role of Kupffer cells in sepsis. Hence, the second part of this 
thesis (Chapter 6) uses GdCl3 to explore the role of Kupffer cells in liver and lung injury, 
inflammation and systemic inflammatory response in CLP-induced sepsis.  
Liver sinusoidal endothelial cells (LSECs) play an important role in the exchange of 
endogenous substrates between sinusoidal blood and hepatic parenchyma. Although the 
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physiological and pathological significance of LSEC fenestrae has been increasingly 
recognised, understanding the structural changes in LSEC fenestrae during sepsis is still at 
early stage. Studying structural alteration of LSEC fenestrae will help contribute to our 
understanding of the systemic complications associated with sepsis. Previous studies have 
demonstrated that inflammatory mediators, particularly TNF-α, play a key role in the 
structural changes of LSEC fenestrae following sepsis; however, these studies were confined 
to LPS-induced endotoxaemia (235, 261, 262). Therefore, to further explore structural 
alterations in LSEC fenestrae it is necessary to use an animal model of sepsis that mimics 
human sepsis. Furthermore, the roles of H2S and SP (as a mediators of inflammation) and 
Kupffer cells (as key resident macrophages) in the modulation of LSEC fenestrae during sepsis 
have not yet been elucidated. Therefore, the third part of this thesis (Chapter 7) explores 
structural alterations in LSEC fenestrae following sepsis and examines the effects of Kupffer 
cell inactivator GdCl3, as well as gene deletion of H2S-synthesising enzyme CSE and SP 
encoding PPTA on sepsis-induced structural alterations in LSEC fenestrae.  
The fatal outcome in sepsis is mainly due to an overwhelming inflammatory response and 
subsequent multiple organ failure. However, clinical approaches based on inflammatory 
cytokines (inhibition of cytokines) have failed to reduce fatal outcomes in septic patients. 
Studying the roles of novel inflammatory mediators such as H2S and SP will help contribute to 
our understanding of the underlying mechanisms of the inflammatory process in human 
sepsis with the aim of improving the outcome of sepsis. Previous studies using different 
experimental sepsis models have shown the importance of H2S in sepsis (43, 44, 140, 141, 
174, 177, 205, 206); however, the importance of H2S in patients with sepsis remains to be 
elucidated. In addition, circulatory SP levels have been assessed in septic patients; however, 
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these studies mainly focused on the comparison of septic patients with healthy controls and 
septic patients who survived compared to those who died. Furthermore, results contradict 
each other (201-203). It is clear that healthy controls are very different physiologically from 
patients who are acutely unwell, and acutely unwell non-septic patients experience a wide 
variety of activated stress responses that may modulate the response to sepsis. Studying the 
role of H2S and SP in human sepsis (associated with infection) in comparison to patients with 
similar disease severity and organ dysfunction from non-infectious complications is therefore 
important in the understanding precise role of H2S and SP in sepsis; however, this remains to 
be elucidated. The final part of this thesis (Chapter 8) therefore explores the alteration of 
circulatory H2S and SP in septic patients and their possible association with inflammatory 
response in septic patients compared to severely ill patients with non-infectious 
complications admitted to the hospital ICU.  
1.6.1 Hypothesis 
The hypothesis of the present thesis was to determine whether CSE-derived H2S, SP and 
Kupffer cells modulate the inflammatory response, organ injury and LSECs fenestration in CLP-
induced sepsis. To investigate this, mice deficient in the CSE gene (H2S-synthesising enzyme), 
mice deficient in the PPTA gene (SP encoding gene), and mice treated with GdCl3 (Kupffer cell 
inhibitor) were used. Furthermore, the thesis was to determine whether alteration of 
circulatory H2S and SP levels correlate with the inflammatory response in septic patients. The 





Figure 1.7 Schematic representation of hypothesis.  
1.6.2 Objectives 
The objective of this study was to investigate the role of H2S, SP and Kupffer cells on the 
inflammatory response, organ injury and LSEC fenestration following CLP-induced sepsis. 
Further, these studies aimed to investigate possible associations between circulatory H2S and 
SP levels and the inflammatory response in septic patients.  
More specifically, the study sought to examine: 
1) The role of H2S on systemic inflammation and organ injury in CLP-induced sepsis.  
2) The underlying mechanisms by which H2S regulates the inflammatory response in CLP-
induced sepsis.  
3) The role of H2S in regulating the production and release of SP and the activation of NK-
1R in CLP-induced sepsis.  
4) The role of Kupffer cells on CLP sepsis-induced organ injury, inflammation and 
systemic inflammatory response.  
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5) The role Kupffer cells, H2S and SP on CLP sepsis-induced structural changes in LSEC 
fenestrae.  
6) To determine alteration in circulatory H2S and SP levels and their association with the 




















The first part of the present study (Chapters 3 to 5) used mice deficient in the gene for the 
H2S-synthesising enzyme CSE to study the role of CSE-derived H2S in sepsis. To the best of my 
knowledge, this is the first time the role of CSE-derived H2S has been studied using CSE KO 
mice in CLP-induced sepsis. Previous research has investigated the role of H2S in sepsis using 
CSE enzyme inhibitor and H2S donors; however, pharmacological inhibitor and donors have 
limitations to their use for investigating the role of H2S in sepsis. For example, PAG has non-
specific actions such as alteration of homocysteine metabolism and inhibition of AST and ALT 
enzyme activities, which are unrelated to CSE enzyme inhibition. Similarly, the therapeutic 
potential of H2S donors such as NaHS and Na2S are limited due to difficulties in obtaining 
precisely-controlled concentrations and possible toxic impact of excess H2S. In addition, 
dosage regime, route and time of administration of H2S donors and inhibitors activate or 
inhibit different signalling pathways, which in turn produce either a pro- or anti-inflammatory 
effect in sepsis. Gene deletion technology overcomes the disadvantages of these inhibitors 
and donors and offers a definitive approach to investigate the role of CSE-derived H2S in 
sepsis. The results of this study provide evidence that contribute to our understanding of the 
potential roles of endogenous CSE-derived H2S in CLP-induced sepsis and the underlying 
mechanisms by which endogenous H2S regulates inflammation and organ injury in sepsis. 
Furthermore, the results presented in these chapters show the interaction between H2S and 
SP in regulating the inflammatory response in sepsis.  
The second part of the present study (Chapter 6) used GdCl3 to investigate the role of Kupffer 
cells in sepsis. This is the first study showing the effect of GdCl3 on CLP sepsis-induced liver 
and lung injury, inflammation and the systemic inflammatory response. Kupffer cells play an 
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important role in inflammation associated with infection; however, the role of Kupffer cells 
on the systemic inflammatory response and multiple organ failure in CLP-induced sepsis is 
unknown. This study helps to elucidate the role of Kupffer cells in liver and lung injury, 
inflammation and the systemic inflammatory response in CLP-induced sepsis.  
The third part of the present study (Chapter 7) used three different approaches (Kupffer cell 
inactivation, CSE gene deletion and PPTA gene deletion) to study the alterations in LSEC 
fenestrae in sepsis. To the best of my knowledge, this is the first study to report structural 
alterations in LSEC fenestrae following CLP-induced sepsis and the effect of GdCl3, CSE gene 
deletion and PPTA gene deletion on CLP sepsis-induced structural changes in LSEC fenestrae. 
LSEC fenestrae play a key role in the transfer of endogenous substrates and mediators 
between the sinusoidal blood and the space of Disse. Inflammation associated with infection 
causes structural changes in LSEC fenestrae; however, the alteration of LSEC fenestrae during 
inflammation associated with sepsis was unknown. This study demonstrates the structural 
alterations in LSEC fenestrae following CLP-induced sepsis and the role of Kupffer cells, CSE 
or CSE-derived H2S and SP on CLP sepsis-induced alterations in LSEC fenestrae.  
Finally, the present study investigated the alteration in circulatory H2S and SP levels and their 
association with inflammatory response in septic patients as compared to non-septic patients 
with similar disease severity and organ dysfunction admitted to the ICU (Chapter 8). The 
results of this study have increased our understanding of the role of H2S and SP during the 
inflammatory response in septic patients. They have also shed light on the correlation 
between experimental sepsis and human sepsis with regard to the proinflammatory role of 




Materials and methods 
 
2.1 Materials  
The DuoSet® Enzyme-linked Immunosorbent Assay (ELISA) Development System (for TNF-α, 
IL-6, IL-1β, MCP-1 and MIP-2α) and Substrate Reagent Pack (stabilised tetramethylbenzidine 
and hydrogen peroxide mixture) were purchased from R&D Systems (Minneapolis, USA). The 
SP Enzyme Immunoassay (EIA) kit was purchased from Peninsula Laboratories International, 
Inc. (California, USA). The TransAmTM NF-B p65 transcription factor ELISA kit (Active Motif) 
was purchased from Australian Biosearch (Wangarra, Australia). The clone 4E1-1B7 
monoclonal antibody against CSE was purchased from Abnova (Taipei, Taiwan). The rabbit 
monoclonal antibody against phospho-p44/42 MAPK (ERK1/2) and rabbit monoclonal anti-
p44/42 MAPK (pERK1/2) antibody were purchased from Cell Signalling (Boston, USA). The 
rabbit polyclonal antibody against glyceraldehyde 3-phosphate dehydrogenase (GAPDH), 
rabbit polyclonal IgG antibody against hypoxanthine phosphoribosyl transferase 1 (HPRT) and 
goat anti-mouse IgG-HRP conjugated-secondary antibody were purchased from Santa Cruz 
Biotechnology, Inc. (Texas, USA). The rabbit polyclonal antibody against NK-1R was purchased 
from Abcam (Victoria, Australia). Prestained recombinant protein molecular weight markers, 
30% acrylamide/bis solution and the DC protein assay kit were obtained from Bio-rad 
(California, USA). Halt Protease Inhibitor Cocktail and Halt Phosphatase Inhibitor Cocktail 
were purchased from Thermo Scientific Pierce Protein Biology (Rockford, USA). Nitrocellulose 
blotting membrane and filter paper (Whatman™ 3030-861) were obtained from GE 
Healthcare (Little Chalfont, UK). The chemiluminescence detection kit was purchased from 
Perkin Elmer (Massachusetts, USA). Glutaraldehyde, Grade I (25% in H2O), zinc acetate, 
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hexadecyltrimethylammonium bromide (hDMAB), calcium chloride anhydrous (CaCl2), 
paraformaldehyde (powder, 95%), trichloroacetic acid (TCA), sodium cacodylate trihydrate, 
gadolinium chloride hexahydrate (GdCl3.6H2O), ammonium persulphate (APS), glycerol, N’N’-
tetramethylethylenediamine (TEMED), Tween20, PLP, hexamethyldisilazane (HMDS), L-
cysteine, sulfuric acid (H2SO4), hydrochloric acid (HCl), Tris base, sodium dodecyl sulfate (SDS), 
ethylenediaminetetraacetic acid (EDTA), N,N-dimethyl-p-phenylenediamine sulfate (NNDM), 
ferric chloride (FeCl3), 2-mercaptoethanol, N-ethyl maleimide (NEM), sodium chloride (NaCl), 
potassium chloride (KCl), sodium hydroxide (NaOH), sodium deoxycholate, sodium 
dihydrogen phosphate (NaH2PO4), disodium hydrogen phosphate (Na2HPO4), potassium 
dihydrogen phosphate (KH2PO4) and glycine were purchased from Sigma-Aldrich (St Louis, 
USA). Sodium pentobarbital (60 mg/kg; 150 mg/kg), buprenorphine (Temgesic, 0.2mg/kg) and 
isoflurane were obtained from Christchurch Animal Research Area (CARA) and the 
commercial mice diet was obtained from Envigo (Cambridgeshire, UK).  
2.2 Buffers and solutions  









PBS was prepared by dissolving 8 g NaCl, 0.2 g KCl, 2.84 g 
Na2HPO4 and 0.2 g KH2PO4 in 1 L ultrapure water (provided in 
the facility at University of Otago-Christchurch). 
 
Tris-buffered saline (TBS) 
TBS was prepared by dissolving 2.4 g Tris base and 8 g NaCl in 
900 mL ultrapure water. pH was adjusted to 7.6 with either 
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TBST was prepared by adding 1 mL Tween20 to 1 L of TBS.  
Transfer buffer Transfer buffer for western blotting was prepared by 
dissolving 3.02 g Tris base and 14.4 g glycine in 500 mL of 
ultrapure water. To this, 100 mL of methanol was added and 
made up to 1 L with ultrapure water.  
Running buffer Upper tank buffer was prepared by dissolving 30 g Tris base, 
144 g glycine and 10 g SDS in ultrapure water; final volume 
was adjusted to 1 L with ultrapure water. 
Lower tank buffer was prepared by dissolving 20 g Tris base in 
ultrapure water; final volume was adjusted to 1 L with 
ultrapure water.  
Western blotting blocking 
solution 
Western blotting blocking solution was prepared by dissolving 
2.5 g milk powder in 50 mL TBST.  
1.5 M Tris (pH 6.8, stock 
buffer for stacking gel) 
118.20 g Tris-HCl and 90.82 g Tris base were dissolved in 700 
mL ultrapure water and pH was adjusted to 6.8 either with 
NaOH or HCl. The volume was adjusted to 1L with ultrapure 
water (solution cooled to room temperature before making 
the final pH adjustment).  
1.5 M Tris (pH 8.8, stock 
buffer for stacking gel) 
41.19 g Tris-HCl and 150 g Tris base were dissolved in 700 mL 
ultrapure water and pH was adjusted to 8.8 either with NaOH 
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or HCl. The volume was adjusted to 1L with ultrapure water 
(solution cooled to room temperature before making the final 
pH adjustment). 
Protein loading buffer (3x) To prepare 45 mL of stock, 4.5 g of SDS was dissolved in 20 mL 
of ultrapure water and then 6.25 mL 1M Tris solution (pH 
adjusted to 6.8), 15 g sucrose, 1.5 mL of 100 mM EDTA and 6 
mg bromophenol blue were added and stirred to dissolve 
before the addition of 7.2 mL 2-mercaptoethanol; final 
volume was adjusted to 45 mL with ultrapure water. 
10% stacking gel  10% stacking gel was prepared by adding 1.67 mL of 30% Bis-
acrylamide to a mixture of 1.25 mL Tris-HCl buffer (1.5 M, pH 
8.8), 1.98 mL ultrapure water, 50 µL of 10% (w/v) APS and 50 
µL of 10% (w/v) SDS. 5 µL TEMED was added immediately 
prior to pouring the gel to initiate polymerisation.  
5% resolving gel To prepare 5% resolving gel, 0.83 mL of 30% Bis-acrylamide 
solution was added to a mixture of 0.63 mL Tris-HCl buffer (1 
M, pH 6.8), 3.4 mL ultrapure water and 50 µL of 10% (w/v) 
APS,  50 µL of 10% (w/v) SDS. 5 µL TEMED was added 
immediately prior to pouring the gel to initiate 
polymerisation. 
Radioimmunoprecipitation 
assay (RIPA) buffer 
RIPA buffer was prepared by dissolving 10 mM Tris-Cl (5 mL) 
(pH 8.0), 1 mM EDTA (186 mg) (EDTA), 140 mM NaCl (500 mg), 
1% Triton X-100 (5 mL), 0.1% sodium deoxycholate, 0.1% SDS 
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(500 mg), 0.9 % NP-40 (4.5 mL) and halt protease inhibitor 
cocktail (1:100) in ultrapure water; final volume was adjusted 
to 500 mL with ultrapure water.  
Sodium phosphate buffer 
(pH 7.4) 
Sodium phosphate buffer (1 L) was prepared by combining 
774 mL NaH2PO4 and 226 mL Na2HPO4. pH was adjusted to 
7.4. 
Neutral phosphate-
buffered formalin (10%) 
To prepare 1L of 10% neutral phosphate-buffered formalin, 
100 mL of 37% stock formalin was added to 900 mL ultrapure 
water and then neutralised by dissolving 4 g NaH2PO4 and 6.5 
g Na2HPO4 into the solution.  
Electron Microscopy (EM) 
fixative 
To prepare 100 mL EM fixative, 8 g paraformaldehyde was 
dissolved in 25 mL ultrapure water by heating (65°C). 10 mL 
of 25% glutaraldehyde, 50 mL of 0.2 M sodium cacodylate 
buffer, 2 g sucrose and 2 mL of 2 mM CaCl2 were dissolved in 
the solution. pH was adjusted to 7.4 either with NaOH or HCl 
and the final volume was adjusted to 100 mL with ultrapure 
water.  
0.2 M Sodium cacodylate 
buffer 
700 mL of 0.2 M sodium cacodylate buffer was prepared by 
dissolving 22.9 g sodium cacodylate trihydrate then adding 
25.2 mL of 0.2 M HCl in 674.8 mL ultrapure water.  
0.1 M Sodium cacodylate 
buffer 
1 L of 0.1 M sodium cacodylate buffer was prepared by 
combining equal volumes of 0.2 M sodium cacodylate buffer 
(500 mL) and ultrapure water (500 mL).  
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250 mM L-cysteine 250 mM L-cysteine was prepared by dissolving 30 mg L-
cysteine in 1 mL of 20 mM pH 7.4 sodium phosphate buffer.  
2 N H2SO4 100 mL of 2 N H2SO4 was prepared by adding 5.5 mL 
concentrated H2SO4 to 94.5 mL ultrapure water.  
30 mM FeCl3 30 mM FeCl3 was prepared by dissolving 4.86 mg FeCl3 in 1 mL 
of 1.2 M HCl.  
18 mM PLP 18 mM PLP was prepared by dissolving 5 mg PLP in 1 mL of 20 
mM Na2HPO4. 
20 mM NNDM   20 mM NNDM was prepared by dissolving 4.18 mg NNDM in 




All mice were maintained in the Christchurch Animal Research Area (CARA) under specific 
pathogen-free (SPF) conditions and were allowed free access to water and sterilised 
commercial mouse diet. Experiments were performed using male mice aged between 8 and 
10 weeks old (weight 25-30 g). C57BL/6J, CSE KO (on a C57BL/6J background), BALB/c and 
PPTA KO (on a BALB/c background) mice were obtained from the CARA. PPTA KO mice were 
a gift from Prof. Allan Basbaum, University of California, San Francisco, USA. CSE KO mice 
generated by crossing CSE heterozygous mice and were a generous gift from Dr. Isao Ishii, 
Graduate School of Pharmaceutical Sciences, Keio University, Japan. All experiments were 
approved by the Animal Ethics Committee of the University of Otago-Christchurch (protocol 
number C3/13) and were performed according to established university guidelines.  
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2.4 Induction of polymicrobial sepsis in mice 
Caecal-ligation and puncture (CLP)-induced sepsis was induced according to a previously 
described protocol with minor modifications (268). Mice were randomly assigned to either a 
control (sham) or experimental group (CLP sepsis). Mice were lightly anesthetised with 
inhaled isoflurane (2% isoflurane in 1 L/min O2) and maintained with isoflurane during surgery 
(1.5% isoflurane in 1 L/min O2). Buprenorphine (Temgesic, 0.2 mg/kg, subcutaneously, s.c.) 
was administered 45 mins prior to surgery for analgesia. Sterile surgical techniques were used 
to perform the CLP operation. After shaving the abdominal fur, a topical disinfectant was 
applied. Thereafter, a small midline incision was made through the skin and peritoneum of 
the abdomen to expose the caecum. The caecal appendage was ligated with silkam 5.0 thread 
at 8-10 mm from the tip of the caecum without occluding the bowel passage then perforated 
in two-evenly spaced locations at the distal end of the caecum with a 22 gauge (22G) sized 
needle. Following this, a small amount of stool was squeezed out through both holes. Finally, 
the bowel was repositioned and the abdomen was sutured with sterile permilene 5.0 thread. 
Mice in the sham operation group underwent the same procedure without caecal-ligation 
and puncture.  
Gadolinium chloride (GdCl3, 10 mg/kg), a selective inhibitor of Kupffer cell activation or saline 
was administered before the CLP or sham operation (prophylactic). Eight hours after the 
operation, mice were euthanised by an intraperitoneal (i.p.) injection of a lethal dose of 
sodium pentobarbital (150 mg/kg). Blood samples were withdrawn from the right ventricle 
using heparinised syringes and centrifuged (1,000 g for 5 mins at 4°C). Thereafter, plasma was 
aspirated and stored at -80°C. Samples of liver and lung tissues were stored at -80°C for 
subsequent measurement.   
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2.5 Western blotting 
Liver and lung tissue lysates were prepared by homogenising ~50 mg of tissue with a Labserv 
homogeniser in ice-cold RIPA buffer supplemented with a halt protease inhibitor cocktail (and 
halt phosphatase inhibitor cocktail for p-ERK1/2). The resulting homogenates were incubated 
at 4°C for 30 mins and centrifuged (10,000 g for 10 mins at 4°C). The clear lysates 
(supernatants) were collected and measured for protein content using the Bio-rad DC protein 
assay and bovine serum albumin (BSA) protein standards as reference. Samples were run on 
a 10% SDS-PAGE gel under reducing conditions with an equal loading of 15 µg of protein from 
each sample per well. Gels were run (using the running buffer) at a constant 200 V until the 
gel front had run out, then transferred (using transfer buffer) onto a 0.45 m nitrocellulose 
membrane and run at a constant 100 V for 1 h using a Bio-rad system. Membranes were then 
rinsed in TBST and blocked with 5% non-fat dry milk prepared in TBST. Blots were cut at the 
37 kDa Mw marking and each portion of the membrane was probed for CSE (~42 kDa; 
1:1,000), anti-ERK1/2 and anti-p-ERK1/2 (~44/42 kDa; 1:2,000), NK-1R (~46 kDa; 1:1,000), and 
GAPDH (~35 kDa; 1:2,000) or HPRT (~23 kDa; 1:1,000) in blocking buffer overnight at 4°C. 
Blots were then washed with TBST three times for 10 mins each then probed with the 
corresponding HRP-conjugated secondary antibody (1:10,000) for 2 h at room temperature. 
Blots were then washed with TBST three times for 10 mins each with a final TBS rinse for 5 
mins. Blots were incubated with a chemiluminescence substrate for 1 min and visualised on 
a chemi-doc system (Uvitec, UK). Bands were semi-quantitated using Alliance 4.2 software 





2.6 H2S-synthesising activity assay  
H2S-synthesising activity in the liver and lung homogenates were measured with a modified 
protocol based on the method described previously (269). Liver and lung tissues (~50 mg 
each) were homogenised using a Labserv homogeniser in 20 mM ice-cold sodium phosphate 
buffer (pH 7.4) with a protease inhibitor cocktail. The reaction mixture contained tissue 
homogenate (230 µL) in 20 mM sodium phosphate buffer (pH 7.4), L-cysteine (10 µL, 250 mM) 
and PLP (10 µL, 18 mM). The reaction was performed in tightly parafilm-sealed microfuge 
tubes and initiated by transferring the tubes from ice to a shaking water bath at 37°C. After 
incubation for 30 mins, 1% w/v zinc acetate (125 µL) was injected to trap evolved H2S. 
Subsequently, a mixture of NNDM (20 mM) in 7.2 M HCl and FeCl3 (30 mM) in 1.2 M HCl (133 
µL, in 1:1 ratio) was injected. Samples were left to incubate at room temperature in the dark 
for 20 mins. Following this, 10% v/v TCA (25 µL) was added to denature the protein and stop 
the reaction. After centrifugation (20,000 g for 10 mins at 4°C), the absorbance of the clear 
supernatant (200 µL) was measured in a 96-well microplate using a spectrophotometer 
(Varioskan flash, Thermo Fisher Scientific) at 670 nm. The H2S concentration was calculated 
against a calibration curve of sodium sulfide (Na2S). Results were then corrected for the 
protein content of the tissue sample determined by the Bio-rad DC protein assay and 
expressed as nmole H2S formed per mg protein.  
2.7. Plasma H2S measurement 
Plasma H2S levels were measured with a modified protocol based on the method described 
previously (270). The reaction mixture contained plasma (100 µL), 20 mM sodium phosphate 
buffer (pH 8.5) (100 µL), L-cysteine (10 µL, 250 mM), PLP (10 µL, 18 mM), 1% w/v zinc acetate 
(100 µL) and a mixture of NNDM (20 mM) in 7.2 M HCl and FeCl3 (30 mM) in 1.2 M HCl (80 µL, 
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in 1:1 ratio). Samples were left to incubate at room temperature in the dark for 20 mins. 
Following this, 10% v/v TCA (120 µL) was added to denature the protein and stop the reaction. 
After centrifugation (7700 g for 5 mins at 4°C), the absorbance of the clear supernatant (150 
µL) was measured in a 96-well microplate using a spectrophotometer (Varioskan flash, 
Thermo Fisher Scientific) at 670 nm. The H2S concentration was calculated against a 
calibration curve of Na2S. Results were expressed as µmole H2S formed per mL plasma.  
2.8 Tissue myeloperoxidase activity measurement  
Leukocyte sequestration in liver and lung tissues was quantified by measuring tissue MPO 
activity as described previously with minor modifications (129). Tissue samples were thawed 
and homogenised using a Labserv homogeniser in ice-cold 20 mM sodium phosphate buffer 
(pH 7.4) (~50 mg/mL) supplemented with a protease inhibitor cocktail. Homogenates were 
then centrifuged (10,000 g for 10 mins at 4°C) and the resulting pellet resuspended in 50 mM 
phosphate buffer (pH 6.0) containing 0.5% w/v hDMAB. The suspension was subjected to 
three cycles of freezing and thawing and further disrupted by sonication on ice (20% power, 
80% pulse for 40 seconds). Samples were then centrifuged (10,000 g for 5 mins at 4°C) and 
the supernatant was used for the MPO activity assay. The reaction mixture consisted of 
supernatant (50 μL), stabilised tetramethylbenzidine and hydrogen peroxide mixture (reagent 
volume: 100 μL). This mixture was incubated at room temperature for ~10 mins for the colour 
to develop and the reaction was terminated with 50 μL of 2 N H2SO4. Absorbance was 
measured using a spectrophotometer (Varioskan flash, Thermo Fisher Scientific) at 450 nm 
with a 570 nm correction. This absorbance was then corrected for the protein content of the 
tissue sample using results from the Bio-rad DC protein assay. The results were expressed as 
fold increases over the control.  
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2.9 Morphological examination of liver and lung damage 
Samples of liver and lung were fixed in 10% v/v neutral phosphate-buffered formalin for 24 h 
at room temperature without rotation and subsequently impregnated in paraffin wax before 
being sectioned to 4-5 m slices and mounted onto microscopic slides. Liver and lung tissue 
sections were dehydrated through a graded ethanol series (100% to 80%) and stained by the 
Christchurch Anatomical Pathology Department with hematoxylin and eosin. Three sections 
were prepared for each liver and lung sample and were examined by light microscopy using 
a Carl-Zeiss Microscope (Axiocam, Germany) (objective lens magnification of ×20; eyepiece 
magnification of ×10). Ten random images (Imager.Z1) from each section of liver and lung 
were taken and assessed for liver and lung pathology. Liver images were assessed for capsular 
inflammation and lobular necrotic damage using modified Knodell Histology Activity Index 
(HAI) of blinded scoring system of liver injury (271, 272), while lung sections were assessed 
for leukocyte infiltration and alveolar wall thickening using blinded lung injury scoring system 
suggested by American Thoracic Society guidelines (273).  
2.10 Measurement of sulfur amino acid homocysteine using HILIC-MS/MS 
A hydrophilic interaction liquid chromatography-mass spectrometry (HILIC-MS/MS) 
technique was used to measure homocysteine levels with a modified protocol based on the 
method described previously (274).  
For measurement of homocysteine, liver and lung tissues (~50 mg each) were homogenised 
using a Labserv homogeniser in 1 mL sodium phosphate buffer (pH 7.4) with a protease 
inhibitor cocktail and centrifuged (1,000 g for 10 mins at 4°C). Supernatants were collected in 
separate tubes and protein content was measured using the Bio-rad DC protein assay and 
57 
 
normalised by diluting with sodium phosphate buffer (pH 7.4). Protein-corrected liver and 
lung supernatants and plasma were treated with an addition of 9-fold excess of acetonitrile 
to sample (20 µL of the sample with 180 µL of acetonitrile added). The samples were left in 
the freezer (-20°C) for 30 mins then centrifuged (1,000 g for 10 mins at 4°C) to collect the 
supernatants. These supernatants were then injected onto the HILIC-MS/MS for 
measurement of homocysteine.  
Chromatography was performed using a Dionex (Sunnyvale, USA) 3000 HPLC. Separation was 
achieved using a Luna HILIC 100 x 2 mm, 3 micron column (Phenomenex, Torrance, USA). The 
sample (20 µL) was injected with a gradient of two solvents (solvent A, ammonium formate 
20 mM, pH 4.2 and solvent B, acetonitrile). Initial conditions were 85% B/15% A at 0.2 mL/min 
flow rate. This was held for 8 mins followed by a gradient of 50/50 over 2.5 mins before re-
equilibration. The column was held at 40°C and samples were kept at 4°C.  
Effluent from the HPLC was directed to a Sciex (Framingham, USA) 4000 QTrap mass 
spectrometer after the first 3 mins. Detection was performed using electrospray ionisation in 
positive mode with multiple reaction monitoring, with needle spray at 4.5 kV, detector 
temperature at 40°C and collisional energy of 24. Homocysteine was monitored using 136.2 
to 90 m/z and this analyte was also confirmed using secondary ions. Data analysis was 
performed using Analyst 1.6 (Sciex, California, USA) and homocysteine levels were expressed 
as mass intensity in arbitrary units (A.U.).  
2.11 Preparation of nuclear extract and determination of NF-κB p65 activation 
Nuclear extracts from liver and lung tissues were prepared using a Nuclear Extraction Kit as 
described by the manufacturer’s protocol (Active Motif, Tokyo, Japan). Liver and lung 
homogenates were prepared by homogenising ~50 mg tissue in 200 µL ice-cold Complete 
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Lysis Buffer (10 mM dithiothreitol (DTT) (0.2 µL), lysis buffer (178 µL), protease inhibitor 
cocktail (2 µL) and phosphatase inhibitor cocktail (20 µL)) on ice using a Labserv homogeniser 
and incubated for 30 mins at 4°C. Tissue homogenates were centrifuged (10, 000 g, 10 mins 
at 4°C) and supernatant/nuclear extract was measured for protein content using the Bio-rad 
DC protein assay. The protein-corrected nuclear extracts were used to measure NF-B p65 
activation.    
To monitor NF-B p65 activation in liver and lung nuclear extracts, a TransAM NF-B p65 
Transcription Factor Assay Kit was used following the manufacturer’s instructions and as 
described previously (275). The kit consists of a 96-well plate, onto which oligonucleotide 
containing the NF-B consensus site (5’-GGGACTTTCC-3’) is bound. The active form of NF-B 
p65 in the nuclear extracts (20 µg) specifically binds to this consensus site and is recognised 
by a primary antibody specific for the activated form of p65 of NF-B. A HRP-conjugated 
secondary antibody provides the basis for the colorimetric quantification. The absorbance of 
the resulting solution was measured 2 mins later (450 nm with a reference wavelength of 655 
nm) using a spectrophotometer (Spectramax, Molecular Devices, USA). The wild-type 
consensus oligonucleotide is provided as a competitor for NF-B p65 binding to monitor the 
specificity of the assay. Results were expressed as fold increases over the control group. 
2.12 Cytokine and chemokine measurement by enzyme-linked immunosorbent 
assay  
Liver, lungs and plasma TNF-α, IL-6, IL-1β, MCP-1 and MIP-2α were measured using ELISA Duo 
Set kits from R&D Systems according to the manufacturer’s protocol. Liver and lung 
homogenates were prepared by homogenising ~50 mg tissue in 1 mL 20 mM sodium 
phosphate buffer (pH 7.4) supplemented with a protease inhibitor cocktail on ice using a 
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Labserv homogeniser. Homogenates were centrifuged (10,000 g for 10 mins at 4°C) and 100 
µL of the supernatant (or 100 µL of plasma) was used for each assay. Each kit consisted of a 
capture and biotin-conjugated detection antibody pair, standards and streptavidin-HRP 
conjugate. ELISA specific plates (Corning, USA) were first coated with capture antibody in PBS 
overnight at room temperature. Plates were then aspirated, washed with PBST (0.05% w/v) 
and blocked with 300 L of BSA (1% w/v) for 1 h at room temperature, followed by washing 
and addition of 100 L samples or standards. After 2 h incubation, plates were decanted, 
washed and 100 L of biotin-conjugated detection antibody was added. After 2 h incubation, 
plates were decanted, washed and 100 L of streptavidin-conjugated HRP was added. After 
a 20 min incubation, plates were decanted, washed and 100 L of substrate reagent was 
added. Plates were incubated at room temperature for up to 20 mins to allow the colour to 
develop and the reaction was terminated by addition of 50 L 2 N H2SO4. Plates were read at 
450 nm on a spectrophotometer (Spectramax, Molecular Devices, USA) with a 570 nm 
correction. Cytokine and chemokine levels were corrected for total protein content measured 
using the Bio-rad DC protein assay and expressed as pg or ng per mg protein in tissue samples 
or ng per mL in plasma.  
2.13 Measurement of SP levels 
SP levels in liver and lung tissues and plasma were measured using the peptide EIA kit from 
Peninsula Laboratories according to the manufacturer’s protocol and as described previously 
(204, 275). Liver and lung tissues (~50 mg of each) were homogenised by adding 1 mL ice-cold 
SP assay buffer (for plasma, an equal amount of assay buffer was added) on ice using a Labserv 
homogeniser. The homogenates were centrifuged (17,000 g for 20 mins at 4°C) and 
supernatants were collected. SP levels were extracted using C18 cartridge columns (Bachem) 
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as described in the manufacturer’s protocol. The C18 columns were equilibrated using Buffer 
A (1% trifluoroacetic acid, TFA) and thereafter, samples were loaded onto the equilibrated C18 
columns. The adsorbed peptide was eluted with Buffer B (60% acetonitrile, 1% TFA and 39% 
distilled water). The samples were freeze-dried and reconstituted in the SP assay buffer.  
SP content in the samples was determined with an EIA kit according to the manufacturer's 
instructions. Each kit consisted of a capture and biotin-conjugated detection antibody pair, 
standards and streptavidin-HRP conjugate. Standards or samples (50 µL of each) and 25 µL 
antiserum were added to precoated (with captured antibody and blocked with 1% BSA) EIA 
plates and incubated for 1 h at room temperature. Thereafter, 25 µL biotin-conjugated 
detection antibody was added. After 2 h incubation, plates were decanted, washed with 300 
µL EIA buffer and 100 µL of streptavidin-conjugated HRP was added. After a 20 min 
incubation, plates were aspirated, washed with 300 µL EIA buffer and 100 µL of TMB solution 
was added. Plates were incubated at room temperature for 30-60 mins to allow the colour to 
develop and the reaction was terminated by addition of 100 µL 2 N H2SO4. Plates were read 
at 450 nm on a spectrophotometer (Spectramax, Molecular Devices, USA) with a 570 nm 
correction. Results were then corrected for the protein content of the tissue samples and 
were expressed as ng per mg protein or ng per 100 µL plasma.  
 
2.14 Measurement of procalcitonin levels  
 
Plasma procalcitonin (PCT) was measured using the ELISA DuoSet kit from R&D Systems 
according to the manufacturer’s protocol. Each kit consisted of a capture and biotin-
conjugated detection antibody pair, standards and streptavidin-HRP conjugate. ELISA-specific 
plates (Corning, USA) were first coated with capture antibody in PBS overnight at room 
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temperature. Plates were then aspirated, washed with PBST (0.05% w/v) and blocked with 
300 L of BSA (1% w/v) for 1 h at room temperature followed by washing and addition of 100 
L plasma or standards. After 2 h incubation, plates were decanted, washed and 100 L of 
biotin-conjugated detection antibody was added. After 2 h incubation, plates were decanted, 
washed and 100 L of streptavidin conjugated-HRP was added. After a 20 min incubation, 
plates were decanted, washed and 100 L of substrate reagent was added. Plates were 
incubated at room temperature for up to 20 mins to allow the colour to develop and the 
reaction was terminated by addition of 50 L 2 N H2SO4. Plates were read at 450 nm on a 
spectrophotometer (Spectramax, Molecular Devices, USA) with a 570 nm correction. PCT 
concentration was expressed as pg per mL in plasma.  
2.15 Scanning electron microscopy  
2.15.1 Liver perfusion and fixation (primary fixation)  
Sample preparation for scanning electron microscopy (SEM) was performed as described 
previously (276). Eight hours after sham or CLP operation, mice were anaesthetised with a 
single i.p. injection of sodium pentobarbital (80 mg/kg). A large midline laparotomy incision 
was made and liver and portal vein were exposed. The portal vein was cannulated with a 22G 
sized intravenous (i.v.) cannula. Liver perfusion was commenced first with approximately 5-
20 mL PBS (pH 7.4; warmed to 37°C) at a pressure of 15 cm height. The vena cava was severed 
before commencing perfusion to minimise outflow resistance and high perfusion pressures. 
PBS was then replaced with EM fixative and perfused for approximately 5 mins until the liver 
was hardened and very pale. Following adequate fixation, the liver was excised, weighed and 
placed in a small amount of fresh EM fixative. Random samples of liver were cut into 1-2 mm3 
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blocks using a sharp scalpel and blocks were immersed in fresh EM fixative for approximately 
24-72 h at 4°C (post-fixation).  
2.15.2 Processing of tissue blocks (secondary fixation) 
After post-fixation, the liver blocks were washed for 5 mins, three times in 0.1 M sodium 
cacodylate buffer and fixed in 2% osmium tetroxide in 0.1 M sodium cacodylate buffer for 2 
h to impregnate the tissue with a heavy metal for interaction with the electron beam. 
Specimens were again washed for 5 mins, three times in 0.1 M sodium cacodylate buffer. 
Specimens were gradually dehydrated in an increasing ethanol gradient: 50% ethanol (twice 
for 10 mins), 70% ethanol (twice for 10 mins), 90% ethanol (twice for 10 mins), 95% ethanol 
(twice for 10 mins) and finally 100% dehydrated ethanol (four times for 5 mins).  
2.15.3 Tissue preparation for scanning electron microscopy  
Processing for SEM involved the complete drying of the tissue. All the ethanol was replaced 
with HMDS and samples were incubated for 10 mins then left for overnight in a fume hood to 
allow residual HMDS to be evaporated. The liver specimen blocks were mounted onto SEM 
slug mounts under the dissecting microscope then coated with a thin layer of platinum using 
the sputter coater to increase the electrical conductivity.  
2.15.4 Tissue examination with scanning electron microscope  
Randomly selected blocks of liver were examined with a JSM6380 SEM (JEOL, Japan) at 15 kV 
acceleration voltage. Examination at low magnification was performed to assess successful 
fixation and tissue drying.  At least ten images of the sinusoidal endothelial cells from each 
mounted slug were taken at 15,000× magnification for visualisation of endothelial lumen 
surface and fenestrations. Fenestration number and diameter were measured, together with 
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total area assessed, using Image J (NIH). These data were used to calculate the porosity (the 
percentage of the LSEC surface area covered with fenestrations) (276).  
2.16. Measurement of plasma ALT and AST activity levels 
Eight hours after CLP or a sham operation, mice were sacrificed and blood samples were 
withdrawn from the right ventricle using heparinised syringes. Plasma was collected following 
centrifugation (1,000g for 5 mins at 4°C) and the ALT and AST activity levels were measured 
following established protocols at Canterbury Health Laboratories, Christchurch, New 
Zealand. The results of ALT and AST activity levels were expressed in U/L. 
2.17 Statistical analysis  
Data are presented as mean + S.E.M. Statistical analysis was performed using GraphPad Prism 
Software version 6.07. (GraphPad Software Incorporated, La Jolla, CA, USA). All experimental 
data were analysed for Gaussian or Normal distribution using the Shapiro-Wilk test. One-way 
Analysis of Variance (ANOVA) with post-hoc Tukey’s test was performed with the Gaussian 
distribution data and a non-parametric Kruskal-Wallis test was performed with the data that 
were not followed Gaussian distribution to compare multiple groups. A P-value of less than 








Chapter 3  
Effect of CSE gene deletion on leukocyte infiltration and organ damage following 
caecal-ligation and puncture-induced sepsis in mice  
 
3.1 Introduction  
Hydrogen sulfide (H2S) has been well known for several decades as a toxic gas with the smell 
of rotten eggs (277, 278). However, it is also generated endogenously through the 
transsulfuration pathway catalysed by CBS and CSE enzymes (279). The sulfur amino acids 
such as homocysteine and cysteine, are the intermediate precursors for H2S synthesis through 
CBS and CSE enzymes (280). Of these two enzymes, CSE is the predominant H2S-synthesising 
enzyme, with significant biological functions in the peripheral organs (281).  
In recent years, H2S has been identified as a mediator of inflammation (43, 44, 173, 174, 177, 
277, 282). H2S synthesised through CSE acts as a proinflammatory mediator in various 
inflammatory conditions including, endotoxaemia (127, 172), haemorrhagic shock (282) and 
sepsis (126, 140, 177). Studies on endotoxaemia-induced by LPS injection showed an increase 
in H2S synthesis and has been associated with inflammation, leukocyte infiltration and 
multiple organ damage (127, 172, 173). However, LPS-induced endotoxaemia does not 
accurately reflect the cytokine profiles and hemodynamic changes of human sepsis (9). 
Alternatively, another disease model, CLP-induced sepsis has been used to study the 
pathogenesis of sepsis that mimics the cytokine profiles and hemodynamic changes of human 
sepsis and has been shown to promote significant inflammatory response (283). Recent 
studies have shown that increased CSE expression and H2S levels are associated with 
leukocyte infiltration and organ injury following CLP-induced sepsis (126, 140, 177). For 
example, it has been shown that treatment with CSE enzyme inhibitor PAG inhibits leukocyte 
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infiltration and liver and lung injury following CLP-induced sepsis (44, 140). These studies 
suggest the significance of H2S in the inflammatory process in sepsis.  
The sulfur amino acid homocysteine plays an important role in immune function and 
inflammation, as well as being one of the intermediate precursors of H2S synthesis (280, 284). 
Homocysteine acts as a potential proinflammatory compound that enhances the production 
of specific cytokines and contributes to the pathogenesis of inflammatory diseases (285, 286). 
Alteration of homocysteine levels has been reported in various inflammatory diseases such 
as cardiovascular diseases (287-289), diabetes (290), cirrhosis (291), rheumatoid arthritis 
(284), chronic kidney damage (CKD) (292) and sepsis (293, 294). For example, it has been 
demonstrated that higher circulating concentrations of TNF-α are significantly correlated with 
hyperhomocysteinemia in atherosclerosis (289). Recent studies have shown that 
homocysteine also induces chemokines such as MCP-1 and MIP-2α in mesangial cells and that 
the induction of these inflammatory mediators is linked to the adverse outcomes in patients 
with cardiovascular disease and CKD (295-298). Furthermore, it has been shown that an early 
increase in plasma homocysteine levels is associated with poor outcomes in patients with 
sepsis (293, 294, 299). Elevated levels of homocysteine have also been observed in peripheral 
blood nuclear cells when exposed to inflammatory stimuli in vitro (300, 301). Based on 
previous research, homocysteine has been implicated in promoting inflammation in several 
different conditions including sepsis.  
The interaction between H2S and homocysteine has been reported in various pathological 
conditions. Although homocysteine is one of the precursors of H2S synthesis and high levels 
of homocysteine seem to promote H2S generation, it has been reported that increased 
peripheral blood levels of homocysteine (or hyperhomocysteinemia) are associated with 
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decreased CSE expression and H2S synthesis (302, 303). For example, it has been shown that 
CSE expression and H2S production are attenuated in the renal cortical tissue of 
hyperhomocysteinemia mice (292). In addition, Li et al. have shown decreased CSE expression 
and H2S production in macrophages exposed to homocysteine in vitro (264). Furthermore, 
mouse glomerular mesangial cells stimulated with homocysteine increase MCP-1 and MIP-2α 
production while endogenous H2S production is decreased (303). Conversely, treatment with 
H2S in conjunction with CSE cDNA over-expression markedly reduced homocysteine-mediated 
upregulation of MCP-1 and MIP-2α in mesangial cells (303). Similarly, H2S prevents renal 
damage and regulates inflammation associated with hyperhomocysteinemia in 
glomerulosclerosis mice (292, 304). Together, these previous studies suggest counter-
regulatory interactions occur between homocysteine, CSE expression and H2S production 
during inflammation in different pathological conditions.  
Although the inflammatory role of H2S has been studied in sepsis using the CSE inhibitor PAG, 
these studies have limitations due to there being possible actions of PAG that are unrelated 
to CSE; this has led to criticism of studies where PAG has been used. For example, PAG has 
non-specific actions such as alteration of homocysteine metabolism (264) and inhibition of 
AST (265) and ALT (266) enzyme activities, which are unrelated to CSE enzyme inhibition. In 
addition, previous studies using H2S inhibitors and donors have reported the anti-
inflammatory effect of H2S in sepsis (305, 306). It is clear that newer and more promising 
alternative tools are required to further investigate the complex biological roles of H2S in 
sepsis. Gene deletion technology offers a definitive approach to investigate the roles of H2S 
in sepsis. In addition, alteration in homocysteine levels and its impact on H2S synthesis remain 
unknown in CLP-induced sepsis.  
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The objective of the present study was to determine whether CSE gene deletion modulates 
homocysteine and H2S synthesis and consequently liver and lung injury in sepsis.  
3.2 Aims 
The present study aimed to determine the effect of H2S-synthesising enzyme CSE gene 
deletion on leukocyte infiltration (as evidenced by MPO activity), homocysteine levels, H2S 
synthesis, and liver and lung injury (evidenced by the amount of oedema and necrosis in the 
tissues). To investigate this, an animal model of CLP-induced sepsis was used in mice deficient 
in the CSE gene and CSE protein expression, H2S-synthesising activity, H2S levels and 
homocysteine levels were measured. Disease severity was assessed by leukocyte infiltration 
and liver and lung damage.  
3.3 Experimental approach 
Thirty two WT (C57BL/6J) and CSE KO (on a C57BL/6J background) (males aged between 8-10 
weeks; 25-30 g) mice were randomly divided into control (WT Sham and CSE KO Sham) and 
experimental (WT Sepsis and CSE KO Sepsis) groups, with eight mice in each group (n=8). 
Sepsis was induced by CLP as described in Section 2.4 and 8 h after CLP or sham operation, 
mice were euthanised by an i.p. injection of pentobarbital (150 mg/kg). Thereafter, blood was 
aspirated, plasma separated and stored at -80°C. Liver and lung tissues were processed and 
stored at -80°C. Subsequently, CSE protein expression (Section 2.5), H2S-synthesising activity 
(Section 2.6), MPO activity (Section 2.8), liver and lung injury (Section 2.9) and homocysteine 
levels (Section 2.10) were measured by the methods described in the Material and Methods 











Figure 3.1 CSE protein expression in WT and CSE KO mice following CLP-induced sepsis. WT and CSE 
KO mice underwent CLP or sham operation. Sham operated mice acted as controls. Eight hours after 
CLP or sham operation, mice were sacrificed and liver and lung tissues were processed to measure CSE 
protein expression in the liver (A and B) and lungs (C and D) by western blotting. After densitometry 
analysis, the data were expressed as ratios of CSE to GAPDH (plotted as the relative-fold increase of 
CSE expression over the sham control). For western blot results, each lane represents a separate 
animal. The blots showed representative of all mice in each group with similar results. There was a 
significant increase in CSE protein expression in the liver and lungs following CLP-induced sepsis 
compared to the sham group in WT mice. There was no CSE protein expression in the liver and lungs of 
CSE KO mice. Data represent mean ± S.E.M. (n=8). The significance of differences among groups was 
evaluated by ANOVA with post-hoc Tukey’s test. Statistical significance was assigned as **P<0.01 and 
***P<0.001. 
 
CLP-induced sepsis resulted in a significant increase of CSE protein expression in both liver 
and lung compared to WT mice that underwent sham operation (liver: 1.98-fold increase 
(P<0.001); lung: 2.49-fold increase (P<0.01)). As expected, CSE protein expression did not 
occur at detectable levels in the liver and lung tissues of CSE KO mice, irrespective of sham 
and CLP operation (Figure 3.1).  
3.4.2 H2S-synthesising activity and H2S levels in WT and CSE KO mice following CLP-induced 
sepsis  
Following CLP-induced sepsis, there was a significant increase in liver H2S-synthesising activity 
and plasma H2S levels compared to WT mice that underwent a sham operation (H2S 
synthesising activity, 35.64 ± 6.88 nmole/mg vs 27.90 ± 4.33 nmole/mg, P<0.05; and H2S 
levels,  3.90 ± 0.31 µmole/mL vs 2.68 ± 0.28 µmole/mL). Mice deficient in the CSE gene 
showed significantly lower liver H2S-synthesising activity and plasma H2S levels compared to 
WT mice following CLP-induced sepsis (6.10 ± 3.25 nmole/mg vs 35.64 ± 6.88 nmole/mg, 
P<0.0001; and H2S levels,  1.72 ± 0.19 µmole/mL vs 3.90 ± 0.31 µmole/mL). These results 
suggest that CSE is the major H2S-synthesising enzyme present in the liver. The experiments 
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in this study failed to detect any measurable levels of H2S-synthesising activity in lungs using 
the method described in Section 2.6 (Figure 3.2).  
 
Figure 3.2 Liver H2S-synthesising activity and H2S levels in WT and CSE KO mice following CLP-induced 
sepsis. WT and CSE KO mice underwent CLP or sham operation. Sham operated mice acted as controls. 
Eight hours after CLP and sham operation, mice were sacrificed and liver tissue and blood were 
processed to measure H2S-synthesising activity and H2S levels, respectively using spectrophotometric 
assay. H2S-synthesising activity and H2S levels increased following CLP-induced sepsis compared to 
sham control in WT mice. CSE KO mice showed lower H2S-synthesising activity and H2S levels compared 
to WT mice following sepsis. Data represent mean ± S.E.M. (n=8). The significance of differences among 
groups was evaluated by ANOVA with post-hoc Tukey’s test. Statistical significance was assigned as 
*P<0.05, **P<0.01 and ****P<0.0001.  
 
3.4.3 Measurement of liver and lung leukocyte infiltration in WT and CSE KO mice following 
CLP-induced sepsis 
Leukocyte infiltration was assessed by measuring liver and lung MPO activity, as an increase 
in MPO activity reflects leukocyte infiltration into these organs. WT mice with CLP-induced 
sepsis showed significantly higher MPO activity in the liver and lungs compared to sham 
operated control mice, with mean fold increases of 1.62 (P<0.05; liver) and 1.91 (P<0.01; 
lung), respectively. The CLP-induced sepsis CSE KO mice showed significantly lower MPO 
71 
 
activity in the liver and lungs compared to WT sepsis mice, with mean fold decreases of 0.91 
vs 1.62  (P<0.01; liver) and 1.00 vs 1.91 (P<0.01; lung), respectively (Figure 3.3). 
 
Figure 3.3 Leukocyte infiltration in the liver and lungs of WT and CSE KO mice following CLP-induced 
sepsis. WT and CSE KO mice underwent CLP or sham operation. Sham operated mice acted as controls. 
Eight hours after CLP or sham operation, mice were sacrificed and liver and lung tissues were processed 
to measure MPO activity in the liver (A) and lungs (B) using spectrophotometric assay. MPO activity 
increased significantly in the liver and lungs of WT mice following CLP-induced sepsis compared to 
sham control. CSE KO mice showed significantly less MPO activity in the liver and lungs compared to 
WT mice following CLP-induced sepsis. Data represent mean ± S.E.M. (n=8). The significance of 
differences among groups was evaluated by ANOVA with post-hoc Tukey’s test. Statistical significance 
was assigned as *P<0.05 and **P<0.01. 
 
 
3.4.4 Liver and lung injury in WT and CSE KO mice following CLP-induced sepsis  
 
Both WT and CSE KO mice showed the typical effects of injury on the liver and lungs following 
CLP-induced sepsis. Liver sections stained with hematoxylin and eosin from WT mice after CLP 
operation were characterised by capsular inflammation, slight hepatocyte necrosis and 
marginated, pavemented and transmigrated neutrophils that could be easily observed 
compared to tissues from sham operated control and CSE KO sepsis (and sham operated) 
mice. Lung sections from the WT mice after CLP operation exhibited characteristic signs of 
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lung injury, including interstitial oedema, alveolar thickening, severe leukocyte infiltration in 
the interstititum and alveoli compared to CSE KO sepsis mice. Normal lung histoarchitecture 









Figure 3.4 Morphological changes in the liver and lungs of WT and CSE KO mice following CLP-
induced sepsis. WT and CSE KO mice underwent CLP or sham operation. Sham operated mice acted as 
controls.  Eight hours after CLP or sham operation, mice were sacrificed and liver and lung tissues were 
processed for histological examination using hematoxylin and eosin staining. Haematoxylin (purple) 
stains nucleic acids (cell nucleus), while eosin (pink) stains protein non-specifically (cell cytoplasm and 
extracellular matrix). Liver images were assessed for capsular inflammation and lobular necrotic 
damage using modified Knodell Histology Activity Index (HAI) of blinded scoring system of liver injury 
(271, 272), while lung sections were assessed for leukocyte infiltration and alveolar wall thickening 
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using blinded lung injury scoring system suggested by American Thoracic Society guidelines (273). 
Representative liver (A) and lung (B) sections show capsular inflammation and focal necrosis in the 
liver and leukocyte infiltration and alveolar thickening in the lungs as a result of CLP-induced sepsis in 
WT mice. CSE KO mice showed less capsular inflammation and focal necrosis in liver and reduced 
leukocyte infiltration and alveolar thickening in lungs following CLP-induced sepsis. Data represent 
mean ± S.E.M. (n=8). The significance of differences between groups was evaluated by non-parametric 
Kruskal–Wallis test. Statistical significance was assigned as *P<0.05 and **P<0.01.  
 
3.4.5 Alteration of homocysteine levels in WT and CSE KO mice following CLP-induced sepsis  
 
Figure 3.5 Alteration of homocysteine levels in WT and CSE KO mice following CLP-induced sepsis. 
WT and CSE KO mice underwent CLP or sham operation. Sham operated mice acted as controls. Eight 
hours after CLP or sham operation, mice were sacrificed and liver and lung tissues and plasma were 
processed to measure homocysteine levels in the liver (A), lungs (B) and plasma (C) using HILIC-MS/MS. 
WT mice with CLP-induced sepsis showed lower liver and plasma levels of the homocysteine compared 
to sham control group. Mice with CSE gene deletion showed significantly lower homocysteine levels in 
the liver and plasma compared to WT mice, which were further lowered in sepsis mice compared to 
the sham operated group in CSE KO mice. There was no significant difference in lung homocysteine 
levels between sepsis and sham groups of both WT and CSE KO mice and between WT and CSE KO 
mice. Data represent mean ± S.E.M. (n=8). The significance of differences among groups was evaluated 
by ANOVA with post-hoc Tukey’s test. Statistical significance was assigned as *P<0.05, **P<0.01 and 
****P<0.0001.   
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WT mice with CLP-induced sepsis showed lower liver and plasma levels of homocysteine 
compared to the sham control group (liver: 0.58 ± 0.09 vs 0.85 ± 0.10; plasma: 0.33 ± 0.05 vs 
0.79 ± 0.09; P<0.0001). Mice with CSE gene deletion showed significantly lower homocysteine 
levels in the liver and plasma compared to WT mice, which were further lowered in sepsis 
mice compared to sham group in CSE KO mice. There was no significant difference in lung 
homocysteine levels between sepsis and sham operated groups of both WT and CSE KO mice 
and between WT and CSE KO mice (Figure 3.5).  
3.5 Discussion  
The present study demonstrated an important role of the H2S-synthesising enzyme CSE on 
leukocyte infiltration and liver and lung injury following CLP-induced sepsis. Mice with CLP-
induced sepsis showed increased liver and lung injury that could be characterised both 
biochemically (leukocyte infiltration, as evidenced by MPO activity) and histologically 
(hematoxylin and eosin stained sections, evidenced by oedema and necrosis). Increased CSE 
protein expression, H2S-synthesising activity and H2S levels are correlated with MPO activity 
and liver and lung injury in CLP-induced sepsis. The results in the CSE KO mice showed less 
H2S-synthesising activity and H2S levels, decreased MPO activity, and liver and lung damage 
following CLP-induced sepsis. These results confirm the previous studies on endogenous H2S 
synthesis through CSE on organ injury and inflammation in sepsis (43, 44, 174, 177, 277). For 
example, prophylactic and therapeutic administration of PAG protected mice against sepsis-
induced inflammation characterised by a decrease in liver and lung MPO activity (44, 140, 
177). Of even greater significance, PAG pre-treatment and post-treatment improved the 
sepsis-associated multiple organ damage, including liver and lung injury (177). A recent study 
has used siRNA to silence CSE gene protected mice against sepsis-induced leukocyte 
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infiltration and liver and lung damage (126). Together, these results suggest that the CSE-
derived H2S regulates leukocyte infiltration and liver and lung injury following CLP-induced 
sepsis.  
The present study also demonstrated changes in homocysteine levels following CLP-induced 
sepsis. Interestingly, results showed decreased levels of homocysteine in the liver and plasma 
following CLP-induced sepsis in mice. These results contradict previously published research 
on the role of homocysteine during inflammatory conditions such as glomerulosclerosis (296), 
atherosclerosis (289), rheumatoid arthritis (284) and sepsis (294). For example, it has been 
reported that increased total homocysteine concentrations are observed in patients with 
sepsis (294). In contrast, another study has shown that homocysteine levels are not 
significantly altered in mechanically ventilated patients with severe sepsis (293). In the 
present study, the decreased levels of homocysteine in the liver and plasma are most likely 
due to increased CSE expression following CLP-induced sepsis. This notion is supported by 
previous research where elevated homocysteine levels were inhibited by increased CSE 
expression (292, 303, 304). However, lung homocysteine levels were not altered despite 
increased lung CSE protein expression following CLP-induced sepsis. The mechanisms 
involving differential effects of CLP-induced sepsis on homocysteine levels in the lungs, liver 
and plasma therefore remain unclear.  
An altered homocysteine interaction with the CSE-H2S synthesis transsulfuration pathway in 
mice deficient in the CSE gene following CLP-induced sepsis has also been demonstrated in 
the present study. Liver and circulatory homocysteine levels were significantly lower in mice 
deficient in the CSE gene compared to WT mice both with sepsis and after the sham 
operation. Furthermore, CSE KO sepsis mice showed significantly lower liver and circulatory 
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homocysteine levels compared to CSE KO sham control mice. These results suggest that 
homocysteine may undergo metabolism via alternative enzymatic pathways such as 
methionine synthase (MTR) and betaine-homocysteine methyltransferase (BHMT) in mice 
deficient in the CSE gene (307). In addition, the decrease in homocysteine levels following 
sepsis in the CSE KO mice may be due to a decrease in the activities of the alternative enzymes 
(MTR and BHMT) involved in the homocysteine metabolism (307). In contrast, CSE gene 
deletion has no effect on lung homocysteine levels. The mechanisms involving differential 
regulation of homocysteine levels in different organs in mice deficient in the CSE gene 
following CLP-induced sepsis remain unknown.  
CLP-induced sepsis is, of course, multifactorial and numerous mediators other than CSE-
derived H2S are involved. CSE gene deletion partly reversed the pathological progression of 
sepsis. Based on the results, the present study suggests that CSE-derived H2S is one of the 
pivotal factors in determining the severity of organ damage in sepsis. At the same time, some 
limitations of the current study need mention. This study is limited to only one time point (8 
h post-CLP) and represents changes that occur at that time point only. In addition, the 
mechanisms by which sepsis upregulates CSE expression and subsequent H2S synthesis were 
not elucidated. A recent study has demonstrated the potential roles of microRNA-21 (miR-21) 
in specificity protein-1 (SP1) mediated regulation of CSE gene expression in smooth muscle 
cells  (308, 309). Whether sepsis modifies these elements in the CSE promoter region and 
therefore raise the expression of CSE is yet to be investigated. Furthermore, this study has 
not investigated CLP sepsis- and CSE gene deletion-induced discrepancies in the regulation of 
homocysteine in different organs.  
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In conclusion, CSE-derived H2S plays a role in the regulation of leukocyte infiltration into 
tissues and liver and lung injury following CLP-induced sepsis. Although homocysteine is a 
precursor for H2S synthesis through the CSE transsulfuration pathway, it does not play any 
role in leukocyte infiltration or organ damage associated with sepsis. The present study 
contributes to our understanding of the role of CSE-derived H2S in the regulation of leukocyte 


















Effect of CSE gene deletion on proinflammatory cytokines, and chemokines and 
the ERK1/2-NF-B p65 pathway following caecal-ligation and puncture-induced 
sepsis in mice 
 
4.1 Introduction 
Cystathionine--lyase (CSE) is the predominant H2S-synthesising enzyme with significant 
biological functions (279). Upregulation of CSE expression and associated H2S synthesis has 
been demonstrated in various inflammatory diseases including acute pancreatitis (129, 131, 
132, 149), inflammatory bowel disease (133), arthritis (270, 310, 311), airway inflammation 
(312), hind-paw oedema (137, 174), burn injuries (313, 314), endotoxaemia (127, 172), 
haemorrhagic shock (282) and CLP-induced sepsis (43, 44, 126, 140, 177, 315). Increased CSE 
expression and H2S synthesis have also been reported in immune response cells such as 
macrophages when stimulated with LPS (316-318). Previous research indicates that CSE-
derived H2S contributes to the inflammatory response and regulates the severity of multiple 
organ injury following endotoxaemia and sepsis. For example, it has been shown that 
endotoxaemia and sepsis are associated with increased CSE expression and activity and in 
turn H2S overproduction (43, 44, 127, 172, 177). Intervention studies using PAG have shown 
this compound to exhibit anti-inflammatory activity and protect mice against sepsis-
associated multiple organ injury, supporting a role for H2S in sepsis (140, 177).  
In an experimental animal model of sepsis and human sepsis, a great number of bacterial 
compounds initiate excessive production and release of proinflammatory cytokines (TNF-α, 
IL-6 and IL-1β) and chemokines (MCP-1 and MIP-2α) (319-321). Elevated levels of 
proinflammatory cytokines and chemokines correlate with increased CSE expression, as well 
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as activity and H2S synthesis in CLP-induced sepsis and LPS-induced endotoxaemia (43, 126, 
173). Hence, it is necessary to understand the possible mechanisms through which CSE or 
CSE-derived H2S modulate the development of inflammation and affect multiple organ injury 
in CLP-induced sepsis.  
Proinflammatory mediators particularly TNF-α activate various MAPK signalling networks, 
thereby regulating NF-B activation and subsequent transcriptional regulation of 
proinflammatory genes in many inflammatory diseases (55, 322). Notably, the activation of 
ERK has been shown to be an essential temporal regulator of NF-B activity (323). ERK1/2 
induces NF-B activation by stimulating ERK1/2 downstream MAPK-activated protein kinases 
(MKs) such as ribosomal S6 kinase-1 and mitogen- and stress-activated protein kinase-1 (324, 
325). Early research investigated the possible interactions between CSE or CSE-derived H2S 
and ERK1/2-NF-B signalling in various in vitro and in vivo inflammatory disease models. For 
example, H2S has been shown to mediate the activation of ERK1/2 when RAW264.7 
macrophages are stimulated with LPS (316). In human macrophages, H2S was found to amplify 
the phosphorylation of ERK1/2 and subsequent activation of NF-B, proinflammatory 
cytokines and chemokines (326). Recent studies in mice have shown that CSE gene deletion 
or silencing of the CSE gene with siRNA inhibits activation of NF-B and ERK1/2-NF-B in 
caerulein-induced acute pancreatitis and LPS-stimulated macrophages, respectively (129, 
317). Similarly, the role of endogenous H2S in mediating inflammation is supported by results 
that show the inhibition of CSE using the inhibitor PAG in CLP-induced sepsis in mice. 
Treatment with PAG attenuates activation of ERK1/2 and NF-B p65 following CLP-induced 
sepsis (43, 44); however, these studies are limited due to a lack of specific evidence of CSE 
enzyme inhibition by PAG to target H2S biosynthesis (264-266). A recent study using siRNA to 
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silence the CSE gene found mice were protected against sepsis-induced liver and lung injury 
as a result of a decrease in proinflammatory cytokines and chemokines (126). However, this 
study did not investigate the mechanism through which CSE or CSE-derived H2S mediates the 
decrease in proinflammatory mediators of inflammation and organ injury in sepsis.  
The objective of the present study was to determine whether CSE gene deletion modulates 
proinflammatory cytokines and chemokines through a mechanism involving ERK1/2-NF-B 
p65 signalling in CLP-induced sepsis in mice.   
4.2 Aims  
Chapter 3 has shown that deletion of the CSE gene protects mice against leukocyte infiltration 
and liver and lung injury following CLP-induced sepsis. The present study aimed to determine 
the effect of CSE gene deletion on the activation of ERK1/2 (p-ERK1/2) and NF-B p65 
translocation and the subsequent effect on proinflammatory cytokine (TNF-α, IL-6 and IL-1β) 
and chemokine (MCP-1 and MIP-2α) generation following CLP-induced sepsis in mice.  
4.3 Experimental approach 
Thirty two WT (C57BL/6J) and CSE KO (on a C57BL/6J background) (males aged between 8-10 
weeks; 25-30 g) mice were randomly divided into control (WT Sham and CSE KO Sham) and 
experimental (WT Sepsis and CSE KO Sepsis) groups with eight mice in each group (n=8). 
Sepsis was induced by CLP as described in Section 2.4 and 8 h after CLP or sham operation the 
mice were euthanised by an i.p. injection of pentobarbital (150 mg/kg). Thereafter, blood was 
aspirated and plasma separated and stored at -80°C. Samples of liver and lungs were 
processed and stored at -80°C. Subsequently, p-ERK1/2 and ERK1/2 protein expression 
(Section 2.5), NF-B p65 activation (Section 2.11), and cytokine and chemokine levels (Section 
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2.12) were measured by the methods described in the Materials and Methods of Chapter 2.  
Statistical analysis was performed as described in Section 2.17.  
4.4 Results 
4.4.1 Phosphorylation of ERK1/2 in WT and CSE KO mice following CLP-induced sepsis 
The western blot showed that CLP-induced sepsis significantly increased the phosphorylation 
of ERK1/2 in the liver and lungs compared to the sham control in WT mice (liver: p-ERK1, 2.10 
± 0.34-fold increase (P<0.01), p-ERK2, 2.37 ± 0.42-fold increase (P<0.05); lung: p-ERK1, 3.17 ± 
0.64-fold increase (P<0.001), p-ERK2, 2.58 ± 0.59-fold increase (P<0.01)). Mice with CSE gene 
deletion showed lower ERK1/2 phosphorylation in the liver and lungs following sepsis 
compared to their WT counterparts (liver: p-ERK1, 1.00 ± 0.00-fold less (P<0.01), p-ERK2, 0.79 
± 0.21-fold less (P<0.05); lung: p-ERK1, 1.83 ± 0.12-fold less (P<0.05), p-ERK2, 1.37 ± 0.13-fold 
less (P<0.01)) and there was no significant difference between sham and CLP-induced sepsis 








Figure 4.1 Phosphorylation of ERK1/2 in WT and CSE KO mice following CLP-induced sepsis. WT and 
CSE KO mice underwent CLP or sham operation. Sham operated mice acted as controls. Eight hours 
after CLP or sham operation mice were sacrificed and liver and lung tissues were processed to measure 
phospho-ERK1/2 (p-ERK1/2) and total ERK1/2 protein expression in the liver (A and B) and lungs (C and 
84 
 
D) using western blotting. After analysis by densitometry, the data were expressed as the ratio of p-
ERK1/2 to total ERK1/2 (plotted as the relative-fold increase of p-ERK1/2 expression over the sham 
control). For western blot results, each lane represents a separate animal. The blots shown are 
representative of all animals in each group with similar results. There was a significant increase in 
phosphorylation of ERK1/2 in the liver and lungs following CLP-induced sepsis compared to sham 
control in WT mice. CSE KO mice showed significantly lower phosphorylation of ERK1/2 in the liver and 
lungs compared to WT mice following CLP-induced sepsis. Data represent mean ± S.E.M. (n=8). The 
significance of differences among groups was evaluated by ANOVA with post-hoc Tukey’s test. 
Statistical significance was assigned as *P<0.05, **P<0.01 and ***P<0.001.    
 
4.4.2 Effect of CSE gene deletion on liver and lungs NF-B p65 activation following CLP-
induced sepsis  
 
Figure 4.2 Activation of NF-B p65 in WT and CSE KO mice following CLP-induced sepsis. WT and CSE 
KO mice underwent CLP or sham operation. Sham operated mice acted as controls. Eight hours after 
CLP or sham operation, mice were sacrificed and liver and lung tissues were processed to measure NF-
B p65 activity in the nuclear extracts of liver and lungs using an NF-B p65 immuno assay. CLP-
induced sepsis resulted in a significant increase in NF-B p65 activity compared to sham control in WT 
mice. CSE KO mice showed significantly lower NF-B p65 activation compared to WT mice following 
CLP-induced sepsis. Data represent mean ± S.E.M. (n=8). The significance of differences among groups 
was evaluated by ANOVA with post-hoc Tukey’s test. Statistical significance was assigned as **P<0.01 
and ***P<0.001.      
 
As expected, the activity of NF-B p65 in the nuclear extracts of liver and lung tissues 
increased significantly after CLP-induced sepsis compared to sham control in WT mice (liver: 
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2.08 ± 0.75-fold increase (P<0.001); lung: 2.18 ± 0.59-fold increase (P<0.01)). CSE KO mice 
with CLP operation showed significantly lower NF-B p65 activation in comparison to their 
respective WT mice (liver: 0.92 ± 0.14-fold less (P<0.001); lung: 1.02 ± 0.25-fold less (P<0.01)). 
There was no significant difference between sham and CLP-induced sepsis CSE KO mice 
(Figure 4.2).    
4.4.3 Effect of CSE gene deletion on liver proinflammatory mediators following CLP-induced 
sepsis  
The elevated production of proinflammatory mediators is a feature of sepsis. WT mice with 
CLP-induced sepsis showed significantly higher levels of cytokines (TNF-α, IL-6 and Il-1β) and 
chemokines (MCP-1 and MIP-2α) in liver samples compared to mice with the sham operation 
(TNF-α: 7.11 ± 2.50 ng/mg vs 4.72 ± 0.93 ng/mg (P<0.05); IL-6: 0.61 ± 0.25 ng/mg vs 0.35 ± 
0.07 ng/mg (P<0.05); IL-1β: 0.82 ± 0.22 ng/mg vs 0.3 ± 0.07 ng/mg (P<0.0001); MCP-1: 550.51 
± 129.70 ng/mg vs 274.35 ± 36.67 ng/mg (P<0.0001); and MIP-2α: 1.73 ± 0.45 ng/mg vs 0.82 
± 0.05 ng/mg (P<0.0001)). IL-1β and MCP-1 levels in CSE KO mice were significantly elevated 
following CLP-induced sepsis; however, the extent of these increases was significantly lower 
in the CSE KO mice compared to WT mice (TNF-α: 3.57 ± 0.76 ng/mg vs 7.11 ± 2.50 ng/mg 
(P<0.01); IL-6: 0.27 ± 0.07 ng/mg vs 0.61 ± 0.25 ng/mg (P<0.01); IL-1β: 0.61 ± 0.12 ng/mg vs 
0.82 ± 0.22 ng/mg (P<0.05); MCP-1: 347.47 ± 106.29 ng/mg vs 550.51 ± 129.70 ng/mg 





Figure 4.3 Alteration of liver cytokine and chemokine levels in WT and CSE KO mice following CLP-
induced sepsis. WT and CSE KO mice underwent CLP or sham operation. Sham operated mice acted as 
controls. Eight hours after CLP or sham operation, mice were sacrificed and liver tissue was processed 
to measure cytokine (TNF-α (A), IL-6 (B) and (IL-1β (C)) and chemokine (MCP-1 (D) and MIP-2α (E)) 
levels using ELISA. CLP-induced sepsis resulted in a significant increase in liver proinflammatory 
cytokine and chemokine levels. There was a significant reduction in all these mediators in CSE KO mice 
compared to WT mice following CLP-induced sepsis. Data represent mean ± S.E.M. (n=8). The 
significance of differences among groups was evaluated by ANOVA with post-hoc Tukey’s test. 
Statistical significance was assigned as *P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001.  
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4.4.4 Effect of CSE gene deletion on lungs proinflammatory mediators following CLP-
induced sepsis  
Substantial elevations in lungs cytokine (TNF-α, IL-6 and IL-1β)  and chemokine (MCP-1 and 
MIP-2α) concentrations were seen following CLP-induced sepsis animals compared to sham 
operation in WT mice (TNF-α: 1.70 ± 0.51 ng/mg vs 1.10 ± 0.28 ng/mg (P<0.05); IL-6: 0.72 ± 
0.15 ng/mg vs 0.37 ± 0.15 ng/mg (P<0.001); IL-1β: 0.95 ± 0.22 ng/mg vs 0.23 ± 0.10 ng/mg 
(P<0.001); MCP-1: 1880.37 ± 937.36 ng/mg vs 622.6 5± 202.17 ng/mg (P<0.001); and MIP-2α: 
1.37 ± 0.40 ng/mg vs 0.77 ± 0.35 ng/mg (P<0.01)). Mice with CLP sepsis and CSE gene deletion 
showed significantly lower levels of these cytokines and chemokines compared to WT mice 
with CLP sepsis (TNF-α: 1.00 ± 0.24 ng/mg vs 1.70 ± 0.51 ng/mg (P<0.01); IL-6: 0.50 ± 0.12 
ng/mg vs 0.72 ± 0.15 ng/mg (P<0.05); IL-1β: 0.65 ± 0.16 ng/mg vs 0.95 ± 0.22 ng/mg (P<0.05); 
MCP-1: 919.17 ± 352.87 ng/mg vs 1880.37 ± 937.36 ng/mg (P<0.05) and MIP-2α: 0.90 ± 0.36 
ng/mg vs 1.37 ± 0.40 ng/mg (P<0.05)). However, levels of IL-6 and IL-1β in CSE KO mice with 
CLP-induced sepsis were significantly higher compared to KO mice that had undergone sham 







Figure 4.4 Alteration of lungs cytokine and chemokine levels in WT and CSE KO mice following CLP- 
induced sepsis. WT and CSE KO mice underwent CLP or sham operation. Sham operated mice acted as 
controls. Eight hours after CLP or sham operation, mice were sacrificed and lung tissues were processed 
to measure cytokine (TNF-α (A), IL-6 (B) and (IL-1β (C)) and chemokine (MCP-1 (D) and MIP-2α (E)) 
levels using ELISA. CLP-induced sepsis resulted in a significant increase in lung proinflammatory 
cytokine and chemokine levels. There was a significant reduction in all these mediators in CSE KO mice 
compared to WT mice following CLP-induced sepsis. Data represent mean ± S.E.M. (n=8). The 
significance of differences among groups was evaluated by ANOVA with post-hoc Tukey’s test. 
Statistical significance was assigned as *P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001.  
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4.4.5 Effect of CSE gene deletion on circulatory proinflammatory mediators following CLP-
induced sepsis 
WT mice with CLP-induced sepsis showed significantly increased circulatory proinflammatory 
cytokine (TNF-α, IL-6 and IL-1β) and chemokine (MCP-1 and MIP-2α) levels compared with 
sham control animals (TNF-α: 0.17 ± 0.04 ng/mL vs 0.10 ± 0.02 ng/mL (P<0.01); IL-6: 0.07 ± 
0.03 ng/mL vs 0.01 ± 0.006 ng/mL (P<0.0001); IL-1β: 0.15 ± 0.03 ng/mL vs 0.048 ± 0.041 ng/mL 
(P<0.0001); MCP-1: 917.52 ± 203.20 ng/mL vs 210.72 ± 57.84 ng/mL (P<0.0001); and MIP-2α: 
0.13 ± 0.06 ng/mL vs 0.03 ± 0.01 ng/mL (P<0.0001)). Mice deficient in the CSE gene with CLP-
induced sepsis also showed significantly higher levels of cytokines and chemokines, with the 
exception of TNF-α and MIP-2α, which were not significantly elevated. However, the extent 
of these increases was significantly lower in the CSE KO mice compared to WT mice following 
CLP-induced sepsis (TNF-α: 0.10 ± 0.02 ng/mL vs 0.17 ± 0.04 ng/mL (P<0.01); IL-6: 0.03 ± 0.01 
ng/mL vs 0.07 ± 0.03 ng/mL (P<0.001); IL-1β: 0.09 ± 0.04 ng/mL vs 0.15 ± 0.03 ng/mL (P<0.01); 
MCP-1 639.23 ± 224.03 ng/mL vs : 917.52 ± 203.20 ng/mL (P<0.01); and MIP-2α: 0.06 ± 0.01 







Figure 4.5 Alteration of plasma cytokine and chemokine levels in WT and CSE KO mice following CLP-
induced sepsis. WT and CSE KO mice underwent CLP or sham operation. Sham operated mice acted as 
controls. Eight hours after CLP or sham operation, mice were sacrificed and plasma was harvested to 
measure cytokine (TNF-α (A), IL-6 (B) and (IL-1β (C)) and chemokine (MCP-1 (D) and MIP-2α (E)) levels 
using ELISA. CLP-induced sepsis resulted in a significant increase in plasma proinflammatory cytokine 
and chemokine levels. There was a significant reduction in all these mediators in CSE KO mice compared 
to WT mice following CLP-induced sepsis. Data represent mean ± S.E.M. (n=8). The significance of 
differences among groups was evaluated by ANOVA with post-hoc Tukey’s test. Statistical significance 
was assigned as **P<0.01, ***P<0.001 and ****P<0.0001.  
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4.5 Discussion  
The study described here in Chapter 3 has provided convincing evidence that CSE-derived H2S 
regulates leukocyte infiltration into the tissues and subsequently liver and lung injury 
following CLP-induced sepsis in mice. The results of the present study demonstrate that mice 
deficient in the CSE gene have decreased proinflammatory cytokine and chemokine levels 
following CLP-induced sepsis. Further, the results in CSE KO mice show that CSE gene deletion 
not only decreased phosphorylation of ERK1/2 but also inhibited NF-B p65 DNA binding 
activity in the liver and lungs following CLP-induced sepsis. As a result, proinflammatory 
cytokine and chemokine levels are decreased in the liver, lungs and circulatory system. There 
is little published information on the importance of the H2S in inflammation and the 
mechanism by which CSE-derived H2S alters the inflammatory response in sepsis using CSE 
inhibitor PAG (43, 44, 140, 174, 177). For example, it has been shown that inhibition of CSE 
with PAG significantly decreases ERK1/2 phosphorylation, NF-B activation and subsequent 
cytokine (TNF-α, IL-6 and IL-1β) and chemokine (MCP-1 and MIP-2α) production in the liver 
and lungs (43, 44). However, the use of PAG for investigating the role of H2S in sepsis has 
limitations, due to its other, non-specific actions such as alteration of homocysteine 
metabolism and inhibition of ALT and AST enzyme activities (264-266). However, despite the 
non-specific actions of PAG, the results of previous studies are in agreement with the present 
study using CSE KO mice. These results together suggest that a temporal increase in CSE 
protein expression and subsequent H2S synthesis during sepsis correlates with the occurrence 
of phosphorylation of ERK1/2 and activation of NF-B p65 and subsequently regulates 
generation of the proinflammatory cytokines and chemokines.  
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It is important to note that CSE gene deletion did not completely inhibit ERK1/2 
phosphorylation, NF-B p65 activation or proinflammatory mediator production, which 
suggests that mediators other than CSE-derived H2S are involved in the activation of the 
ERK1/2-NF-B p65 pathway in CLP-induced sepsis. At the same time, some limitations of the 
current study need mention. This study is limited to one time point (8 h post-CLP) and 
represents changes that occur at that time point only. In addition, although the present study 
indicates that CSE-derived H2S regulates the inflammatory response via the ERK1/2-NF-B 
p65 signalling cascade, it is difficult to establish from the present experimental data how CSE-
derived H2S directly or indirectly regulates NF-B p65 activation. A recent study found that 
H2S activates NF-B by sulfhydrating the cysteine residues or that other sites of the p65 
subunit of NF-B may elicit the transcriptional activation of proinflammatory genes (327); 
however, this has not been investigated in the present study. Furthermore, H2S may also 
induce NF-B activation through mechanisms other than ERK1/2 phosphorylation. For 
example, it has been shown that H2S induces a dose-dependent increase in intracellular 
calcium ions (Ca+2) and protein kinase A (PKA), which facilitate NF-B translocation into the 
nucleus where it binds to DNA in microglial cells (114). These mechanisms are yet to be 
investigated in CLP-induced sepsis.   
In summary, the results of the present study demonstrated that the CSE-derived H2S regulates 
production and release of proinflammatory mediators and exacerbates the systemic 
inflammatory response in sepsis through a mechanism involving NF-B p65 via increased 
activation or phosphorylation of ERK1/2. The present study contributes to our understanding 





 Effect of CSE gene deletion on substance P and neurokinin 1 receptor following 
caecal-ligation and puncture-induced sepsis in mice 
 
5.1 Introduction  
Substance P (SP) is an 11 amino acid immunoregulatory peptide, a member of the tachykinin 
family, encoded by the preprotachykinin A (PPTA) gene (199, 328). Although SP is a peptide 
primarily of neuronal origin, animal studies in rodents have demonstrated its production in 
non-neuronal tissues and inflammatory cells (329). The biological actions of SP are primarily 
mediated through NK-1R, a G-protein coupled receptor (198). SP mediated-activation of NK-
1R on effector cells elicits local vasodilation and increases endothelial microvascular 
permeability and plasma extravasation, thereby promoting local inflow of inflammatory and 
immune cells (195). SP has also been implicated in inducing the release of proinflammatory 
mediators and stimulating the chemotaxis of lymphocytes, monocytes and neutrophils (197). 
By promoting vasodilation, extravasation, leukocyte chemotaxis and cytokine release, SP acts 
as an important mediator of inflammation in many inflammatory diseases, including 
inflammatory bowel disease (330), airway inflammation, arthritis (331, 332), acute 
pancreatitis (131, 333), sepsis (199, 203), endotoxaemia (200, 334) and burn injuries (335).  
Various preclinical and clinical studies have studied the importance of SP in sepsis. In one 
study, circulatory levels of SP were reported to decrease in patients with sepsis and septic 
shock (202). In contrast, other clinical studies have shown that high serum levels of SP are 
related to the lethal outcome of sepsis and that these increased SP levels act as a predictive 
indicator of mortality during the late course of sepsis and septic shock (201, 203). Previous 
studies have shown the proinflammatory role of SP in sepsis and endotoxaemia in rodents. 
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For example, CLP-induced sepsis is associated with an increase in plasma and pulmonary 
levels of SP and genetic deletion of the PPTA has been shown to convey significant protection 
against inflammation, organ injury and mortality in mice, improving survival rate (197, 199). 
In addition to PPTA gene deletion, treatment with the NK-1R antagonist modulates the lung 
injury and inflammatory response in mice against CLP-induced sepsis (195, 198). Similarly, 
LPS-induced neutrophil adherence in vitro (334) and endotoxaemia-induced inflammation 
and multiple organ injury in mice (200) are found to stimulate the release of SP, while PPTA 
gene deletion protected mice against inflammation and organ damage (200). These studies 
suggest that SP plays an important role in sepsis and associated organ injury. Although 
elevated SP levels have been found in sepsis and associated organ injury, to date the 
underlying mechanisms by which the release and production of SP are regulated remain 
unclear.   
Several in vitro and in vivo studies have suggested that H2S is involved in regulating the release 
of SP, leading to the development and exacerbation of inflammation in sepsis. For example, 
pulmonary defense against inhaled H2S gas was modified by pretreatment with capsaicin, 
which is known to deplete SP local sensory nerves (336). In isolated rat urinary bladders, H2S 
has been reported to stimulate the release of tachykinins and in turn activate NK-1R and NK-
2R through capsaicin-sensitive afferent neurons (337, 338). Similarly, in another study H2S 
provoked the tachykinin-mediated neurogenic inflammatory response in guinea pig airways 
(339). However, these studies investigated the role and physiological significance of H2S in the 
lungs or isolated tissues using either H2S donor NaHS or H2S gas, both of which are unrelated 
to the inflammatory role in sepsis.  
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Previous studies have demonstrated that H2S donor NaHS increases the release of SP and that 
in turn, SP promotes inflammation and lung injury through activation of NK-1R in mice (204). 
In animal models of sepsis, it has been shown that H2S upregulates the generation of SP, which 
contributes to lung inflammation and injury via activation of the NK-1R. This provides some 
evidence for the role of SP in H2S-induced lung inflammation (141). In addition, H2S regulates 
systemic inflammation and multiple organ failure via transient receptor potential vanilloid 
type 1 (TRPV1)-mediated enhancement of SP production and activation of the ERK1/2-NF-B 
pathway in CLP-induced sepsis (205, 206). However, these previous studies used CSE inhibitor 
PAG or H2S donors such as NaHS and Na2S to investigate the interaction between CSE-derived 
H2S and SP production in sepsis; their limitations in investigating the role of H2S in sepsis have 
been discussed in Chapter 1 (Section 1.6).  
The objective of the present study was to determine whether CSE gene deletion modulates 
SP and NK-1R in CLP-induced sepsis in mice.  
5.2 Aims  
The results in Chapter 4 have shown that deletion of the CSE gene protects mice against 
increased inflammatory response through activated ERK1/2-NF-B p65 signalling following 
CLP-induced sepsis. The present study aimed to determine the effect of CSE gene deletion on 
SP production and NK-1R protein expression following CLP-induced sepsis. 
5.3 Experimental approach 
Thirty two WT (C57BL/6J) and CSE KO (on a C57BL/6J background) (males aged between 8-10 
weeks; 25-30 g) mice were randomly divided into control (WT Sham and CSE KO Sham) and 
experimental (WT Sepsis and CSE KO Sepsis) groups, with eight mice in each group (n=8). 
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Sepsis was induced by CLP as described in Section 2.4 and 8 h after CLP or sham operation 
mice were euthanised by an i.p. injection of pentobarbital (150 mg/kg). Thereafter, blood was 
aspirated, plasma separated and stored at -80°C. Samples of liver and lungs were processed 
and stored at -80°C. Subsequently, SP levels (Section 2.13) and NK-1R protein expression 
(Section 2.5) were measured by the methods described in the Materials and Methods of 
Chapter 2. Statistical analysis was performed as described in Section 2.17.  
5.4 Results 
5.4.1 CSE gene deletion affects SP levels following CLP-induced sepsis 
Induction of sepsis by CLP in WT mice resulted in a significant increase in the liver, lungs and 
plasma levels of SP compared to the sham control (liver: 0.91 ± 0.14 ng/mg vs 0.18 ± 0.01 
ng/mg (P<0.001); lungs: 0.68 ± 0.17 ng/mg vs 0.21 ± 0.01 ng/mg (P<0.01); plasma: 0.72 ± 0.11 
ng/mL vs 0.21 ± 0.02 ng/mL (P<0.0001)). Next, the effect of CSE gene deletion on the levels 
of SP following sepsis was examined. As shown in Figure 5.1, mice lacking the CSE gene had 
significantly lower liver, lungs and plasma levels of SP compared to WT mice following 
induction of CLP sepsis (liver: 0.91 ± 0.14 ng/mg vs 0.46 ± 0.10 ng/mg; lungs: 0.68 ± 0.17 ng/mg 




Figure 5.1 SP levels in WT and CSE KO mice following CLP-induced sepsis. WT and CSE KO mice 
underwent CLP or sham operation. Sham operated mice served as controls. 8 h after CLP or sham 
operation, mice were sacrificed and SP levels in liver (A), lungs (B) and plasma (C) were measured using 
a SP immunoassay. SP levels were significantly increased in WT mice following CLP-induced sepsis 
compared to sham control. CSE KO mice had significantly lower SP levels compared to WT mice 
following CLP-induced sepsis. Data represent mean ± S.E.M. (n=8). The significance of differences 
among groups was evaluated by ANOVA with post-hoc Tukey’s test. Statistical significance was 
assigned as *P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001.  
 
5.4.2 Effect of CSE gene deletion on NK-1R protein expression following CLP-induced sepsis 
Protein expression levels of NK-1R in the liver and lungs were investigated using western blot. 
Densitometry analysis of western blots showed that liver and lungs NK-1R protein expression 









Figure 5.2. NK-1R protein expression in WT and CSE KO mice following CLP-induced sepsis. WT and 
CSE KO mice underwent CLP or sham operation. Sham operated mice served as controls. 8 h after CLP 
or sham operation, mice were sacrificed. The NK-1R protein expression in liver (A and B) and lungs (C 
and D) were measured by western blot. After analysis by densitometry, the data were expressed as 
ratios of NK-1R to GAPDH (plotted as the relative fold increases of NK-1R expression over the sham 
control). For western blot results, each lane represents a separate animal. The blots shown are 
representative of all animals in each group. There was a significant increase in NK-1R expression in the 
liver and lungs of WT mice following CLP-induced sepsis compared to sham control. CSE KO mice 
showed significantly decreased NK-1R protein expression in the liver and lungs compared to WT mice 
following CLP-induced sepsis. Data represent mean ± S.E.M. (n=8). The significance of differences 
among groups was evaluated by ANOVA with post-hoc Tukey’s test. Statistical significance was 
assigned as *P<0.05.    
 
(liver: 1.40 ± 0.01-fold increase (P<0.05); lungs: 8.68 ± 1.97-fold increase (P<0.05)). CSE KO 
mice showed significantly decreased NK-1R protein expression following CLP sepsis compared 
to the WT sepsis mice (liver: 1.11 ± 0.01-fold decrease (P<0.05); lungs: 0.93 ± 0.26-fold 
decrease (P<0.05)) (Figure 5.2). 
5.5 Discussion 
Previous studies in Chapter 3 and 4 showed the importance of CSE-derived H2S on organ injury 
and the inflammatory response following CLP-induced sepsis. In this chapter, the role of 
endogenous CSE-derived H2S on the upregulation of SP levels and NK-1R expression following 
CLP-induced sepsis is described. SP has been proposed as a key mediator of inflammation in 
sepsis and endotoxaemia and associated organ injury (195, 197-199, 201, 334). In the present 
study, a significant increase in plasma and tissue (liver and lung) SP levels and subsequent NK-
1R expression (in liver and lungs) following CLP-induced sepsis was shown. Gene deletion of 
the CSE enzyme attenuated the observed increase in levels of SP and NK-1R protein 
expression in sepsis compared to their WT counterparts, suggesting that H2S synthesised 
through CSE-facilitated the production of SP production and subsequent NK-1R activation in 
CLP-induced sepsis. The findings of the present chapter are consistent with earlier 
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observations with pharmacological inhibitor of CSE such as PAG (141, 205, 206) and H2S donor 
such as NaHS (204); these results reinforce the essential role of CSE-derived H2S on SP-
mediated inflammation and organ injury in sepsis. Of course, CLP-induced sepsis is 
multifactorial and numerous mediators other than CSE-derived H2S are involved. Deletion of 
the CSE gene moderately decreased SP levels and subsequently cytokines and chemokines in 
sepsis (as shown in Chapter 4).  
Endogenous H2S appears to play an important role in regulating the severity of inflammation 
and organ damage in sepsis (43, 44, 140). Thus, it is of interest to determine whether 
endogenous H2S synthesised through CSE is correlated to SP in sepsis. The H2S donor NaHS 
induced the contractile response by provoking the release of SP both in rat gall bladders and 
isolated guinea pig airways and this was totally suppressed with capsaicin or a combination 
of NK-1R and NK-2R antagonists (337-339). Administration of NaHS to normal mice caused a 
significant rise in circulatory levels of SP in a dose-dependent manner (204). Furthermore, 
other studies have previously shown that inhibiting CSE using PAG pre- or post-treatment 
significantly decreased the level of PPTA gene expression and SP in lungs, whereas exogenous 
H2S (NaHS) magnified the pulmonary levels of SP in CLP-induced sepsis (141, 205, 206). On 
the other hand, CSE activity and H2S synthesis in mice genetically deficient in the PPTA gene 
were similar to WT mice in sepsis, indicating that the absence of SP has no effect on the level 
of H2S (141). The experimental results in this chapter consistently show that CSE gene deletion 
significantly decreases levels of SP in the liver, lungs and plasma of CLP-induced sepsis mice. 
This indicates that CSE-derived H2S is located upstream of SP and plays an important role in 
regulating the production and release of SP in sepsis. In addition, the experiments in this 
chapter tested the relationship between CSE and NK-1R, which also increased following 
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sepsis. Mice deficient in the CSE gene showed significantly decreased NK-1R protein 
expression in the liver and lungs. This indicates that CSE-derived H2S stimulates liver and lung 
inflammation via SP is mainly mediated by NK-1R.  
The experimental findings of the present study indicate that the increased CSE-mediated H2S 
synthesis (shown in Chapter 3) in sepsis upregulates SP production. Although the present 
study suggests that CSE-derived H2S modulates the production of SP and activation of NK-1R, 
the mechanism in this process remains unclear. Previous studies have suggested that H2S may 
regulate the release of SP in guinea pig airways and rat urinary bladders via TRPV1 on sensory 
nerve endings (337-339). In addition, inhibition of sensory nerves with capsaicin or 
pretreatment with capsazepine (a TRPV1 antagonist) protected mice from H2S-induced lung 
inflammation (205). Similarly, previous studies have also shown that the depletion of SP by 
genetically removing the PPTA gene and blocking the effect of SP by pretreatment with the 
NK-1R inhibitor not only alleviates lung damage caused by sepsis but also decreases lung 
microvascular permeability impaired by exogenous H2S (195, 198, 199). The precise 
mechanism by which CSE-derived H2S elicits its effect on SP and thereby contributes to sepsis 
and associated inflammation and organ injury remains to be investigated.  
In conclusion, the present findings show that CSE-derived H2S plays an important role in 








Effect of Kupffer cell inactivation by gadolinium chloride on inflammation 
following caecal-ligation and puncture-induced sepsis in mice 
 
6.1 Introduction  
Kupffer cells are resident liver macrophages, derived prenatally from yolk sac cells and 
maintained into adulthood without replenishment from blood monocytes (217-219). Kupffer 
cells play essential roles in tissue homeostasis, and remodelling and regulation of metabolic 
functions in the liver (218). As highly phagocytic cells, they are primarily responsible for 
sequestering pathogenic substances, including bacteria and LPS bacterial endotoxins, from 
the portal circulation (220). Upon activation, Kupffer cells are known to release biologically-
active substances such as reactive oxygen and nitrogen radicals, peptide mediators, 
eicosanoids and proinflammatory cytokines (TNF-α, IL-6 and IL-1β) and chemokines (MCP-1 
and MIP-2α). The released mediators help recruit other inflammatory cells such as 
neutrophils and monocytes from circulation to the liver to overcome an ongoing bacterial or 
endotoxin challenge (221). Although these cells and cellular responses are necessary to 
combat infection and endotoxins, persistently high or overwhelming activation may result in 
an uncontrolled initiation of the proinflammatory cascade, leading to a systemic 
inflammatory response and potentially to multiple organ dysfunction syndrome (MODS) (222-
224).  
Gadolinium chloride (GdCl3) is a lanthanide that is commonly used to evaluate the functional 
roles of Kupffer cells  in several processes (220, 232). While the exact mechanism of action of 
GdCl3 is not yet clear, it has been proposed that it inhibits Kupffer cell phagocytosis by 
competitive blockade of K type Ca+2 channels and thereby inhibits phagocytosis at their 
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surface attachment and engulfment phases. This results in reduced Kupffer cell activation and 
subsequently Kupffer cell number (225, 232). Blockading of Kupffer cell phagocytosis by GdCl3 
has been used to study Kupffer cell function both in vivo and in vitro.  
The role of Kupffer cells has been studied in various experimental animal disease models using 
GdCl3, including hepatic ischaemia-reperfusion injury (240), bile duct ligation-induced 
obstructive jaundice (224), LPS-induced endotoxaemia (221, 222, 225, 226) and CLP-induced 
sepsis (220, 227-230). Much evidence has been accumulated on the protective effect of 
Kupffer cell inactivation against liver injury and inflammation. Treatment with GdCl3 reduces 
elevated serum ALT and AST enzyme activities following endotoxaemia (222, 223, 231), 
trauma (229), sepsis (220) and radiation-induced liver injury (233). Activation of Kupffer cells 
with stimulants such as LPS produces ROS and proinflammatory cytokines (particularly TNF-
α), resulting in oxidative stress and inflammation, indicating that activation of Kupffer cells 
could be responsible for liver damage. Increased superoxide production and hepatic 
expression of TNF-α, IL-1β and IL-6 in response to LPS-induced Kupffer cell activation is 
decreased by GdCl3 (231-234). Similarly, experimental evidence has shown that inhibition of 
Kupffer cell phagocytosis by GdCl3 attenuates sepsis-associated hepatocellular and hepatic 
drug-metabolising dysfunction by reducing the expression of cyclooxygenase-2 (COX-2) (229) 
and modulation of the inflammatory response (220), respectively. A recent study has also 
demonstrated that enhanced susceptibility of jaundiced animals to endotoxaemia was 
reduced with GdCl3 pretreatment (224). Conversely, as a part of the counter-regulatory 
mechanism, Kupffer cells release the anti-inflammatory cytokine IL-10 to overcome the 
inflammatory response of activated Kupffer cells. The inflammatory response to 
endotoxaemia is downregulated by local release of IL-10 from Kupffer cells (235). However, 
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in contrast to previous reports some studies show Kupffer cells eliminate LPS and other agents 
primarily from the portal circulation and protect the hepatocytes from exposure to high levels 
of LPS and other oxidative stresses. For example, inactivation of Kupffer cells with GdCl3 has 
led to elevated serum ALT and AST enzyme activities in rats with obstructive jaundice exposed 
to endotoxaemia (224). Similarly, treatment with clodronate liposomes, another Kupffer cell 
inhibitor, and GdCl3 had no effect on leukocyte MPO activity in the liver following LPS-induced 
endotoxaemia (223, 239). Furthermore, in vitro Kupffer cells isolated from GdCl3-treated 
animals produced more superoxide and TNF-α compared with control cells (232). These 
conflicting results could be due to several factors such as the difference between the 
pathology of disease models studied, the dosage regime of GdCl3 and euthanasia time points.  
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are the first steps in 
the development of multiple organ failure in patients with sepsis (230, 236). There have been 
significant efforts to understand lung injury in endotoxaemia and sepsis models and GdCl3 
treatment. However, there is still a poor understanding of the mechanisms by which GdCl3 
modulates lung injury or the role of Kupffer cells in causing lung injury. For example, 
treatment with GdCl3 abrogates ozone-induced pulmonary injury by modulation of 
inflammatory mediator production (237). It has also been shown that GdCl3 attenuates LPS-
induced pulmonary apoptosis by decreased activation of caspase-3; however, this had no 
effect on the increased mRNA expression of proinflammatory cytokines such as TNF-α, IL-6 
and IL-1β (236). Conversely, GdCl3 has been shown to predispose rats to lung alveolitis and 
lead to increased leukocyte MPO activity in LPS-induced endotoxaemia (223). In parallel, 
increased and decreased expression of MCP-1 and IL-10 in the lungs has been reported 
following treatment with GdCl3 in endotoxaemia (234) and CLP-induced peritonitis (230), 
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respectively. These results on the effect of GdCl3 on lung injury indicate that there is currently 
a poor understanding of its role in lung injury in different disease models of endotoxaemia 
and sepsis. Furthermore, it remains to be elucidated whether inactivation of Kupffer cells by 
GdCl3 can inhibit lung injury and inflammation following CLP-induced sepsis.  
Despite the local effects of GdCl3 on liver and lung injury, Kupffer cell blockade increases the 
circulatory appearance of bacteria and toxins and leads to impaired host defense and poor 
survival. In vivo, mice pretreated with GdCl3 have shown a significant increase in mortality, 
despite apparent improvement in systemic inflammation in CLP-induced sepsis (227). 
Conversely, rats pretreated with GdCl3 have shown improved mortality by suppression of 
superoxide production associated with endotoxaemia (226, 238), hepatic ischaemia-
reperfusion injury when exposed to endotoxins (240) and when hepatectomised rats were 
given endotoxins (222). Furthermore, both GdCl3 and clodronate liposomes have been shown 
to lower serum levels of TNF-α, IL-6 and IL-1β, which were increased following LPS-induced 
endotoxaemia and sepsis (220, 225, 228, 239). However, treatment with GdCl3 has no effect 
on elevated serum TNF-α levels in other disease models (222, 226, 240). 
All previous investigations have used the approach of Kupffer cell inactivation to study the 
role of these cells in different animal disease models of liver and lung inflammation, and the 
chemical tool for these studies was either GdCl3 or clodronate liposomes. However, previous 
studies have focused either on the local (liver or lung inflammation) or the systemic (systemic 
inflammatory response and mortality) effects of Kupffer cell inactivation; none have looked 
into both local and systemic effects in one disease model. In addition, the role of Kupffer cells 
on liver and lung inflammation and systemic inflammatory response, by focusing on 
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proinflammatory cytokines and chemokines profiles remain to be elucidated in CLP-induced 
sepsis model.  
The objective of the present study was to determine whether Kupffer cell inactivation by 
GdCl3 protects against liver and lung injury, inflammation and the systemic inflammatory 
response in CLP-induced sepsis in mice.  
6.2 Aims  
 The present study aimed to determine the effect of GdCl3 pretreatment on leukocyte 
infiltration, ALT and AST activity, and proinflammatory cytokine and chemokine levels on liver 
and lung injury and systemic inflammatory response following CLP-induced sepsis.  
6.3 Experimental approach  
Thirty two C57BL/6J (males aged between 8-10 weeks; 25-30 g) mice were randomly divided 
into control (Sham and Sham + GdCl3) and experimental (Sepsis and Sepsis + GdCl3) groups, 
with eight mice in each group (n=8). GdCl3 was administered (10 mg/kg; i.v., tail vein) before 
the CLP and sham operations and saline-treated CLP and sham mice acted as vehicle controls. 
Sepsis was induced by CLP as described in Section 2.4 and 8 h after CLP or a sham operation, 
mice were euthanised by an i.p. injection of pentobarbital (150 mg/kg). Thereafter, blood was 
aspirated, plasma separated and stored at -80oC. Samples of liver and lungs were processed 
and stored at -80oC. Subsequently, MPO activity (Section 2.8), liver and lung injury (Section 
2.9), ALT and AST enzyme activity levels (Section 2.16) and proinflammatory cytokine (TNF-α, 
IL-6, and IL-1β) and chemokine (MCP-1 and MIP-2α) levels (Section 2.12) were measured by 
the methods described in the Material and Methods of Chapter 2. Statistical analysis was 




6.4.1 Effect of GdCl3 pretreatment on tissue leukocyte infiltration following CLP-induced 
sepsis  
Mice with CLP-induced sepsis showed significantly more MPO activity in the liver and lung 
compared to sham control mice, with a mean fold increase of 1.62-(P<0.05, liver) and 3.63-
fold (P<0.01, lung), respectively, demonstrating leukocyte infiltration occurs following CLP-
induced sepsis. Pretreatment of mice with GdCl3 before induction of sepsis decreased MPO 
activity in the liver compared to sepsis mice without GdCl3 pretreatment, with a mean fold 
increase over the sham control of 0.86 compared to 1.62  (P<0.05). 
 
Figure 6.1 Effect of GdCl3 administration on MPO activity following CLP-induced sepsis. Mice with 
CLP-induced sepsis or sham operation were randomly given GdCl3 (10 mg/kg, i.v.) or saline before the 
CLP or sham operation. Eight hours after CLP or sham operation, mice were sacrificed and MPO activity 
in liver (A) and lungs (B) was measured using a spectrophotometric assay. MPO activity increased 
significantly in the liver and lungs following CLP-induced sepsis compared to the sham control. Mice 
administered with GdCl3 showed significantly decreased mean MPO activity in the liver following 
sepsis, though there was no effect on the mean lung MPO activity. Instead, GdCl3 administered sepsis 
mice showed increased mean lung MPO activity compared to sepsis mice without GdCl3. Data 
represent mean ± S.E.M. (n=8). The significance of differences between groups was evaluated by 





In contrast, lung MPO activity was significantly increased in sepsis mice pretreated with GdCl3 
compared to sepsis mice without GdCl3 pretreatment, with a mean fold increase over the 
sham control of 7.01 compared to 3.63 (P<0.0001) (Figure 1).  
6.4.2 Effect of GdCl3 pretreatment on liver and lungs damage following CLP-induced sepsis   
Mice with CLP-induced sepsis showed the effects of the injury on the liver and lungs. Liver 
sections stained with hematoxylin and eosin from mice after CLP operation were 
characterised by capsular inflammation and focal necrotic damage that could be easily 
observed when compared to sham control sections. Pretreatment of sepsis mice with GdCl3 
showed less capsular inflammation and focal necrotic damage in the liver compared to sepsis 
mice without GdCl3 pretreatment. Lung sections from mice after CLP operation exhibited 
characteristic signs of lung injury, which included leukocyte infiltration and alveolar 
thickening in the interstitium compared to the sham operated mice. In contrast to the liver, 
GdCl3 pretreatment had no significant effect on leukocyte infiltration and alveolar thickening 
in the lungs. However, normal liver and lungs histoarchitecture was observed in the sham 














Figure 6.2 Morphological changes in the liver and lungs following CLP-induced sepsis and the effect 
of GdCl3 pretreatment. In mice, GdCl3 (10 mg/kg, i.v.) or saline was administered before the CLP or a 
sham operation. Eight hours after CLP or sham operation, mice were sacrificed and liver and lung 
tissues were processed for histological examination using hematoxylin and eosin staining. 
Haematoxylin (purple) stains nucleic acids (cell nucleus), while eosin (pink) stains protein non-
specifically (cell cytoplasm and extracellular matrix). Liver images were assessed for capsular 
inflammation and lobular necrotic damage using modified Knodell Histology Activity Index (HAI) of 
blinded scoring system of liver injury (271, 272) whereas lung sections were assessed for leukocyte 
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infiltration and alveolar wall thickening using blinded lung injury scoring system suggested by 
American Thoracic Society guidelines (273). Representative liver (A) and lung (B) sections show 
capsular inflammation and focal necrosis in the liver and leukocyte infiltration and alveolar thickening 
in the lungs as a result of CLP-induced sepsis. Pretreatment with GdCl3 significantly reduced capsular 
inflammation and focal necrosis in liver but failed to reduce leukocyte infiltration and alveolar 
thickening in lungs following CLP-induced sepsis. Data represent mean ± S.E.M. (n=8). The significance 
of differences between groups was evaluated by non-parametric Kruskal–Wallis test. Statistical 
significance was assigned as *P<0.05, **P<0.01 and ***P<0.001.   
 
 
6.4.3 Effect of GdCl3 pretreatment on plasma ALT and AST activity levels following CLP-
induced sepsis  
Increased levels of ALT and AST activity in plasma is an indication of liver damage. CLP-induced 
sepsis in mice was associated with significantly higher levels of plasma ALT and AST activity 
compared to sham control mice (ALT: 48.54 ± 5.86 U/L vs 25.17 ± 2.04 U/L, P<0.001; and AST: 
194.7 ± 21.62 U/L vs 77.75 ± 5.35 U/L, P<0.0001). Pretreatment of sepsis mice with GdCl3 
significantly reduced plasma ALT and AST activity levels compared to sepsis mice without 
GdCl3 pretreatment (ALT: 26.65 ± 1.54 U/L  vs 48.54 ± 5.86 U/L, P<0.01; and AST: 119.0 ± 9.51 
vs U/L 194.7 ± 21.62 U/L, P<0.01). There was no significant difference between GdCl3 
pretreated sham and GdCl3 sepsis mice and sham mice without GdCl3 pretreatment (Figure 




Figure 6.3 Alteration of plasma ALT and AST activity levels following CLP-induced sepsis and the 
effect of GdCl3 pretreatment. In mice, GdCl3 (10 mg/kg, i.v.) or saline was administered before the CLP 
or sham operation. Eight hours after CLP or sham operation, mice were sacrificed and ALT (A) and AST 
(B) activity levels in plasma were measured using the enzymatic method. CLP-induced sepsis resulted 
in a significant increase in plasma ALT and AST activity levels. There was a significant reduction in 
plasma ALT and AST activity levels in sepsis mice pretreated with GdCl3 compared to sepsis mice 
without GdCl3 pretreatment. Data represent mean ± S.E.M. (n=8). The significance of differences 
between groups was evaluated by ANOVA with post-hoc Tukey’s test. Statistical significance was 
assigned as **P<0.01, ***P<0.001 and ****P<0.0001.  
 
 
6.4.4 Effect of GdCl3 pretreatment on liver proinflammatory mediators following CLP- 
induced sepsis  
 
As expected, mice with CLP-induced sepsis showed significantly higher liver levels of cytokines 
(TNF-α, IL-6 and IL-1β) and chemokines (MCP-1 and MIP-2α) compared to control mice with 
a sham operation (TNF-α: 107.5 ± 9.49 ng/mg vs 51.62 ± 13.49 ng/mg (P<0.001); IL-6: 3.68 ± 
0.41 ng/mg vs 3.07 ± 0.46 ng/mg (P<0.05); IL-1β: 0.64 ± 0.09 ng/mg vs 0.33 ± 0.03 ng/mg 
(P<0.01); MCP-1: 1685.0 ± 128.0 ng/mg vs 784.1 ± 66.15 ng/mg (P<0.001); and MIP-2α: 4.99 
± 0.58 ng/mg vs 3.08 ± 0.20 ng/mg (P<0.05)). Sham operations produce a degree of 
inflammation as the pretreatment with GdCl3 reduced cytokine and chemokine levels in the 
sham operated mice. Sepsis mice pretreated with GdCl3 had lower liver levels of 





Figure 6.4 Effect of GdCl3 pretreatment on protein expression levels of cytokines and chemokines in 
the liver from mice with CLP-induced sepsis. Mice with CLP-induced sepsis or a sham operation were 
randomly given GdCl3 (10 mg/kg, i.v.) or saline before the operation. Eight hours after CLP or sham 
operation, mice were sacrificed and cytokine (TNF-α (A), IL-6 (B) and (IL-1β (C)) and chemokine (MCP-
1 (D) and MIP-2α (E)) levels were measured in the liver by ELISA. CLP-induced sepsis resulted in a 
significant increase in liver proinflammatory cytokines and chemokines. There was a significant 
reduction in all these mediators in GdCl3-pretreated mice following CLP-induced sepsis. Data represent 
mean ± S.E.M. (n=8). The significance of differences between groups was evaluated by ANOVA with 






sepsis-induced liver inflammation (TNF-α: 21.44 ± 2.40 ng/mg vs 107.5 ± 9.49 ng/mg 
(P<0.0001); IL-6: 1.53 ± 0.11 ng/mg vs 3.68 ± 0.41 ng/mg (P<0.0001); IL-1β: 0.27 ± 0.06 ng/mg 
vs 0.64 ± 0.09 ng/mg (P<0.001); MCP-1: 1352.0 ± 125.1 ng/mg vs 1685.0 ± 128.0 ng/mg; and 
MIP-2α: 1.75 ± 0.11 ng/mg vs 4.99 ± 0.58 ng/mg (P<0.0001)) (Figure 6.4).    
6.4.5 Effect of GdCl3 pretreatment on lungs proinflammatory mediators following CLP-
induced sepsis  
A substantial elevation of lungs cytokines (TNF-α, IL-6 and IL-1β)  and chemokines (MCP-1 and 
MIP-2α) was seen in CLP-induced sepsis mice compared to sham operated mice (TNF-α: 18.86 
± 1.69 ng/mg vs 5.66 ± 0.32 ng/mg (P<0.01); IL-6: 1.0 ± 0.152 ng/mg vs 0.48 ± 0.06 ng/mg 
(P<0.01); IL-1β: 0.51 ± 0.11 ng/mg vs 0.18 ± 0.04 ng/mg (P<0.01); MCP-1: 524.0 ± 90.39 ng/mg 
vs 142.5 ± 18.85 ng/mg (P<0.01); and MIP-2α: 1.37 ± 0.07 ng/mg vs 0.77 ± 0.13 ng/mg 
(P<0.01)). Pretreatment with GdCl3 failed to decrease levels of proinflammatory cytokines and 
chemokines in the lungs after CLP-induced sepsis. Moreover, lungs TNF-α levels were 
significantly increased in GdCl3 pretreated sepsis mice compared to the sepsis mice without 
GdCl3 pretreatment (TNF-α: 30.07 ± 2.83 ng/mg vs 18.86 ± 1.69 ng/mg (P<0.01); IL-6: 1.32 ± 
0.11 ng/mg vs 1.0 ± 0.152 ng/mg; IL-1β: 0.37 ± 0.01 ng/mg vs 0.51 ± 0.11 ng/mg; MCP-1: 648.1 
± 121.3 ng/mg vs 524.0 ± 90.39 ng/mg and MIP-2α: 1.36 ± 0.11 ng/mg vs 1.37 ± 0.07 ng/mg)) 





Figure 6.5 Effect of GdCl3 administration on the levels of cytokines and chemokines in lungs from 
mice with CLP-induced sepsis. Mice with CLP-induced sepsis or a sham operation were randomly given 
GdCl3 (10 mg/kg, i.v.) or saline before the operation. Eight hours after CLP or sham operation, mice 
were sacrificed and cytokine (TNF-α (A), IL-6 (B) and (IL-1β (C)) and chemokine (MCP-1 (D) and MIP-2α 
(E)) levels were measured in lungs by ELISA. CLP-induced sepsis mice showed significant increases in 
lungs proinflammatory cytokines and chemokines. Pretreatment with GdCl3 had no effect on the 
increased levels of lungs cytokines and chemokines following CLP-induced sepsis. Instead, mean TNF-
α levels were significantly increased compared to sepsis mice without GdCl3 pretreatment. Data 
represent mean ± S.E.M. (n=8). The significance of differences between groups was evaluated by 




6.4.6 Effect of GdCl3 pretreatment on circulatory proinflammatory mediators following CLP-
induced sepsis  
Higher level of circulatory proinflammatory cytokines and chemokines are a feature of sepsis.   
After a CLP operation mice had significantly increased levels of circulatory proinflammatory 
cytokines (TNF-α, IL-6 and IL-1β) and chemokines (MCP-1 and MIP-2α) compared to sham 
control mice (TNF-α: 2.02 ± 0.14 ng/mL vs 0.57 ± 0.03 ng/mL (P<0.0001); IL-6: 0.07 ± 0.01 
ng/mL vs 0.01 ± 0.002 ng/mL (P<0.01); IL-1β: 0.15 ± 0.01 ng/mL vs 0.048 ± 0.01 ng/mL 
(P<0.01); MCP-1: 917.52 ± 71.84 ng/mL vs 210.72 ± 20.45 ng/mL (P<0.0001); and MIP-2α: 0.13 
± 0.02 ng/mL vs 0.03 ± 0.01 ng/mL (P<0.0001)). Sepsis mice pretreated with GdCl3 failed to 
decrease the levels of circulatory proinflammatory cytokines and chemokines. Instead, 
plasma IL-1β levels were significantly increased in GdCl3-pretreated sepsis mice compared to 
sepsis mice without GdCl3 pretreatment (TNF-α: 2.29 ± 0.17 ng/mL vs 2.02 ± 0.14 ng/mL; IL-
6: 0.08 ± 0.01 ng/mL vs 0.07 ± 0.01 ng/mL; IL-1β: 0.24 ± 0.03 ng/mL vs 0.15 ± 0.01 ng/mL 
(P<0.05); MCP-1: 853.0 ± 204.1 ng/mL vs : 917.52 ± 71.84 ng/mL; and MIP-2α: 0.13 ± 0.03 vs 







Figure 6.6 Effect of GdCl3 administration on cytokine and chemokine levels in plasma from mice with 
CLP-induced sepsis. Mice with CLP-induced sepsis or sham operation were randomly given GdCl3 (10 
mg/kg, i.v.) or saline before the operation. Eight hours after CLP or sham operation, mice were 
sacrificed and cytokine (TNF-α (A), IL-6 (B) and (IL-1β (C)) and chemokine (MCP-1 (D) and MIP-2α (E)) 
levels were measured in plasma by ELISA. CLP-induced sepsis mice showed a significant increase in 
mean plasma proinflammatory cytokines and chemokines. GdCl3 pretreatment did not decrease 
plasma cytokine and chemokine levels following CLP-induced sepsis. Instead, IL-1β levels were 
significantly increased compared to sepsis mice without GdCl3 pretreatment. Data represent mean ± 
S.E.M. (n=8). The significance of differences among groups was evaluated by ANOVA with post-hoc 





The results of the present study have shown that Kupffer cells play a key role in CLP-induced 
sepsis, particularly the effects on the liver. The main findings of this study are: (1) increased 
liver injury and inflammation as a result of CLP-induced sepsis in mice was attenuated by 
pretreatment with GdCl3; and (2) pretreatment with GdCl3 failed to protect against CLP-
induced lung injury, inflammation and the systemic inflammatory response in mice.   
Kupffer cells are primary macrophages in the liver. They regulate blood detoxification and 
maintain a functional immune response to exogenous infectious challenge. Activation of 
Kupffer cells during endotoxaemia or bacterial infection has been shown to cause liver injury 
and inflammation during sepsis (220, 228). Proinflammatory cytokines and chemokines 
secreted by activated Kupffer cells mediate liver injury and inflammation in sepsis and 
inactivation of Kupffer cells can provide a survival advantage in sepsis (226). The results of the 
present study demonstrated that pretreatment with GdCl3 resulted in decreased liver 
inflammation, as evidenced by reduced leukocyte MPO activity, proinflammatory cytokines 
such as TNF-α, IL-6 and IL-1β, and chemokines such as MCP-1 and MIP-2α. Histological 
examination of the liver sections showed that pretreatment with GdCl3 reduced capsular 
inflammation and focal necrosis following sepsis. These results are consistent with previous 
reports in animal models of endotoxaemia and sepsis (220, 224, 231, 233, 240). For example, 
it has been shown that treatment with GdCl3 protects animals against liver injury by reducing 
superoxide production and TNF-α levels following LPS-induced endotoxaemia and sepsis (220, 
231, 232). Furthermore, in the present study, sepsis mice pretreated with GdCl3 showed 
reduced levels of plasma ALT and AST activity. In contrast, previous studies have reported 
that treatment with GdCl3 elevated plasma ALT and AST levels in obstructive jaundice mice 
119 
 
exposed to endotoxin (224), while others have reported no such increase in liver enzyme 
levels (220, 234). The conflicting results between this study and other investigations might be 
due to differences in the animal disease model and the dosage regime of GdCl3. The results 
in this chapter support the hypothesis that inactivation of Kupffer cells by GdCl3 can be 
protective against liver injury and inflammation in CLP-induced sepsis.   
Under conditions of sepsis and septic shock, the respiratory system is the most vulnerable 
organ system, and ALI leading to ARDS is the first step in the development of multiple organ 
failure (340). Although there have been sustained efforts to understand lung injury during 
endotoxaemia, and sepsis and GdCl3 treatment, the role of GdCl3 in lung injury is still poorly 
understood. The findings of the present study show that despite improvement of liver injury 
and inflammation by GdCl3 in CLP-induced sepsis, pretreatment of sepsis mice with GdCl3 did 
not decrease lung injury or inflammation. In addition, GdCl3 pretreatment was shown to 
increase leukocyte MPO activity in the lungs of mice with CLP-induced sepsis. Moreover, 
histological examination of the lung sections showed GdCl3 pretreatment failed to reduce 
sepsis induced-leukocyte infiltration and alveolar congestion. It is reasonable to assume that 
in vivo exposure to GdCl3 inhibits the uptake of bacteria or endotoxins by Kupffer cells and 
that this could result in increased exposure of extrahepatic organs such as the lungs to 
infection or endotoxins. Pulmonary cells such as alveolar macrophages can produce 
proinflammatory cytokines and chemokines during sepsis, and it is plausible that production 
of these mediators increased when removal of bacteria or endotoxins by Kupffer cells was 
impaired. Increased lung injury might be due to increased migration of leukocytes, particularly 
neutrophils, into the alveolar space as a result of increased amounts of cytokines and 
chemokines released from activated alveolar macrophages during sepsis in GdCl3-treated 
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mice. These findings suggest that sepsis-induced lung injury and inflammation are 
independent of the direct effect of GdCl3 on Kupffer cells in the liver. Functional differences 
between alveolar macrophages and Kupffer cells have been reported in studies that clearly 
indicate that significant heterogeneity exists between these two cell types (217, 219). 
Although GdCl3 selectively inhibits Kupffer cell activation, it has been shown that GdCl3 
pretreatment alters the responses of alveolar macrophages to ozone exposure; however, the 
mechanism is not known (237). Therefore, the possibility cannot be ruled out that there are 
independent effects of GdCl3 on alveolar macrophages after CLP-induced sepsis.  For example, 
it has been reported that pretreatment with GdCl3 predisposes lungs to alveolitis in 
endotoxaemic rats (223). Conversely, other studies have shown that GdCl3 treatment 
prevents endotoxaemia and sepsis-induced lung injury by a mechanism that involves 
inhibiting production of proinflammatory mediators and caspase-3 and by increasing IL-10 
from Kupffer cells, suggesting an interaction between Kupffer cells and alveolar macrophages 
in lung injury during endotoxaemia and sepsis (230, 234, 236). Further studies are required to 
gain a better understanding of the role of GdCl3 in lung injury during sepsis.   
The results of the present study also showed that circulatory cytokine and chemokine levels 
did not differ between GdCl3-treated and non-treated sepsis mice, suggesting circulatory 
proinflammatory mediators may not accurately reflect those that are secreted by Kupffer 
cells. The results of the present study are supported by previous reports, which indicated that 
serum levels of TNF-α and IL-6 are not affected by GdCl3 in hepatic-reperfusion-induced injury 
exposed to endotoxin and LPS-induced endotoxaemia (222, 226, 240). In contrast, previous 
experiments using both GdCl3 and clodronate liposomes have shown that inactivation of 
Kupffer cells lowered serum levels of TNF-α, IL-6 and IL-1β following LPS-induced 
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endotoxaemia and sepsis (220, 225, 228, 239). The conflicting results between this study and 
other studies might be due to differences in the animal disease model and the dosage regime 
of GdCl3. However, it is reasonable to assume that, as in the lungs, in vivo exposure to GdCl3 
inhibits the uptake of bacteria or endotoxin by Kupffer cells, and that this could result in 
increased exposure of circulatory monocytes and neutrophils to infection or endotoxin. 
Hence, inhibition of Kupffer cells by GdCl3 could potentially increase circulatory levels of 
inflammatory mediators produced by activated monocytes and neutrophils. Therefore, the 
results of the present study suggest that the increased circulatory levels of cytokines and 
chemokines found during sepsis are not directly responsible for the liver injury and similarly 
that the protective effect of GdCl3 against liver damage and inflammation is not due to the 
inhibition of circulatory proinflammatory mediators.  
At the same time, the present study has some limitations. This study is limited by short 
duration of the end endpoint (8 h after CLP-induced sepsis). In addition, the present study did 
not investigate survival rates, which would help to understand the differential effects of GdCl3 
in CLP-idncued sepsis. Also, endpoints such as alveolar thickening may take time to evolve 
and may commence sometime after liver injury has occurred; hence, an 8 h time point may 
be too early to detect effects that may evolve later.  
In conclusion, the experimental results described in this chapter have shown that mice 
pretreated with GdCl3 have decreased liver injury and inflammation following CLP-induced 
sepsis. However, pretreatment with GdCl3 failed to protect mice against sepsis-induced lung 
injury, inflammation and the systemic inflammatory response. Therefore, it is concluded that 
most likely GdCl3 prevents liver injury and inflammation due to a reduced local effect of 
cytokine and chemokine on hepatocytes from Kupffer cells. 
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 Chapter 7 
Effect of caecal-ligation and puncture-induced sepsis on liver sinusoidal 
endothelial cell fenestration (liver sieve) 
 
7.1 Introduction  
Liver sinusoidal endothelial cells (LSECs) are fenestrated endothelial cells that act as a 
permeable barrier between sinusoidal blood and hepatic parenchyma (341). The LSECs 
fenestrations are pores which range in size from 50-250 nm in diameter and form liver sieve 
plates (342). The structural integrity of the fenestrated liver sinusoidal endothelium is 
essential for the maintenance of a normal exchange of fluids, solutes, particles and 
metabolites between sinusoidal blood and hepatic parenchymal cells (343). The diameter and 
number of the fenestrae vary from species to species and within single individuals of a species 
under the influence of various physiological and pharmacological circumstances. For example, 
in comparison with the rat, rabbits have smaller fenestrae and chicken have fewer fenestrae 
(246-248). In addition, differences in fenestrae diameter and frequency vary from one lobe to 
another and within different regions of a lobe. For example, differences in fenestrae diameter 
and frequency in peripheral and centrilobular zones have been demonstrated in the rat liver 
(216). Changes in fenestration diameter and number are also observed in response to a 
variety of biological mediators such as growth factors (VEGF) (250), hormones (serotonin) 
(249) and neurotransmitters (acetylcholine and adrenaline), drugs (pantethine, nicotine) 
(256), toxins (cytochalasin B (251), latrunculin A, misakinolide (252), antimycin A (344), 
thioacetamide (258), dimethylnitrosamine (257) and carbon tetrachloride (345)) and diseases 
such as alcohol abuse associated liver injury (253-255), cirrhosis (258), oxidative stress (259, 
260), inflammation, infection and endotoxaemia (261, 262)). Impairment of substrate 
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exchange through the alteration of LSEC fenestrae is a major contributor to hepatic 
dysfunction and leads to liver and systemic diseases. 
Sepsis involves a systemic inflammatory response to infection and is the leading cause of 
death in intensive care patients (346, 347). During sepsis, both Kupffer cells and LSECs are the 
first responders to invading bacteria and endotoxins (220, 228, 235, 240). Excessive 
stimulation of Kupffer cells during infection or endotoxaemia leads to secretion of an array of 
mediators, including proinflammatory cytokines (TNF-α, IL-6 and IL-1β), arachidonate 
derivatives (thromboxanes and leukotrienes) and biologically-active free radicals (oxygen and 
nitrogen radicals, among others), which lead to LSEC damage and hepatocyte injury (235, 261-
263). LSECs also have the capacity to produce proinflammatory cytokines which are increased 
when LSECs stimulated with LPS (235). For example, it has been shown that LPS induces LSEC 
defenestration by the release of proinflammatory mediators from activated LSECs and 
Kupffer cells (235, 261). Recent evidence has shown that Kupffer cells potentiate LSEC injury 
by ligating programmed death ligand-1 (PD-L1) in sepsis (263). In contrast, Kupffer cells 
protect LSECs by decreasing Fas-mediated apoptosis in sepsis. Nevertheless, CLP sepsis-
induced structural changes in LSEC fenestrae and the role of Kupffer cell inactivation on these 
changes remain to be elucidated.  
The role of H2S and SP has been well-documented in the animal models of endotoxaemia and 
sepsis (44, 140, 177, 197, 198, 348-350). H2S synthesised through CSE acts as a 
proinflammatory mediator in LPS-induced endotoxaemia and CLP-induced sepsis and is 
associated with liver injury and inflammation (43, 44, 126, 140, 177, 317). A mechanism of 
CSE-derived H2S-mediated inflammation involves activation of ERK1/2 and NF-B p65 
signalling and subsequent transcription of proinflammatory mediators (particularly TNF-α) 
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(43, 44) (also shown in Chapter 4). In addition, SP and subsequent activation of NK-1R are 
under the control of H2S and it has been shown that SP acts as the upstream regulator of CSE 
or CSE-derived H2S-mediated inflammation (141) (also shown in Chapter 5). However, as an 
important regulators of inflammation, the role of neither H2S nor SP on LSEC fenestrae 
following CLP-induced sepsis is known.  
The objective of the present study was to determine whether sepsis alters LSEC fenestrae and 
if so, to investigate the potential roles of Kupffer cell, CSE-derived H2S and SP on sepsis-altered 
LSEC fenestrae.  
7.2 Aims   
The previous chapters (Chapters 3 to 5) have shown the importance of CSE-derived H2S 
signalling on inflammation and organ injury following CLP-induced sepsis. These chapters 
focused on the mechanisms involved in CSE-derived H2S-mediated inflammation and 
interaction with SP and NK-1R following sepsis. In addition, in Chapter 6 the role of GdCl3 on 
sepsis-associated liver and lung injury, inflammation and systemic inflammatory response 
was investigated.  
The present study aimed to examine the structural changes in LSEC fenestrae (diameter, 
frequency, porosity and gaps formation) induced by CLP-induced sepsis and the effect of 
GdCl3, CSE gene deletion and PPTA gene deletion on CLP sepsis-induced structural changes in 
LSEC fenestrae.   
7.3 Experimental approach  
Three sets of experiments were performed. In the first experiment, sixteen C57BL/6J (males 
aged between 8-10 weeks; 25-30 g) mice were randomly divided into control (Sham operation 
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and Sham operation + GdCl3) and experimental (Sepsis and Sepsis + GdCl3) groups, with four 
mice in each group (n=4). GdCl3 was administered (10 mg/kg; i.v., tail vein) before the CLP and 
sham operations and saline-treated CLP and sham mice acted as vehicle controls.  
In the second experiment, sixteen WT (C57BL/6J) and CSE KO (on a C57BL/6J background) 
(males aged between 8-10 weeks; 25-30 g) mice were randomly divided into control (WT 
Sham operation and CSE KO Sham operation) and experimental (WT Sepsis and CSE KO Sepsis) 
groups, with four mice in each group (n=4).  
In the third experiment, sixteen WT (BALB/c) and PPTA KO (on a BALB/c background) (males 
aged between 8-10 weeks; 25-30 g) mice were randomly divided into control (WT Sham 
operation and PPTA KO Sham operation) and experimental (WT Sepsis and PPTA KO Sepsis) 
groups, with four mice in each group (n=4).  
In all these experiments, sepsis was induced by CLP as described in Section 2.4 and 8 h after 
CLP or sham operation mice were anaesthtised by an i.p. injection of pentobarbital (80 
mg/kg). Liver perfusion was performed and perfusion-fixed liver sections were processed for 
scanning electron microscopy, as described in Section 2.15. Statistical analysis was performed 
as described in Section 2.17.  
7.4 Results 
7.4.1 Effect of CLP-induced sepsis and GdCl3 pretreatment on LSEC fenestration  
Changes in LSEC fenestration was assessed by scanning electron micrographs and showed 
LSEC defenestration following CLP-induced sepsis, as evidenced by decreased frequency, and 
porosity and more gaps formation in the LSECs compared to sham control (gap area: 0.18 ± 
0.01 nm2/µm2 vs 0.02 ± 0.01 nm2/µm2). Sepsis mice pretreated with GdCl3 showed 
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significantly less defenestration (increased frequency and porosity) and fewer gaps formation 
compared to mice without GdCl3 pretreatment (gap area: 0.07 ± 0.01 nm2/µm2 vs 0.18 ± 0.01 








 Figure 7.1 Effect of GdCl3 pretreatment on LSEC defenestration following CLP-induced sepsis in mice, 
assessed using scanning electron microscopy (SEM). Mice with CLP-induced sepsis or sham operation 
were randomly given GdCl3 (10 mg/kg, i.v.) or saline before the CLP or sham operation. Eight hours 
after CLP or sham operation, liver perfusion was performed through the cannulation of portal vein 
using a fixative buffer (2.5% glutaraldehyde in cacodylate buffer). Perfusion-fixed liver sections were 
processed to measure changes in LSEC fenestration using SEM. (A) Representative images of LSEC 
micrographs and (B) average gap area in LSEC fenestrae. CLP-induced sepsis resulted in a significant 
increase of LSEC injury, as evidenced by gaps formation. Mice pretreated with GdCl3 showed fewer 
gaps formation compared to mice without GdCl3 following CLP-induced sepsis. Data represent mean ± 
S.E.M. (n=4). The significance of differences among groups was evaluated by ANOVA with post-hoc 
Tukey’s test. Statistical significance was assigned as *P<0.05.  
 
Table 7.1 Effect of GdCl3 pretreatment on LSEC fenestration in mice following CLP-induced sepsis, 








Mice with CLP-induced sepsis or sham operation were randomly given GdCl3 (10 mg/kg, i.v.) or saline 
before the CLP or sham operation. Eight hours after CLP or sham operation, liver perfusion was 
performed through cannulation of portal vein using a fixative buffer (2.5% glutaraldehyde in 
cacodylate buffer). Perfusion-fixed liver sections were processed to measure changes in LSEC 
fenestration using SEM. CLP-induced sepsis resulted in a significant decrease in frequency and porosity 
in LSEC fenestrae. There was a significant increase (except diameter) of frequency and porosity of LSEC 
fenestrae in GdCl3 pretreated mice compared to mice without GdCl3 pretreatment following sepsis. 
Data represent mean ± S.E.M. (n=4). The significance of differences among groups was evaluated by 
ANOVA with post-hoc Tukey’s test. Statistical significance was assigned as **P<0.01 and ***P<0.001 
vs sham and ##P<0.01 vs sepsis.   
 
 7.4.2 Alteration of LSEC fenestration in WT and CSE KO mice following CLP-induced sepsis. 
Scanning electron micrographs showed that CLP-induced sepsis was associated with 
defenestration (decreased diameter, frequency and porosity) and gaps formation in LSEC 
Treatment group Diameter of 
 fenestrae (nm) 




      Sham + GdCl3 
Sepsis  
Sepsis + GdCl3 
137.63 ± 6.46 
126.37 ± 7.72 
123.45 ± 3.13 
119.51 ± 5.42 
 
8.42 ± 0.50 
9.18 ± 0.29 
    6.56 ± 0.28** 
    9.19 ± 0.71### 
12.51 ± 0.59 
12.23 ± 0.27 
     8.40 ± 0.67*** 




fenestrae compared to sham control in WT mice (gap area: 0.18 ± 0.01 nm2/µm2 vs 0.02 ± 
0.01 nm2/µm2). Sepsis mice deficient in the CSE gene showed less defenestration (increased 
diameter, frequency and porosity) and fewer gaps formation than WT sepsis mice (gap area: 










Figure 7.2 Effect of CLP-induced sepsis on LSEC fenestration in WT and CSE KO mice, assessed using 
scanning electron microscopy (SEM). WT and CSE KO mice underwent CLP or sham operation. Sham 
operated mice acted as controls. Eight hours after CLP or sham operation, liver perfusion was 
performed through the cannulation of portal vein using a fixative buffer (2.5% glutaraldehyde in 
cacodylate buffer). Perfusion-fixed liver sections were processed to measure LSEC injury using SEM. (A) 
Representative images of LSEC micrographs and (B) average gap area in LSEC fenestrae. CLP-induced 
sepsis resulted in a significant increase of LSEC injury, as evidenced by gaps formation in WT mice. CSE 
KO mice showed significantly fewer gaps formation compared to WT mice following CLP-induced 
sepsis. Data represent mean ± S.E.M. (n=4). The significance of differences among groups was 
evaluated by ANOVA with post-hoc Tukey’s test. Statistical significance was assigned as ****P<0.0001.  
 
Table 7.2 Effect of CLP-induced sepsis on LSEC fenestration in WT and CSE KO mice, assessed using 







WT and CSE KO mice underwent CLP or sham operation. Sham operated mice acted as controls. Eight 
hours after CLP or sham operation, liver perfusion was performed through the cannulation of portal 
vein using a fixative buffer (2.5% glutaraldehyde in cacodylate buffer). Perfusion-fixed liver sections 
were processed to measure changes in LSEC fenestration using SEM. CLP-induced sepsis resulted in a 
significant decrease of diameter, frequency and porosity in LSEC fenestrae of WT mice. There was a 
significant increase (except diameter) of frequency and porosity in LSEC fenestrae of CSE KO mice 
compared to WT mice following sepsis. Data represent mean ± S.E.M. (n=4). The significance of 
differences among groups was evaluated by ANOVA with post-hoc Tukey’s test. Statistical significance 
was assigned as *P<0.05 and **P<0.01 vs WT sham and #P<0.05 and ##P<0.01 vs WT sepsis.  
 
7.4.3 Alteration of LSEC fenestration in WT and PPTA KO mice following CLP-induced sepsis 
Scanning electron micrographs show that CLP-induced sepsis was associated with 
defenestration (decreased frequency and porosity) and gaps formation in LSEC fenestrae 
compared to sham operated WT mice (gap area: 0.12 ± 0.02 nm2/µm2 vs 0.06 ± 0.01 
nm2/µm2). Sepsis mice deficient in the PPTA gene showed less defenestration (increased 
Group Diameter of 
 fenestrae (nm) 




CSE KO Sham 
WT Sepsis 
CSE KO Sepsis 
137.63 ± 6.46 
118.51 ± 3.07 
123.45 ± 3.13* 
125.91 ± 5.42 
 
8.42 ± 0.50 
8.44 ± 1.00 
  6.56 ± 0.28* 
8.92 ± 0.68# 
12.51 ± 0.59 
10.49 ± 0.66 
8.40 ± .67** 




frequency and porosity) and fewer gaps formation than WT sepsis mice (gap area: 0.09 ± 0.01 











Figure 7.3 Effect of CLP-induced sepsis on LSEC fenestration in WT and PPTA KO mice, assessed using 
scanning electron microscopy (SEM). WT and PPTA KO mice underwent CLP or sham operation. Sham 
operated mice acted as controls. Eight hours after CLP or sham operation, liver perfusion was 
performed through the cannulation of portal vein using a fixative buffer (2.5% glutaraldehyde in 
cacodylate buffer). Perfusion-fixed liver sections were processed to measure LSECs injury using SEM. 
(A) Representative images of LSEC micrographs and (B) average gap area in LSEC fenestrae. CLP-
induced sepsis resulted in a significant increase of LSEC injury as evidenced by gaps formation in WT 
mice. PPTA KO mice showed fewer gaps formation in LSEC fenestrae compared to WT mice following 
CLP-induced sepsis. Data represent mean ± S.E.M. (n=3-4). The significance of differences among 
groups was evaluated by ANOVA with post-hoc Tukey’s test. Statistical significance was assigned as 
*P<0.05.  
 
Table 7.3 Effect of CLP-induced sepsis on LSEC fenestration in WT and PPTA KO mice, assessed using 
scanning electron microscopy (SEM). 
 





WT and PPTA KO mice underwent CLP or sham operation. Sham operated mice acted as controls. Eight 
hours after CLP or sham operation, liver perfusion was performed through cannulation of portal vein 
using a fixative buffer (2.5% glutaraldehyde in cacodylate buffer). Perfusion-fixed liver sections were 
processed to measure for changes in LSEC fenestration using SEM. CLP-induced sepsis resulted in a 
significant decrease in frequency and porosity in LSEC fenestrae of WT mice. PPTA KO mice showed an 
increase (not significant) of frequency and porosity in LSEC fenestrae compared to WT mice following 
CLP-induced sepsis. Data represent mean ± S.E.M. (n=3-4). The significance of differences among 
groups was evaluated by ANOVA with post-hoc Tukey’s test. Statistical significance was assigned as 
*P<0.05 and **P<0.01 vs WT sham.  
 
7.5 Discussion  
The present study demonstrates that increased inflammatory response in CLP-induced sepsis 
causes structural changes in LSEC fenestrae. Results of Chapter 4 and 6 have demonstrated 
the role of proinflammatory cytokines and chemokines in CLP-induced sepsis. The results 
Group Diameter of 
 fenestrae (nm) 




  PPTA KO Sham 
WT Sepsis 
 PPTA KO Sepsis 
149.39 ± 12.40 
135.83 ± 7.83 
143.91 ± 9.04 
144.68 ± 8.39 
10.63 ± 1.54 
11.60 ± 2.56 
6.40 ± 2.49* 
      9.05 ± 0.94 
18.44 ± 2.18 
17.64 ± 3.28 
    11.05 ± 3.23** 
       15.71 ± 2.19 
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from the three experiments here show defenestration in LSECs, i.e. decreased diameter, 
frequency and porosity of LSEC fenestrae following CLP-induced sepsis. These structural 
changes in LSEC fenestrae are comparable with earlier observations from different 
laboratories. For example, it has previously been reported that increased inflammatory 
response associated with endotoxaemia and sepsis causes structural changes in LSEC 
fenestrae, i.e. defenestration of LSECs (228, 235, 259, 260, 351). In vivo experiments of LPS-
induced endotoxaemia or pyocyanin challenge, a virulence factor of Pseudomonas 
aeruginosa-induced liver injury are associated with defenestration in LSEC fenestrae (262, 
352). Similarly, in vitro experiments with isolated LSECs exposed to pyocyanin or LPS resulted 
in a decrease in porosity, LSEC fenestrae enlargement and sieve plate disruption (352, 353). 
Together, the results of the present study suggest that inflammatory response associated 
with sepsis causes defenestration in LSEC fenestrae. 
For the first time, the experimental data of the present study demonstrates the formation of 
gaps in LSEC fenestrae following CLP-induced sepsis. Gaps are large defects in LSEC fenestrae 
(usually more than 250 nm in diameter) that are associated with LSEC injury. Mice with CLP-
induced sepsis showed more gaps formation in LSEC fenestrae than sham control mice. 
Increased formation of gaps in LSEC fenestrae might be due to increased inflammatory 
mediators and oxidative stress in sepsis. The concept of gaps formation has been described 
by previous studies using different experimental disease models during oxidative stress and 
endotoxaemia; however, the mechanism of their formation remains unclear. Fraser et al. 
reported the formation of large gaps in the liver sinusoidal endothelium following high 
perfusion pressure of the liver (354). Furthermore, large gaps formation has previously been 
seen in LSEC fenestrae following hepatic venous outflow obstruction, irradiation and oxidative 
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stress; these gaps occur as a result of loss or degradation of sieve plates (259, 355, 356). Most 
gaps in the endothelium that occur after oxidative stress are of similar size distribution as the 
sieve plates (259). Similarly, the experiments in this study show consistency in gaps formation 
following CLP-induced sepsis. The results of the present study demonstrate the significance 
of gaps formation in LSEC fenestrae, which are mainly due to increased inflammation and 
oxidative stress following CLP-induced sepsis.  
Based on the CLP sepsis-induced defenestration and gaps formation in LSEC fenestrae, the 
first approach of the present study was to investigate the role of Kupffer cell-secreted 
proinflammatory mediators on the alteration of LSEC fenestrae following CLP-induced sepsis 
in mice. To prove this, the present study used the chemical compound GdCl3, which 
inactivates Kupffer cells, to see the effect on CLP sepsis-induced defenestration and gaps 
formation in LSEC fenestrae. The results of Chapter 6 demonstrated that GdCl3 pretreatment 
decreases proinflammatory mediators and subsequently reduces liver injury following sepsis. 
In the present study, GdCl3 pretreatment resulted in less defenestration and fewer gaps 
formation in LSEC fenestrae following CLP-induced sepsis. The findings are consistent with 
previously published reports on the GdCl3 effect on LSEC defenestration using different 
experimental models including LPS-induced endotoxaemia in rats or in vitro exposure to the 
pseudomonas toxin pyocyanin (223, 262, 351, 357-359). Some previous evidence suggests 
that released TNF-α from activated Kupffer cells causes defenestration in LSEC fenestrae 
during infection and endotoxaemia (262, 360). However, these previous studies have no 
mention of the significance of gaps formation in LSEC fenestrae. The results of the present 
study suggest that Kupffer cells signalling to LSECs contribute to the regulation of fenestration 
and gaps formation.  
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The second approach was to use mice deficient in the CSE or PPTA genes separately to study 
the role of H2S or SP on CLP sepsis-induced defenestration and gaps formation in LSEC 
fenestrae. The results of the present experiments with CSE gene deficient mice and PPTA gene 
deficient mice show less defenestration and fewer gaps formation in LSEC fenestrae following 
CLP-induced sepsis. Previous studies have shown that CSE-derived H2S acts as an 
inflammatory mediator in sepsis and endotoxaemia by increasing proinflammatory cytokines 
(TNF-α, IL-6 and IL-1β) and chemokines (MCP-1 and MIP-2α) (43, 126, 173, 177, 317). It has 
also been shown that SP acts as an upstream regulator of CSE-derived H2S-mediated 
inflammation in sepsis (141). In addition, the experimental results in Chapter 4 demonstrated 
that mice deficient in the CSE gene regulate liver injury and inflammation following CLP-
induced sepsis. Mice with a CSE deficient gene have also shown decreased SP production 
following CLP-induced sepsis, suggesting that SP acts as an upstream regulator of CSE-derived 
H2S-mediated inflammatory response (shown in Chapter 5). As a regulators of inflammation, 
H2S and SP play a role in the structural changes observed in LSEC fenestrae. For the first time, 
the results of the present study indicate that increased inflammatory mediators through CSE-
derived H2S and SP following CLP-induced sepsis play a key role in the structural changes and 
gaps formation in LSEC fenestrae. 
Elucidating the mechanisms involved in the regulation and formation of LSEC fenestrations is 
important in understanding the underlying pathology of liver diseases. Several previous in 
vivo and in vitro studies have demonstrated the mechanisms of LSEC defenestration 
associated with different experimental disease models of liver injury. For example, the 
mechanism of alcohol-induced liver injury and defenestration of LSECs involves deposition of 
collagen, laminin, fibronectin and other connective tissue matrices in the space of Disse (254, 
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255, 361-363). This is due to activation (transformation) of fat storage cells (Ito cells) to 
produce collagen with secondary changes in the endothelial cells by ethanol or one of its 
metabolites (361, 363). Ageing, a natural process of the body, also increases the thickness of 
LSECs with a reduction in the number of LSEC fenestrae (364-366). Pseudocapillarisation and 
the formation of basement membrane with perisinusoidal fibrosis and central vein fibrosis 
are involved in the defenestration process of LSECs with ageing (365, 367, 368). Other studies 
have identified the involvement of actin cytoskeleton in the fenestration and defenestration 
process of LSECs (251, 252, 341, 344, 369-374). Various actin cytoskeleton disruptors such as 
cytochalasin B, latrunculin A, antimycin A, misakinolide and dihydrohalichondramide cause a 
significant increase in the size and frequency of fenestrae, with a subsequent loss of liver sieve 
plates (252, 343, 344, 371). These previous studies have established the importance of 
cytoskeleton and membrane rafts in the dynamics of LSEC fenestrae. In addition to the 
structural changes in the LSECs, abnormal function of LSECs has been reported during 
experimental sepsis. LSECs undergo Fas-mediated apoptosis through activation of gp130 
expression and by ligating programmed cell death ligand 1 (PD-L1) (263, 375). In both these 
experiments, Kupffer cells were the key macrophages of LSEC injury during sepsis.  
The present results show that released proinflammatory mediators following sepsis cause 
LSEC defenestration and that Kupffer cells, CSE-derived H2S and the SP play an important role 
in regulating fenestral structures in LSECs. Nevertheless, the present experiments did not 
investigate the mechanisms of defenestration in LSEC fenestrae following CLP-induced sepsis. 
Furthermore, this study is limited by the short duration of the endpoint (8 h post-CLP). It is 
important to study the time dependent changes in LSEC fenestrae for longer periods using 
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the same animal disease model for better understanding of defenestration process in LSECs; 
however, this has not been investigated in the present study.  
 In conclusion, for the first time the present study has demonstrated that the CSE-derived H2S, 
SP and Kupffer cells play a role in the regulation of defenestration and gaps formation in LSEC 
fenestrae following CLP-induced sepsis. The present study indicates the importance of H2S, 
SP and Kupffer cells in the structural maintenance of LSEC fenestrae under the 

















Circulatory hydrogen sulfide and substance P levels in patients with sepsis 
admitted to the intensive care unit 
 
8.1 Introduction 
Sepsis is life-threatening organ dysfunction that arises from the body’s response to infectious 
stimuli (1). Despite advances in antimicrobial therapy and supportive care, sepsis remains a 
leading cause of death in critically ill patients in the ICU and arises from an overwhelming 
inflammatory response and multiple organ injury (23, 376). For instance, in the United States, 
sepsis incidence rates increased from 359 cases per 100,000 population in 2003 to 535 cases 
per 100,000 population in 2009 (a 49% increase), accounting for more than $20 billion (5.2%) 
of total United States hospital costs in 2011 (4, 6, 8). Although antibiotic treatment may 
efficiently eradicate the infection, it does not specifically reverse the systemic inflammation 
and its sequelae. A better understanding of the pathogenesis of sepsis is central to identifying 
novel targets for new therapeutic interventions designed to reverse systemic inflammation 
and its sequelae.  
H2S and SP act as proinflammatory mediators in both infectious and non-infectious 
inflammatory disease models such as sepsis (43, 197), acute pancreatitis (129, 377) and burn 
injuries (313, 378). For example, increased H2S-synthesising activity and plasma H2S levels 
were observed in CLP-induced sepsis and caerulein-induced acute pancreatitis (132, 177). 
Treatment with H2S donors such as NaHS and Na2S increased systemic inflammatory 
response, whereas the CSE inhibitor PAG protected against organ injury and inflammatory 
response in sepsis and acute pancreatitis (43, 44, 140, 177). Similarly, increased upregulation 
of SP and NK-1R activation have been reported in sepsis and acute pancreatitis. Treatment 
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with NK-1R antagonist and gene deletion of PPTA showed protection against organ injury, 
inflammation and systemic inflammatory response following sepsis and acute pancreatitis 
(195, 197). These results suggest that H2S and SP have a proinflammatory role in inflammatory 
diseases.  
Although H2S and SP are known proinflammatory mediators in experimental sepsis and other 
inflammatory disease models, their role in human sepsis has been poorly understood. One 
study has reported higher serum H2S levels in septic patients compared to non-septic and 
healthy subjects; however, this study was confined to a very small number of patients (n=5) 
(172). Similarly, previous studies have also reported circulatory SP levels in septic patients 
(201-203). For example, Arnalich et al. observed lower SP levels in plasma of both septic and 
septic shock patients (associated with infection) compared with healthy volunteers for all 
time points analysed (onset, 12 h and 24 h) (202). In contrast, Beer et al. observed higher 
serum SP levels in post-operative septic patients than in patients without post-operative 
sepsis, with similar malignant disease on all days analysed. However, when survivors and non-
survivors were compared, higher SP levels were only associated with lethal outcome during 
the late course of sepsis (203). In contrast, a recent study by Lorente et al. found that surviving 
septic patients showed higher serum SP levels than nonsurvivors (201). These studies, with 
small numbers of septic patients in the case of H2S, and controversial reports with SP, have 
clouded our understanding of the role of H2S and SP in septic patients. In addition, healthy 
controls are very different physiologically from patients who are acutely unwell. Acutely 
unwell non-septic patients experience a wide variety of activated stress responses that may 
modulate the response to sepsis. Therefore, studying role of H2S and SP in human sepsis 
(associated with infection) in comparison to patients with similar disease severity and organ 
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dysfunction from non-infectious complications is important in understanding the precise role 
of H2S and SP in sepsis.  
The objective of this study was to determine the circulatory H2S and SP levels in septic patients 
compared to patients with similar disease severity and organ dysfunction complications from 
non-infectious aetiology admitted to the ICU.  
8.2 Aims 
The aims of this study was to determine:  
1) The alteration in plasma H2S and SP levels in septic patients compared to non-septic 
patients in the acute phase of the illness; and  
2) The association between plasma H2S and SP levels and the inflammatory response in 
septic patients compared to non-septic patients. 
8.3 Experimental approach  
8.3.1 Design and subjects  
The study was approved by the Health and Disability Ethics Committee (HDEC), Wellington, 
New Zealand (protocol number 15/STH/36). This study was conducted on intensive care 
patients at Christchurch Hospital, New Zealand. Informed consent was obtained from patients 
in all cases. Where patients were unable to give consent, provisional consent was obtained 
from family members or friends and consent was reviewed with the patient when they 
recovered. The selection criteria was broadly based on those used for the Australasian 
Resuscitation in Sepsis Evaluation-Randomised Controlled Trial (ARISE-RCT) (379). All patients 
older than 18 years admitted to the ICU were included in the study, except those not expected 
to survive 72 h or when consent could not be obtained. Patients with suspected or confirmed 
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infection, systemic inflammatory response syndrome, evidence of either refractory 
hypotension or hypoperfusion and whose first dose of IV antimicrobial therapy commenced 
prior to randomisation were included in the sepsis cohort. Patients admitted to the general 
ICU without sepsis or other known inflammatory conditions with matched age, gender, 
severity of illness and organ dysfunction were included in the non-septic cohort. Patients aged 
below 18 years and with a contraindication to blood products, hemodynamic instability due 
to active bleeding, pregnancy (confirmed or suspected) and in-patient transfer from another 
acute health care facility were excluded from this study. Two independent investigators 
assessed patients for study eligibility according to the described criteria and collected data 
throughout the study period.  
All patients with sepsis and non-sepsis were treated by standard supportive treatment, fluid 
resuscitation, vasoactive drugs, medical and technological interventions for organ 
dysfunction or failure, and empirical antibiotic therapy according to hospital practice 
guidelines. Relevant clinical details were taken from hospital records and the interpretation 
discussed with Professor Geoffrey Shaw and Professor Stephen Chambers. Professor Geoff 
Shaw is an intensive care specialist with clinical and research interests in the area of sepsis 
and sepsis biomarkers and participated in study design, patient recruitment, and analysis of 
clinical data, and in dissemination of results. Professor Stephen Chambers is a physician 
researcher with interests in the area of infectious diseases and participated in study design, 
data analysis and dissemination of results.  
8.3.2 Variables recorded  
The following variables were recorded for each patient: age and sex, type of infection, Acute 
Physiology and Chronic Health Evaluation (APACHE) II and III Scores, Simplified Acute 
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Physiology Score (SAPS) II, while failure of organs and severity of MODS were evaluated by a 
Sequential (Sepsis-Related) Organ Failure Assessment (SOFA) Score. APACHE II and III and 
SAPS II were determined on the day of ICU admission whereas SOFA scores were determined 
daily on observation from day 0 to day 4 (1, 380).  
8.3.3 Blood sampling and laboratory assays  
Blood samples were collected from all ICU patients from the time of admission to 96 h, with 
collections at different time intervals (0 h, 12 h, 24 h, 48 h, 72 h and 96 h). Collection of blood 
samples were stopped if the patient was discharged from ICU to another hospital ward in 
between blood collection time points.  
 Blood samples from septic and non-septic patients were drawn through venipuncture, 
collected in a plastic tube containing EDTA, then immediately placed on ice. Assays for blood 
lactate and C-reactive protein (CRP) were performed at Canterbury Health Laboratory (CHL), 
Christchurch, New Zealand. Remaining blood samples were centrifuged at 1,000xg for 10 mins 
at 4oC and plasma was stored at -80oC for further analysis. Plasma H2S (Section 2.7), SP 
(Section 2.13), IL-6 (Section 2.12) and procalcitonin (PCT) (Section 2.14) levels were measured 
by the methods described in the Materials and Methods (Chapter 2).  
8.3.4 Statistical analysis 
All the data were analysed for Gaussian or Normal distribution using the Shapiro-Wilk test.  
Demographics were presented as means with a 95% confidence interval. Non-parametric 
Wilcoxon Rank Sum test was used to compare the medians of septic and non-septic groups 
(rather than means) when normality assumption was violated. When normality assumptions 
held, ordinary t-test was carried out to assess the statistical difference in means. A Repeated 
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Measures two-way ANOVA (RM-two-way ANOVA) was applied to compare two groups at 
different time points. P-values less than 0.05 indicated a significant difference between two 
groups. All statistical analysis were performed using SAS 9.3 and GraphPad Prism 6.07.  
8.4 Results  
8.4.1 Demographic characteristics of patients 
A total of thirty seven (n=37) patients were recruited for this study. Of these, fourteen 
patients (n=14) were non-septic and twenty three (n=23) were septic. There was no significant 
difference in the mean age of either of the two groups; however, a male predominance was 
seen in both groups. A summary of the major reasons for admission to ICU and infecting 
organisms identified are shown in Table 8.1. Detailed tables, including the major presenting 











Table 8.1 Characteristics of patients with non-sepsis and sepsis admitted to medical intensive care 
unit (ICU) during the 2015-16 study period. 
* Polymicrobial infection denotes when more than one organism was identified from a normally sterile 
site. Ten of these patients had peritonitis from intra-abdominal pathology, one Fournier’s gangrene 
and one with infection of ischium. ** No patient was not identified with any organisms.  
Characteristic Non-sepsis Sepsis 
Demographics 
Number of patients (N) N=14 N=23 
Age in years (Mean ± SD), (95% CI)  64.06 ± 2.73 
(59.56-68.56) 
63.92 ± 2.96 
(58.11-69.73) 
Male 10 12 
Female 4 11 
 
Major reasons for admission to ICU   
Post-coronary artery by-pass grafting 4  
Post-repair of aortic dissection  2  
Persistent seizures causing multiple fractures and soft  
tissue injury 
2  
Post-surgery aortic stenosis 1  
Cardiac arrest out of hospital causing brain injury 1  
Myocardial infarction  1  
Congestive heart failure 1  
Failed renal transplant 1  
Car crash causing multi-trauma  1  
   
Peritonitis of multiple causes  10 
Community-acquired pneumonia  6 
Fournier’s gangrene  1 
Necrotizing pancreatitis  1 
Pancreatitis, cholecystitis  1 
Septic arthritis  1 
Osteomyelitis and soft tissue infection   1 
Pyelonephritis with obstructed outflow tract  1 
Post-coronary artery by-pass surgery infection  1 
   
Type of microorganism causing sepsis 
Polymicrobial sepsis*  N=12 
Pseudomonas aeruginosa  N=4 
Candida albicans  N=1 
Cytomegalovirus  N=1 
Escherichia coli   N=1 
Klebsiella pneumoniae  N=1 
Legionella sp.  N=1 
Pantoea agglomerans  N=1 
No organism identified**  N=2 
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8.4.2 Comparison of disease severity and organ dysfunction between septic and non-septic 
patients  
Patient disease severity and organ dysfunction of both septic and non-septic patients are 
shown in Table 8.2. The APACHE II and III and SAPS II scores calculated at the time of ICU 
admission and SOFA scores (from day 0 to day 4 of ICU admission) were not statistically 
different between septic and non-septic patients. SOFA scores gradually decreased from day 
0 to day 4 in both septic and non-septic groups. Seven of the total thirty seven (7/37) patients 
died (four from the non-sepsis group and three from the sepsis group) during the observation 
period in the ICU.  
Table 8.2 Disease severity, organ dysfunction scores and mortality in septic and non-septic patients 
admitted to the medical intensive care unit (ICU) during the 2015-16 study period. 
 
Fourteen non-septic patients and twenty three septic patients were included in this study. There was 
no significant difference in APACHE II and III, SAPS II and SOFA scores between septic and non-septic 
patients. SOFA scores gradually decreased from day 0 to day 4 in both septic and non-septic groups. A 
total of seven patients (four from the non-septic group and three from the septic group) died during 
the observation period in the ICU. Results were expressed as mean ± S.E.M (n=14 with non-septic 
patients and n=23 with septic patients). Statistical significance between two groups was evaluated by 
ordinary t-test.  
Characteristic Non-sepsis Sepsis 
Disease severity and organ dysfunction scores (Mean ± S.E.M) 
APACHE II (Day 0) 21 ± 1.70 19.04 ±1.23 
APACHE III (Day 0) 77.76 ± 5.61 76.32 ± 5.44 
SAPS II (Day 0) 46.47 ± 3.02 45.26 ± 3.28 
SOFA (Day 0) 10.47 ± 0.68 9.04 ± 0.52 
SOFA (Day 1) 9.93 ± 0.94 7.94 ± 0.69 
SOFA (Day 2) 9.15 ± 0.93 7.13 ± 0.85 
SOFA (Day 3) 8.50 ± 1.04 5.80 ± 0.83 
SOFA (Day 4) 7.78 ± 1.49 6.77 ± 1.46 
 
Mortality (30 day mortality) 
Total patients  N=14 N=23 
Died 4 3 
Alive 10 20 
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8.4.3 Plasma H2S and SP levels in septic patients compared to non-septic patients  
Plasma levels of H2S and SP were measured in both septic and non-septic patients at various 
time points (from 0 h to 96 h). Septic patients showed higher H2S and SP levels compared to 
non-septic patients at every time point, except for H2S at 96 h. Plasma H2S levels were 
significantly higher at 12 h (1.45 vs 0.75; p<0.05) and 24 h (1.11 vs 0.72; p<0.01), whereas 
plasma SP levels were only significant at 48 h (0.55 vs 0.31; p<0.05) compared to non-septic 
patients.  
 
Figure 8.1 Plasma levels of H2S and SP in septic patients. Blood samples were withdrawn from 
intensive care septic and non-septic patients at different time intervals (0 h, 12 h, 24 h, 48 h, 72 h and 
96 h). Plasma was aspirated and H2S (A) and SP (B) levels were measured using spectrophotometric 
and SP immunoassay, respectively. Septic patients showed higher circulatory H2S and SP levels 
compared to non-septic patients, with differences in H2S levels being significant at 12 h and 24 h and 
with differences in SP levels being significant at 48 h. Graphs represent median with interquartile range 
(n=14 with non-septic patients and n=23 with septic patients). Repeated Measures two way ANOVA 
was used to plot the graphs and statistical significance between two groups at different time points 
was evaluated by non-parametric Wilcoxon Rank Sum test. Statistical significance was assigned as 







Table 8.3 Plasma H2S and SP levels in septic patients.   
Time Parameter Non-sepsis Sepsis P-value 
0 hours 
H2S (µM/mL) 1.01 (0.19 – 2.65) 1.06 (0.31 – 8.20) 0.5148 
SP (ng/mL) 0.19 (0.02 – 1.42) 0.58 (0.00 – 10.31) 0.2739 
 
12 hours 
H2S (µM/mL) 0.75 (0.22 – 1.49) 1.45 (0.31 – 11.52) 0.0215 
SP (ng/mL) 0.26 (0.13 – 1.24) 0.55 (0.00 – 10.79) 0.6915 
 
24 hours 
H2S (µM/mL) 0.72 (0.17 – 0.91) 1.11 (0.24 – 3.70) 0.0056 
SP (ng/mL) 0.43 (0.08 – 1.21) 0.53 (0.02 – 11.00) 0.5773 
 
48 hours 
H2S (µM/mL) 0.61 (0.10 – 2.42) 1.16 (0.21 – 23.07) 0.1184 
SP (ng/mL) 0.31 (0.01 – 1.41) 0.55 (0.17 – 18.39) 0.0473 
 
72 hours 
H2S (µM/mL) 0.52 (0.03 – 1.82) 1.16 (0.35 – 10.31) 0.0806 
SP (ng/mL) 0.29 (0.10 – 1.27) 0.88 (0.04 – 12.35) 0.1098 
 
96 hours 
H2S (µM/mL) 1.72 (0.17 – 4.11) 1.19 (0.55 – 4.14) 0.9247 
SP (ng/mL) 0.35 (0.17 – 1.15) 0.87 (0.02 – 2.36) 0.1200 
Blood samples were withdrawn from intensive care septic and non-septic patients at different time 
intervals (0 h, 12 h, 24 h, 48 h, 72 h and 96 h). Plasma was aspirated and H2S and SP levels were 
measured using spectrophotometric and SP immunoassay, respectively. Septic patients showed higher 
circulatory H2S and SP levels compared to non-septic patients, with differences in H2S levels being 
significant at 12 h and 24 h and with differences in SP levels being significant at 48 h. Statistical 
significance between two groups at different time points was evaluated by nonparametric Wilcoxon 
Rank Sum test. Results were expressed as median with range. (n=14 with non-septic patients and n=23 
with septic patients). P-values less than 0.05 were considered statistically significant.  
 
8.4.4 Plasma PCT, IL-6, CRP and blood lactate levels in septic patients compared to non-
septic patients.  
Septic patients showed higher plasma PCT, IL-6 and CRP levels at all time points except, at 96 
h in the case of PCT and IL-6. Although septic patients showed higher plasma PCT, IL-6 and 
CRP levels, these were not significant at all the time points when compared to non-septic 
patients. Plasma PCT levels in septic patients were significantly higher at 0 h (1.45 vs 0.75; 
p<0.05), whereas IL-6 levels were significantly higher at all time points except 96 h (0 h, 522.35 
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vs 144.05, p<0.0001; 12 h, 281.8 vs 94.26, p<0.001; 24 h, 198.7 vs 77.54, p<0.001; 48 h, 147.15 
vs 53.135, p<0.001; and 72 h, 103.4 vs 42.93, p<0.01) compared to non-septic patients.  
 
Figure 8.2 Plasma levels of PCT, IL-6, CRP and blood lactate in septic patients. Blood samples were 
withdrawn from intensive care septic and non-septic patients at different time intervals (from day 0 to 
day 4 at 0 h, 12 h, 24 h, 48 h, 72 h and 96 h). Plasma was aspirated and PCT (A) and IL-6 (B) levels were 
measured by immunoassay, while CRP (C) and lactate (D) levels were measured by spectrophotometric 
assay. Septic patients showed higher circulatory PCT and IL-6 levels compared to non-septic patients, 
with significance at 0 h for PCT and at 0 h, 12 h, 24 h, 48 h and 72 h for IL-6. Septic patients showed 
higher circulatory CRP levels compared to non-septic patients, with significance at day 0, day 1 and 
day 2. There was no difference between septic and non-septic patient blood lactate levels except at 
day 3 when being significantly higher levels were seen in septic patients. Graphs represent median with 
interquartile range (n=14 with non-septic patients and n=23 with septic patients). Repeated Measures 
two way ANOVA was used to plot the graphs and statistical significance between two groups at 
different time points was evaluated by non-parametric Wilcoxon Rank Sum test. Statistical significance 




In the case of CRP, septic patients showed significantly higher CRP values at day 0 (302.5 vs 
83, p<0.001), day 1 (339 vs 165, p<0.001) and day 2 (284 vs 195, p<0.05). In contrast, there 
was no difference in blood lactate levels between septic and non-septic patients, except at 
day 3 (1.1 vs 0.6, p<0.01) when they were significantly higher in septic patients.  
Table 8.4 Plasma PCT, IL-6, and CRP and blood lactate levels in septic patients.  
Time Parameter Non-sepsis Sepsis P-value 
0 hours 
PCT (pg/mL) 120.95 (66.86-145.2)  371.4 (72.93 – 4644.38) 0.0472 
IL-6 (pg/mL) 114.05 (9.31 – 403.3) 522.35 (119 – 8441.4) <0.0001 
CRP (mg/L) 83 (17 – 303) 302.5 (70 – 460) 0.0004 
Blood Lactate (mmol/L) 1.85 (0.4 – 6.0) 2.1 (0.4 – 6.5) 0.4686 
 
12 hours 
PCT (pg/mL) 121.5 (81.66 – 157.8) 414.5 (34.59 – 4953.19) 0.0513 
IL-6 (pg/mL) 94.265 (8.5 – 677.6) 281.8 (39.17 - 3965) 0.0010 
CRP (mg/L) - - - 
Blood Lactate (mmol/L) - - - 
 
24 hours 
PCT (pg/mL) 93.01 (39.86 – 141.3) 437 (28.21 – 5208.51) 0.0513 
IL-6 (pg/mL) 77.54 (8.64 – 219) 198.7 (59.37 – 1334) 0.0004 
CRP (mg/L) 165 (14 – 336) 339 (99 – 450) 0.0005 
Blood Lactate (mmol/L) 1.35 (0.5 – 7.5) 1.8 (0.5 – 5.6) 0.7799 
 
48 hours 
PCT (pg/mL) - - - 
IL-6 (pg/mL) 53.135 (11.92-135.2) 147.15 (25.17 – 945.20) 0.0004 
CRP (mg/L) 195 (7 – 313) 284 (111 – 497) 0.0187 
Blood Lactate (mmol/L) 1.1 (0.6 – 12.0) 1.4 (0.6 – 3.1) 0.6346 
 
72 hours 
PCT (pg/mL) - - - 
IL-6 (pg/mL) 42.93 (18.47 – 83.33) 103.4 (29.42 – 1088.2) 0.0041 
CRP (mg/L) 163 (18 – 306) 179 (57 – 374) 0.2465 
Blood Lactate (mmol/L) 0.6 (0.05 – 1.0) 1.1 (0.5 – 3.3) 0.0011 
 
96 hours 
PCT (pg/mL) - - - 
IL-6 (pg/mL) 48.69 (17.2 – 290.5) 91.3 (19.36 – 310.9) 0.1278 
CRP (mg/L) 166.5 (81 – 262) 165 (40 – 377) 0.9646 
Blood Lactate (mmol/L) 0.8 (0.5 – 1.5) 1.1 (0.7 – 2.9) 0.0976 
Blood samples were withdrawn from intensive care septic and non-septic patients at different time 
intervals (from day 0 to day 4 at 0 h, 12 h, 24 h, 48 h, 72 h and 96 h). Plasma was aspirated and PCT 
and IL-6 levels were measured by immunoassay, while CRP and lactate levels were measured by 
spectrophotometric assay. Septic patients showed higher circulatory PCT and IL-6 levels compared to 
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non-septic patients, with significance at 0 h for PCT and at 0 h, 12 h, 24 h, 48 h and 72 h for IL-6. Septic 
patients showed higher circulatory CRP levels compared to non-septic patients, with significance at 
day 0, day 1 and day 2. There was no difference between septic and non-septic patient blood lactate 
levels, except at day 3 when significantly higher lactate levels were seen in septic patients. Statistical 
significance between two groups at different time points was evaluated by non-parametric Wilcoxon 
Rank Sum test. Results were expressed as median with range. (n=14 with non-septic patients and n=23 
with septic patients). P-values less than 0.05 were considered as statistically significant.   
 
8.5 Discussion 
The studies described in Chapters 3 to 5 showed the proinflammatory role of CSE-derived H2S 
and the importance of H2S-mediated upregulation of SP in CLP-induced sepsis. In this chapter, 
the alteration of plasma H2S and SP levels in septic patients was described. The most relevant 
and new finding of this study shows that septic patients have higher circulatory H2S and SP 
levels than patients with similar disease severity and organ dysfunction from non-infectious 
complications. This study also suggests that there is a correlation of initial plasma H2S and SP 
concentrations and the inflammatory response in septic patients at the time of admission to 
the ICU.  
This is the first report to study alterations in plasma H2S levels in septic patients. The results 
of the present study demonstrate that septic patients have higher plasma H2S levels 
compared to non-septic patients without infectious complications, with peak values at 48 h. 
Circulatory SP levels followed a similar pattern to H2S levels: higher in septic patients than 
non-septic patients, with peak values at 48 h. Previously, circulatory SP levels have been 
assessed in septic patients; however, these studies mainly focused on comparison of septic 
patients with healthy controls, survival with non-survival septic patients and reported results 
contradict one another (201-203). For example, Arnalich et al. and Mpouzika et al. observed 
lower SP levels in septic patients than in control subjects (202). In contrast, Beer et al. found 
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higher serum SP levels in post-operative septic patients than control subjects and during the 
final phase of lethal sepsis (203). A recent study by Lorente et al. showed higher serum SP 
levels in survivor septic patients than non-survivors (201). None of these studies observed the 
association of SP concentrations in septic patients compared to patients with similar non-
infectious complications. This study shows, for the first time, that higher circulatory H2S and 
SP levels are associated with sepsis in a patient cohort with severe clinical conditions requiring 
admission to intensive care.  
Inflammation is an essential host defense mechanism required for protection against 
pathogenic microorganisms; however, an excessive inflammatory response is harmful to the 
host. In sepsis, there is a loss of homeostatic control over the inflammatory response 
mounted against an infectious agent, resulting in a proinflammatory, procoagulant state that 
can result in organ dysfunction and even death. The present study demonstrates that as 
mediators of inflammation, elevated plasma H2S and SP levels at initial time points are 
important for the host defensive mechanism to eradicate infections. However, overwhelming 
increases in circulatory H2S and SP levels exacerbate the systemic inflammatory response that 
leads to organ damage. Different experiments using mouse models (of CLP-induced sepsis) 
confirm the detrimental role of H2S and SP in sepsis (43, 126, 140, 177, 195, 197, 381). 
Increased tissue H2S-synthesising activity, plasma H2S levels and tissue and plasma SP levels 
were found following CLP-induced sepsis (177, 197). Administration of H2S donors such as 
NaHS and Na2S showed increased liver and lung inflammation and systemic inflammation 
whereas treatment with PAG and an NK-1R antagonist showed protection against CLP sepsis-
induced organ injury and inflammation (44, 140, 195). The results with CSE KO mice described 
in Chapters 3 and 4 and previous studies with PPTA KO mice showed protection against CLP 
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sepsis-induced organ injury and inflammation (199, 200). Together, the results of the present 
study suggest that alteration in circulatory H2S and SP levels in septic patients are consistent 
with results from experimental sepsis studies and that these mediators play an important role 
in the inflammatory process of sepsis in both experimental and human sepsis. 
The present study documented the severity of the disease and multiple organ dysfunction in 
both septic and non-septic patients at presentation to the ICU and over the course of the 
admission. As expected, there was no significant difference in disease severity and organ 
dysfunction scores such as APACHE II and III, SAPS II and SOFA between these two groups and 
as expected. SOFA scores gradually decreased from day 0 to day 4 as the patients improved. 
These results demonstrate that a severely disordered physiological response and organ 
dysfunction alone are not associated with changes in circulatory levels of H2S and SP but, are 
specific to the inflammatory response. Therefore, non-septic patients served as an 
appropriate control group.  
Altered plasma H2S and SP levels are positively correlated with PCT and CRP levels in septic 
patients. CRP is an acute reactant protein commonly used to detect inflammation caused by 
different aetiologies, including sepsis (382, 383). On the other hand, it is well known that 
elevated levels of plasma PCT positively correlate with severity of infection. Over the last 
decade, PCT has grown increasingly popular as a diagnostic marker for bacterial infections 
and, it has been suggested, is more helpful than CRP (384, 385). Various recent studies also 
confirm the significant relationship between elevated plasma PCT levels and inflammatory 
response in sepsis (386-390). Results of the present study show that septic patients have 
higher plasma levels of both CRP and PCT, with peak values at day 1 (24 h) and 48 h, 
respectively. Although septic patients have higher plasma CRP levels, altered patterns of CRP 
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levels were not closely correlated with plasma H2S and SP levels; alternatively, PCT levels 
follow H2S and SP levels more closely. Plasma H2S, SP and PCT levels gradually increased from 
0 h to reach peak values at 48 h, then decreased thereafter to 96 h. These results suggest that 
in septic patients elevated circulatory PCT levels are more strongly correlated with H2S and SP 
levels than are CRP levels. These results confirm that higher circulatory H2S and SP levels are 
more strongly induced in septic patients than in patients with non-infectious complications.  
The present study also demonstrated alterations in plasma IL-6 levels, which correlated with 
plasma H2S and SP levels in septic patients. IL-6 serves as both a marker and mediator for 
severity of sepsis and is a predictor of early-phase acute response in septic patients. Several 
reports indicate that plasma IL-6 may be used as a diagnostic marker for the presence of 
bacteremia (391-393). The results of the present study showed higher plasma IL-6 levels in 
septic patients compared to non-septic patients at the time of admission (0 h) to the ICU. 
However, IL-6 levels gradually decreased from 0 h to 96 h and at 96 h there was no significant 
difference between septic and non-septic patients. Although septic patients showed higher 
plasma IL-6 levels, there was no correlation between IL-6 and altered H2S and SP levels. In 
contrast to IL-6, H2S and SP levels gradually increased from 0 h to 48 h, then decreased 
towards 96 h. Together, these results suggest that IL-6 may be used clinically as an early stage 
predictor of sepsis, while H2S and SP become elevated at a later stage (within 48 h) of the 
inflammatory response in septic patients.  
The alteration of plasma H2S and SP levels in septic patients followed two phases. In the first 
48 h of the ICU admission, plasma H2S and SP levels gradually increased from 0 h, reaching 
peak values at 48 h. During the second phase, between 48 h and 96 h, levels gradually 
decreased and at 96 h there was no difference. In addition, an increase in H2S levels preceded 
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increases in SP levels, as shown in previous studies on experimental sepsis (141). Based on 
these observations, it is reasonable to assume that during the early stages of infection or 
sepsis, elevated H2S and SP levels from activated immune cells are essential to achieve 
adequate host defense against invading pathogens. At later stages of infection, resolution of 
inflammation and restoration of normal tissue function are critical events following the 
clearance of the infectious agent. The pattern of decreased PCT and CRP levels and SOFA 
scores, along with H2S and SP levels, was consistent with the resolution of inflammation and 
restoration of normal tissue function at later stages (after 48 h) of sepsis.  
This study was not powered to find which concentrations of H2S and SP would predict the 
onset or prognosis of sepsis; both the small number of patients and the heterogeneous nature 
of patients admitted to intensive care did not allow for such interpretation. Although septic 
patients showed higher circulatory H2S and SP levels and a positive correlation with sepsis, 
these mediators were not significant at all time points. In addition, the initial height of H2S 
and SP concentrations (0 h to 48 h) did not correlate with the later course of the disease (48 
h to 96 h). Therefore, further studies with a larger sample size, that would allow subset 
analysis of separate causes of sepsis such as pneumonia or abdominal sepsis, are required to 
predict significance and prognostic importance of H2S and SP in human sepsis.  
In conclusion, for the first time, this study shows that higher circulatory H2S and SP levels are 
associated with the inflammatory response in septic patients. The results show that H2S and 
SP are important in clinical sepsis and that increases in H2S levels precede those in SP levels, 
as they are in experimental sepsis. Therefore, alteration in circulatory H2S and SP levels may 
be of pathological significance in septic patients and research into modifications in H2S and 




General discussion, conclusions and future perspectives 
 
9.1 General discussion 
The objective of this study was to investigate the role of the endogenous H2S, SP and Kupffer 
cells on the inflammatory response, organ injury and LSEC fenestration following CLP-induced 
sepsis. Further, this thesis investigated alteration of circulatory H2S and SP levels and their 
possible association with the inflammatory response in septic patients.  
The first part of the thesis (Chapters 3 to 5) examined whether endogenous CSE-derived H2S 
would affect the inflammatory response and organ injury following sepsis. These chapters 
also examined the mechanisms by which CSE-derived H2S regulates inflammation and 
interaction between H2S and SP in sepsis. The intensity of systemic inflammation was 
evaluated by tissue MPO activity, a marker of leukocyte infiltration, while the severity of 
MODS was evaluated by histology. It was found (Chapter 3) that CLP-induced sepsis resulted 
in a significant increase in CSE protein expression in liver and lung tissues, H2S-synthesising 
activity in the liver and H2S levels in the plasma suggesting increased endogenous H2S 
synthesis by CSE following CLP-induced sepsis. For the first time, the present study revealed 
that mice with CSE gene deletion have less sepsis-associated systemic inflammation and 
organ injury (liver and lung oedema and necrosis). Although previous findings using the CSE 
inhibitor PAG have showed protection against CLP sepsis-induced systemic inflammation and 
organ injury, these studies have limitations due to the non-specific actions of PAG such as 
inhibition of ALT and AST enzyme activities that are unrelated to CSE enzyme inhibition (140, 
174, 177, 265, 266, 277). In addition, dosage regime, route and time of administration of H2S 
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donors and inhibitors activate or inhibit different signalling pathways, which in turn produce 
either a pro- or anti-inflammatory effect in sepsis. The results in Chapter 3 have demonstrated 
that CSE-derived H2S plays an important role in regulating leukocyte infiltration and 
associated liver and lung injury.  
To further elucidate the role of CSE-derived H2S in sepsis, the association between cytokine 
and chemokine expression and the involvement of ERK1/2-NF-B signalling with increased 
endogenous H2S in sepsis was investigated (Chapter 4). It was found that mice with CSE gene 
deletion had lower proinflammatory cytokine (TNF-α, IL-6 and IL-1β) and chemokine (MCP-1 
and MIP-2α) generation following sepsis, which is consistent with data on tissue MPO activity 
and liver and lung organ injury. In addition, mice deficient in the CSE gene not only had less 
ERK1/2 phosphorylation, but also reduced NF-B p65 activation. These results demonstrated 
for the first time that temporal regulation of CSE expression, H2S-synthesising activity and H2S 
levels correlate with the activation of ERK1/2-NF-B p65 signalling. Although previous studies 
using PAG and H2S donors such as Na2S, NaHS and GYY4137 have investigated the 
mechanisms involved in the H2S-mediated inflammatory response in sepsis, these studies 
suffered due to the limitations of PAG and H2S donors, as described in Section 1.6 (Chapter 1) 
(43, 44, 129, 133, 172, 176, 265-267, 313, 317). Together, these findings suggest that 
increased CSE-derived H2S in sepsis may participate in the phosphorylation of ERK1/2 and 
thereby promote activation of NF-B p65, leading to increased production of 
proinflammatory mediators and exacerbating systemic inflammation and multiple organ 
damage.  
Further investigation then focused on the relationship between H2S and SP in sepsis (Chapter 
5). Mice with CSE gene deletion showed less SP production and NK-1R protein expression 
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following sepsis. These results are consistent with previous studies with PAG (141) and 
suggest a potential linkage between CSE-derived H2S and the production of SP and 
subsequent activation of NK-1R in sepsis.  
Together, results from the first part of the thesis (Chapters 3 to 5) suggest that increased CSE-
derived H2S regulates inflammatory response and organ damage, both directly and indirectly, 
following sepsis. Through activation of the ERK1/2-NF-B p65 signalling pathway and 
subsequent release of proinflammatory cytokines and chemokines, H2S directly regulates 
inflammation and organ damage following sepsis. Indirectly, H2S increases proinflammatory 
cytokine and chemokine generation by upregulating SP production and subsequent NK-1R 
activation following CLP-induced sepsis.  
The second part of the thesis (Chapter 6) explored the role of Kupffer cells in sepsis-associated 
liver and lung injury, inflammation and the systemic inflammatory response. This is the first 
study to report the significance of Kupffer cell inactivation on multiple organ damage and 
systemic inflammatory response following CLP-induced sepsis. GdCl3 pretreatment resulted 
in protection against sepsis-induced liver injury and inflammation as evidenced by a decrease 
in liver MPO activity, liver necrosis and oedema and liver proinflammatory cytokines and 
chemokines. In contrast, GdCl3 pretreatment failed to protect against sepsis-induced lung 
injury and inflammation, and the systemic inflammatory response. However, previous 
research has reported results contradictory to the present experiments; this could be due to 
differences in the experimental animal disease model and dosage regime of GdCl3 (220, 223-
225, 228, 237-239). The results from the present experiments suggest that GdCl3 




The results from the first two parts of the thesis (Chapters 3 to 6) suggest the significance of 
both CSE-derived H2S and Kupffer cells in the inflammatory process during sepsis. Although 
Kupffer cells are crucial in trafficking pathogenic substances and subsequent local and 
systemic inflammatory response, inactivation of Kupffer cells by GdCl3 selectively protects 
mice against liver inflammation and injury, whereas CSE gene deletion protects against liver 
and lung inflammation, injury and the systemic inflammatory response in sepsis.  
The third part of the thesis (Chapter 7) examined structural changes in LSEC fenestrae 
following CLP-induced sepsis and the effect of GdCl3, CSE gene deletion and PPTA gene 
deletion on CLP sepsis-induced structural changes in LSEC fenestrae. This is the first study to 
report the importance of H2S, SP and Kupffer cells on CLP sepsis-induced structural changes 
in LSEC fenestrae. Mice with CLP-induced sepsis showed defenestration (decreased diameter, 
frequency and porosity) and increased formation of gaps in LSEC fenestrae. These results are 
consistent with previous studies, which showed the release of proinflammatory mediators 
and the inflammatory response are associated with infection and endotoxaemia leading to 
defenestration in LSECs (235, 261, 262, 352, 353, 394, 395). In this study, mice pretreated 
with GdCl3, CSE gene deletion and PPTA gene deletion showed less defenestration and fewer 
gaps formation in LSEC fenestrae following sepsis. Together, these results suggest the 
importance of inflammatory mediators released by activation of Kupffer cells, H2S and SP 
during sepsis as they may play a role in the regulation of LSEC fenestrae.  
The final part of this thesis (Chapter 8) examined the alteration of circulatory H2S and SP levels 
in patients with sepsis admitted to the ICU. The is the first study to report an alteration in 
circulatory H2S levels in septic patients and the possible association between circulatory H2S 
and SP levels and the inflammatory response as compared to patients with similar disease 
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severity and organ dysfunction from non-infectious complications. The results showed that 
septic patients have higher circulatory H2S and SP levels and that these are associated with 
the inflammatory response in septic patients. Furthermore, these results shed light on the 
correlation between experimental sepsis and human sepsis with regard to the 
proinflammatory role of H2S and SP.  
9.2 Conclusions and future perspectives  
The work of this thesis shows the importance of the CSE-derived H2S, SP and Kupffer cells in 
mediating the regulation of the inflammatory response, organ injury and structural changes 
in LSEC fenestrae in sepsis. Increased CSE-derived H2S may upregulate the systemic 
inflammatory response and thus contribute to organ damage in sepsis. For instance, it may 
provoke the production of proinflammatory mediators (cytokines and chemokines) as well as 
leukocyte trafficking via the activation of the ERK1/2-NF-B p65 pathway. It may also 
stimulate the generation of SP and subsequent NK-1R activation, which aggravate liver and 
lung inflammation and injury. Furthermore, increased CSE-derived H2S and SP may cause 
defenestration and the formation of gaps in LSEC fenestrae. As a result, inhibition of the 
proinflammatory effect of the CSE-derived H2S through a CSE gene knockout approach seems 
to protect animals against the sepsis-associated inflammatory response, organ injury and 
defenestration in LSECs. Furthermore, inactivation of Kupffer cells using GdCl3 may protect 
against liver injury, inflammation and LSEC defenestration in sepsis.  
This thesis also shows the significance of circulatory H2S and SP on the inflammatory response 
in septic patients. Higher circulatory H2S and SP levels may be associated with the 
inflammatory response in septic patients.  The schematic summary of the thesis conclusions 
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depicted in Figure 9.1 
 
Figure 9.1 Schematic summary of the role of CSE-derived H2S, SP and Kupffer cells in sepsis. Sepsis 
results in increased CSE protein expression, H2S-synthesising activity and H2S levels. Increased 
endogenous H2S through CSE stimulates the activation of ER1/2, which subsequently activates the NF-
B. As a result, the transcription of genes for proinflammatory mediators is upregulated. The amplified 
production of cytokines and chemokines, together with the augmented leukocyte infiltration, 
aggravates the systemic inflammatory response in sepsis, exacerbating sepsis-associated multiple 
organ failure. The CSE-derived H2S can also provoke the production of SP and NK-1R expression, which 
worsen systemic inflammatory response and organ injury by leukocyte chemotaxis and cytokine 
release. Sepsis also leads to the increased activation of Kupffer cells, which leads to the production of 
proinflammatory cytokines and chemokines, causing liver and lung injury, inflammation and systemic 
inflammatory response in sepsis. Increased H2S and SP production and Kupffer cell activation also cause 
liver sieve injury by increasing defenestration and gaps formation in LSEC fenestrae.  
 
The important contributions of this study are that it: 
 Demonstrates the proinflammatory role of the CSE-derived H2S in CLP-induced sepsis 
160 
 
and associated organ injury;  
 Presents mechanisms by which CSE-derived H2S modulates the inflammatory 
response and may contribute to a better understanding of the proinflammatory role 
of the H2S in inflammatory diseases; 
 Demonstrates that Kupffer cells are important in modulating hepatic injury following 
various potentially hepatotoxic insults but it appears that they have little effect on 
other organs, e.g., lung;  
 Demonstrates for the first time the role of Kupffer cells, CSE-derived H2S and SP on 
CLP sepsis-induced structural changes in LSEC fenestrae; and  
 Demonstrates for the first time the alteration of circulatory H2S levels in septic 
patients and a possible association between altered circulatory H2S and SP levels and 
inflammatory response in septic patients.  
 
As research in this area is still at an early stage, several key aspects are recommended for 
exploration in future studies:  
 The work presented in this study was limited to only one time point (8 h post-CLP) and 
represents changes that occur at that point only. Studying time-dependent changes in 
the inflammatory response, organ injury and structural changes in LSEC fenestrae for 
longer periods (at multiple time points) using same CLP model would lead to a better 
understanding of the roles of CSE-derived H2S, SP and Kupffer cells in sepsis.  
 The mechanisms by which CLP sepsis-induced upregulation of CSE is not known. A 
recent study has demonstrated the potential role of microRNA (miR-21) in specificity 
protein-1 (SP1)-mediated regulation of CSE gene expression in smooth muscle cells 
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(309); however, further experiments need to be performed using CLP sepsis model to 
determine whether sepsis modifies these elements in the CSE promoter region and 
therefore increases the expression.  
 The mechanisms involved in CSE-derived H2S-mediated activation of ERK-1/2 and NF-
B p65 and SP remain unknown. Recently, Sen et al. have reported that H2S activates 
NF-B by sulfhydrating the cysteine residues or other sites of the p65 subunit of NF-
B and thereby elicits the transcriptional activation of proinflammatory genes (327). 
Furthermore, H2S may induce NF-B activation through mechanisms other than 
ERK1/2 phosphorylation. For example, it has been shown that H2S induces a dose-
dependent increase in intracellular calcium ions (Ca+2) and PKA, which facilitate NF-B 
translocation into the nucleus where it binds to DNA in microglial cells (114). These 
mechanisms are yet to be investigated in CLP-induced sepsis. In addition, it is not clear 
that whether pathophysiological action of H2S are mainly due to its direct effect or 
substances derived from H2S. This is a current challenge in this field because of 
complexity of H2S signalling and needs to be further investigated.  
 The role of GdCl3 in differential regulation of inflammation and organ injury in sepsis 
are unclear. Further investigations to understand the mechanisms in differential 
regulation of Kupffer cell mediated inflammation and multiple organ injury are 
required.  
 The mechanisms by which CSE-derived H2S, SP and Kupffer cells mediate structural 
changes in LSEC fenestrae in sepsis are unknown. One possible mechanism is 
structural alteration in cytoskeleton of LSEC fenestrae by H2S and SP and the 




 The present study showed that higher circulatory levels of H2S and SP in patients with 
sepsis admitted to the ICU; however, this study was limited by the small number of 
patients recruited into the study. Further investigations with large number of patients 
and using specific H2S inhibitors and donors and SP activators are required to 
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11 Appendix  
11.1 Summary of primary diagnosis, complications and comorbidities of patients 
with non-sepsis admitted to the ICU during the 2015-16 study period.  
 
Non-Sepsis cohort  
 Primary diagnoses  Complications Comorbidities  
 
1 Failed living donor renal 
transplant  
Pulseless electrical activity 
cardiac  arrest, Fast atrial 
fibrillation, Bowel Ileus and 
Wound dehiscence 




gout, asthma and 
hyperparathyroidism  
 
1 Car crash Multi-trauma Nil 
2 Cardiac arrest out of 
hospital 
Traumatic brain injury and 
subarachnoid haemorrhage 
Splenic lymphoma,  
diverticular disease and 
prostate cancer 
4 Myocardial infarction Refractory ventricular 
tachycardia 
Nil 
5 Congestive heart failure Hypotension Susac syndrome, non-Hodgkin’s 
lymphoma, gout, autologous bone 
marrow transplantation and 
chronic renal impairment 
6 Post-coronary artery by-
pass grafting 
Hypotension Hypertension and goitre 
 
7 Post-coronary artery by-
pass grafting 
Hypotension Myocardial infarction, 
atrial fibrillation, 
hypercholesterolemia and  
ischaemic cardiac myopathy 
8 Post-coronary artery by-
pass grafting 
Asystolic cardiac arrest Hypertension, hyperlipidaemia 
and high Body Mass Index (BMI)  
9 Post-coronary artery by-
pass grafting 
Required re-exploration of 
surgical site 
Ischaemic heart disease, type 2 
diabetes, obesity and 
hyperlipidaemia  
 
10 Post-type A aortic 
dissection-repair 
Ventricular tachycardia, cardiac 
arrest, multifocal cerebral 
infarcts and right sided 
hemiplegia 
Hypertension, pyelonephritis and 
high BMI 




infarction,  hypothyroidism and 
cerebrovascular accident 
 
12 Post-surgery for Type A 
aortic dissection 
Hypotension Prostate cancer and myocardial 
infarction 
13 Glioblastoma with 
seizures  
Aspiration lung injury Hypertension 
14 Astrocytoma causing 
status epilepticus  
Multi-trauma Hypertension 
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11.2 Summary of primary diagnosis, complications and comorbidities of patients 
with sepsis admitted to the ICU during the 2015-16 study period.  
 
Sepsis-cohort  
S. no Primary diagnoses  Complications Comorbidities  
 
1 Perforated appendix  Peritonitis  Prior sleeve gastrectomy surgery 
2 Perforated bowel  Peritonitis and left 
pneumothorax 
Atrial fibrillation, ischemic heart disease 
and dyslipidaemia  
3 Sigmoid perforation  and 
Hartmann’s procedure 
Faecal peritonitis  Chronic obstructive pulmonary disease 
(COPD) and hypertension 
 
4 Sigmoid tumour and 
Hartmann’s procedure 
Peritonitis  Myocardial infarction, ischaemic heart 
disease, hypertension and dyslipidaemia 
 
5 Perforated diverticulum, 
emergency Hartmann’s 
procedure 
Peritonitis Alport syndrome and hypertension 
6 Perforation sigmoid colon 
and post laparoscopic 
hernia repair 
Peritonitis and 
candidaemia   
Cervical cancer 





8 Perforated diverticulitis  
 
Peritonitis Obstructive sleep apnea, obesity, previous 
pancreatitis, hypertension, 
cerebrovascular accident, atrial fibrillation 
and type 2 diabetes mellitus  
9 Resection of ischaemic 
small bowel and loop 
ileostomy 
Peritonitis  Previous Roux en Y for Candy Cane 
syndrome, Sphincter of Oddi dysfunction, 
diverticulosis,  
malnutrition and bipolar disorder 
10    
11 Fourniers gangrene   Type 2 diabetes 
12 Pancreatitis Cholecystitis and 
hepatobiliary sepsis 
Ischaemic heart disease, heart failure, 
hypercholesterolemia, diverticulosis and 
chronic obstructive pulmonary disease 
13 Necrotising pancreatitis  Previous trans urethral prostatectomy and 
lumber disc prolapse 
14 Osteomyelitis and soft 
tissue infection left ischial 
tuberosity. 
Type I respiratory 
failure 
T8 paralgia, biventricular pacemaker,  
cerebrovascular accident, obstructive sleep 
apnea obesity, melanoma hyperlipidaemia, 
colostomy, nissen fundoplication, 
depression and cholecystectomy 
15 Post-operative coronary 
artery bypass grafting  
Candidaemia  Ischaemic heart disease, COPD; chronic 
kidney disease and left ventricular ejection 
fraction (LVEF) <25% 
16 Pelvic ureteric junction  
obstruction of kidney 
Pyelonephritis Renal calculi and glomerulonephritis 
17 Septic arthritis knee Pneumonia Chronic kidney impairment 
18 Community-acquired 
pneumonia 













 Myocardial infarction and atrial fibrillation 
22 Community-acquired 
pneumonia  
Lung abscess Nil 
23 Community-acquired 
pneumonia 
Pulmonary oedema Ischaemia heart disease, Coronary artery 
bypass grafting (CABG), obstructive sleep 
apnoea, COPD and increased BMI 
  
 
 
